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Abstract 
This study explored the role of the research nurse in New Zealand (NZ) Level III intensive 
care units (ICU).  Little was known about this role in NZ prior to this study.  A qualitative, 
descriptive approach, using semi-structured interviews was used.  The study was conducted 
in six Level III ICUs throughout NZ, who employed a research nurse.  Interviews were 
conducted with research nurses (n = 11), the doctors they work with (principal investigators) 
(n = 6) and nurse managers (n = 6) for the ICUs, and the findings were triangulated.  The 
views across all ICUs and stakeholders were generally similar, with differences only being 
in some operational areas.  This study found that the primary role of the research nurse was 
trial management, where they coordinated all elements of trial conduct.  Almost half of the 
research nurses were also involved in trial design through their positions on management 
committees.  Research nurses also played a vital role in patient and trial advocacy, and they 
bridged the knowledge gap by bringing research to staff nurses, patients and their families.  
The issue of consent for clinical trials in the ICU setting was significant, as this was a 
process which research nurses were very involved in.  Consenting patients was a shared 
responsibility of research nurses and doctors.  There was a perception that research nurses 
were senior nurses, but not necessarily because of their role in research.  The majority of 
research nurses reported to a nursing line manager, and also had an informal accountability 
to the principal investigator (PI).  Research nurses and PIs worked closely in the pursuit of 
rigorous research for ICU patients, and research nurses were highly regarded by PIs.  This 
study provides clarity about the research nurse‟s role and showcases their key contribution 
in ensuring that NZ ICUs undertake high quality research, thus contributing to potential 
improvements for future patients‟ outcomes. 
 
Keywords: Research nurse, research coordinator, intensive care, role, New Zealand, 
descriptive methodology  
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Glossary 
Associate Charge Nurse 
Manager (ACNM) 
Senior nurse who provides clinical coordination and 
leadership, and manages resources for a shift.  Also called 
„charge nurse‟.  Reports to the nurse manager.1 
Adverse Event Any untoward event or symptom either related to or not 
related to the study treatment.
2
 
ANZICS Australia and New Zealand Intensive Care Society.  A 
professional body for intensivists
3
. 
Blinded Where one or more parties are kept unaware of whether a 
subject is on a study treatment or control arm.
4 
 
Case Report Form (CRF) An electronic or paper form to record all information, 
including data for a study subject.
4
 
Central Venous Line (CVL) An intravenous catheter which is inserted into a large vein. 
CICM College of Intensive Care Medicine.
5 
The body which 
provides training, education and professional development 
for intensivists. 
Clinical Director Senior medical officer in charge of the ICU. 
Competence “A legal term used to denote capacity to act on one‟s own 
behalf, the ability to understand information presented, to 
appreciate the consequences of acting (or not acting) on that 
information, and to make a choice.”  (p. 99)2 
CTG ANZICS Clinical Trials Group.  A collaborative group of 
intensivists and researchers committed to conducting high 
quality research in ICU.
6
 
Full Time Equivalence 
(FTE) 
The proportion of a full-time (40 hour) working week.  1.0 
FTE is full-time. 
GCP Good clinical practice (also called „Good clinical research 
practice‟ and International Conference on Harmonisation 
good clinical practice [ICH-GCP]).  An international standard 
for the  ethical conduct of clinical research.
4
 
HDEC New Zealand Health and Disability Ethics Committee
2
 
Incompetence (or 
incapacity) 
A legal term meaning an inability to manage one‟s own 
affairs 
2
.  Patients in ICU are often termed „incompetent‟ due 
to their severity of illness, and level of consciousness 
(resulting from their illness, or induced through to sedation)  
Nurse Manager (NM) Clinical leader for nurses.  Has overall responsibility for ICU 
nursing staff and provides professional leadership to nursing 
staff.  Manages systems, processes and resources.
1
 
Monitor Also called „Study monitor‟.  The person who oversees the 
conduct of a trial, and ensures that it complies with GCP 
guidelines.
4
 
  
x 
NZNO New Zealand Nurses Organisation.  A professional body and 
union for nurses in NZ.
7
 
Protocol Also called study protocol.  “A document that describes the 
objective(s), design, methodology, statistical considerations, 
and organization [sic] of a trial” (p.10).4 
Protocol violation or 
deviation 
An incident where the protocol is not adhered to. 
RAM Responsibility Assignment Matrix
8
 
Reportable event Any adverse event which puts a patient or staff member at 
risk, or has the potential to do so. 
Serious Adverse Event “Any untoward medical occurrence that at any dose; results 
in death, is life-threatening, required inpatient hospitalization 
[sic] or prolongation of existing hospitalization, results in 
persistent or significant disability/incapacity or is a 
congenital anomaly/birth defect” (p. 9 - 10).4 
Screening log The log which is kept and reported to the sponsor, of all 
patients who were considered for a clinical trial, but were 
excluded. 
Sponsor “An individual, company, institution or organization which 
takes responsibility for the initiation, management, and/or 
financing of a clinical trial” (p. 10).4 
Subinvestigator “Any individual member of the of the clinical trial team 
designated and supervised by the investigator at a trial site to 
perform critical trial-related procedures and/or make 
important trial-related decisions” (p. 10).4 
Adapted from: 
1 District Health Boards/New Zealand Nurses Organisation.  (2012). District Health Boards/New 
Zealand Nurses Organisation Multi-employer collective agreement 2011 - 2015.  Retrieved 23 July, 
2012, from http://www.nzno.org.nz/dhb  
2 Ministry of Health.  (2006). Operational standard for ethics committees.  Retrieved 10 November, 
2011, from 
http://www.ethicscommittees.health.govt.nz/moh.nsf/pagescm/6777/$File/OperationalStandard2006.p
df 
3 Australian and New Zealand Intensive Care Society. (2010). 'About us' webpage.  Retrieved 30 
November, 2010, from http://www.anzics.com.au/about-us 
4 European Medicines Agency. (2002). Note for guidance on good clinical practice Step 5.  Retrieved 
10 May, 2012, from 
http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC5000028
74.pdf 
5 College of Intensive Care Medicine. (2012). 'About us' webpage.  Retrieved 12 June, 2012, from 
http://www.cicm.org.au/aboutus.php 
6 Clinical Trials Group. (2010). CTG website.  Retrieved 30 November, 2010, from 
http://www.anzics.com.au/clinical-trials-group 
7 New Zealand Nurses Organisation (2009) Home page.  Retrieved 29 July, 2012, from 
http://www.nzno.org.nz/ 
8 Project Management Institute. (2008). A guide to the project management body of knowledge 
(PMBOK guide). PA: Project Management Institute.
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Chapter 1     Introduction  
Intensive care is an environment in which highly skilled healthcare professionals work 
together to provide high quality care to critically ill patients, to give them the best chance of 
survival, long-term quality of life, or a dignified death.  Intensive care research has the 
capacity to improve patient-centred outcomes and quality of life for future intensive care 
unit (ICU) patients.  Conducting research in ICU is challenging, as the patients are amongst 
the sickest and most vulnerable in the healthcare system.  Research nurses play a key role in 
overcoming these challenges and „making research happen‟ in the ICU.  This thesis reports 
on a study that explores the role of research nurses in New Zealand (NZ) ICUs. 
 
This chapter introduces the research question, aims and objectives for the study.  The 
background about the impetus for this study is provided, then how the research question was 
formulated.  The setting and design is then outlined, key terms are introduced and an 
overview of the thesis is given. 
  
This study is important because many ICUs in NZ employ research nurses to assist in 
conducting clinical research trials.  However, little is known about the details of the role and 
work of research nurses and their contribution to ICU patient care in NZ.  While there is 
international data about the role in general, much of it has been undertaken in populations 
with less acutely unwell participants.  Studies set in Australian ICUs included NZ 
respondents; however, NZ has been grouped with Australia in analysing the role.  This 
study will add to a growing body of knowledge about the role of the research nurse, and 
describe the role in an acute clinical setting.  Describing what research nurses do, will also 
be a first step to understanding the role, enabling future development of the role including 
career pathways and professional opportunities.   
 
Research nurses have various titles including research nurse, clinical research nurse, 
research coordinator and specialty nurse research.  But do they share the same role and do 
they all do the same work?  What is that work, and what is important about the work they 
do?  This study sought to examine the role of the research nurse in the research process, and 
was designed to examine the role from the perspective of the research nurse themselves, the 
doctor they work closely with (principal investigator) and their nurse manager. 
2 
Research question 
The research question for this thesis is „What is the role of the Research Nurse in New 
Zealand Level III Intensive Care Units?‟   
Aims and objectives of this study 
Aims 
This study aims primarily to describe the role and responsibilities of the ICU research nurse.  
This will enable increased understanding of the role and the contribution research nurses 
make to research and patient care in ICU.  A secondary aim is to describe the structures and 
funding arrangements of the research departments the research nurses work in.  This study 
does not aim to assess whether one version of the role is better than another but describes 
the role from different perspectives, thus allowing the reader to decide if the role within a 
particular ICU aligns to their beliefs. 
Objectives 
The objectives were to gather data about the research nurse role from three different 
participant groups; Research Nurses, Principal Investigators and Nurse Managers, by way of 
semi-structured interviews.   
It was expected that this research would: 
 Describe the demographics of research nurses currently working in NZ ICUs 
 Identify important components of the role, the work they do and how different this 
was across NZ  
Secondary objectives were to: 
 Identify the structure of the individual ICU research departments 
 Identify key relationships pertinent to the research nurse role 
 Examine the similarities and differences about the role between professional groups 
 Examine the similarities and differences about the role within ICUs. 
Background 
ICU is a clinical area I know well, having worked as a staff nurse, clinical nurse coordinator 
(equivalent to associate charge nurse manager [ACNM]) and since 2007 as a research nurse.  
As an ICU research nurse working in a Level III NZ ICU, I am an insider in this study.  The 
implications of this to the study are discussed in Chapter 4.  The majority of my work 
involves managing clinical trials and I also advise and assist nurses and doctors with their 
3 
research and audit projects.  There has been someone assisting with research in this ICU 
since the 1990s.  Initially this was an ICU technician (F. Fitzjohn, personal communication, 
26
th
 April, 2012) then from 2003 until 2006, research was managed by a staff nurse 
seconded part-time from ICU clinical work.  The position of „Clinical Research Nurse‟ was 
first formally established in July 2006 and in 2008, the role title was changed to „Specialty 
Nurse Research‟ and the current position was established.  The role was recognised as a 
designated senior nurse position at the same time (District Health Boards/New Zealand 
Nurses Organisation [DHB/NZNO], 2012 ). 
 
When I began working as a research nurse, I had little orientation and learned by „doing‟.  I 
drew on my experience in ICU, my academic background and any professional development 
opportunities that came my way.  I turned to principal investigators (PIs), previous research 
nurses and study monitors for guidance and gradually built my skill level and 
understanding.  Throughout this time I had a growing awareness that this role was not well 
understood or highly regarded.  There seemed to be an imbalance between the high level of 
responsibility and a lack of recognition and understanding about the role.  I attended a study 
day at the hospital I work in, where one talk unfavourably compared research nurses with 
„nurse researchers‟ who conduct their own nursing research.  The speaker implied that 
research nurses were basically „doing a job‟, were „doing doctor‟s research‟, didn‟t care 
about patient outcomes and were very poorly thought of by academic nurses.  I already had 
doubts about how research was viewed within my own hospital and ICU because, despite 
support from the ICU Charge Nurse Manager, no space was allocated for research nurses in 
a newly planned ICU.  Research nurses from all clinical areas were to work in a research 
department located far from ICU.  While suitable for many clinical areas, I thought this 
showed lack of understanding about ICU research, which operates 24 hours a day, seven 
days a week, and is very „hands on‟.   
 
These issues made me question whether other ICU research nurses around NZ did the same 
work as I did, in the same way and faced the same challenges.  However, there was little 
evidence about the work of the ICU research nurse and none specifically about NZ.  The 
literature review by Bell (2009) had reaffirmed that it was a nursing role by aligning it to the 
Nursing Council of NZ competencies, thus paving the way for future research into research 
nurses in NZ.  I attended two presentations by Leonie Walker, a researcher from the New 
Zealand Nurses Organisation (NZNO), who highlighted the lack of job security experienced 
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by many research nurses, citing her experience in the United Kingdom (United Kingdom 
Clinical Research Collaboration, 2007), the need for recognition of, and a career pathway 
for research nurses in NZ (Walker, 2009b, 2010).  Walker summarised her views in an 
article in the NZNO journal, Kai Tiaki (2009a), stating that research nurses deserve to be 
recognised for the “complexity and importance of the professional roles they perform and 
the specialised knowledge and skills they possess” (p. 26).  She recommended that research 
nursing should be considered a speciality, and attention to career progression was required.   
Formulating the research question 
In formulating the research question, the literature was reviewed to see what studies had 
already been conducted and if they were relevant to the NZ setting.  The term „research 
coordinator‟ as a nurse was first used in the literature in 1970 (Kerman, 1970) and the term 
„research nurse‟ in 1976 (Edwards, 1976).  The volume of literature gradually increased 
throughout the 1980s and 1990s, with much of the earlier literature being experiential 
accounts about this emerging role (Ahern, Kruger, Gatcomb, Petit, & Tamborlane, 1989; 
Chadwick, 1992; Fowler & Stack, 2007; Mullin et al., 1984; Stephens-Lloyd, 2004; Waller, 
2002).  Issues which were evident in the literature included whether research nurses could 
be considered nurses as they were often regarded as data collectors by their colleagues 
(Kenkre & Foxcroft, 2001) and whether research nursing could be seen as a specialty (Raja-
Jones, 2002; Stephens-Lloyd, 2004).  Expert opinion articles provided useful background 
information about research and the research nurse role, particularly about strategies to 
overcome challenges, such as the establishment of networks (Chatfield, 2008; Chester, 
Kennedy, Hynd, & Matthews, 2007; Kenkre & Foxcroft, 2001; Poston & Buescher, 2010).  
While experiential accounts frequently echoed my own experiences, they did not provide 
evidence.  Empirical studies began to emerge in the 2000s and are discussed in detail in 
Chapter 3. 
 
While much was written about the role internationally, literature about research nurses in 
NZ has traditionally been combined with Australia in studies.  Was the role different in NZ, 
or were the expectations and challenges faced the same?  Much of the published literature is 
set in the United States of America (USA), which has a very different healthcare system to 
NZ.  As will be shown in Chapter 3, there are five Australian publications about the 
research nurse which are set in ICU; however the NZ data component was small and not 
analysed separately. 
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What better people to seek advice from when designing this study than the research nurses 
themselves?  The ICU research nurses in NZ have become a cohesive group, with the 
establishment of annual meetings and an informal network in 2009.  Before details of this 
research were finalised, I approached the NZ ICU Clinical Research Nurses Group at a 
meeting in August 2010, to gauge their level of interest and the feasibility of conducting this 
study.  They were all enthusiastic about the idea and said they would like to participate.  The 
possibility of including the PIs, who are the doctors they work closely with and their nurse 
managers (NMs) in the study was also broached with them.  The nurses thought this was a 
good idea and that their PIs and NMs were likely to participate.  Discussion about design 
and methods was also had with the group.  Their main suggestions included keeping a diary 
as a way of recording their work for a period of time, and conducting a focus group.  These 
suggestions are reviewed in Chapter 4 where the rationale for choosing a qualitative 
descriptive approach is discussed. 
Setting for research 
The setting for this study was six Level III ICUs in five NZ cities that employed at least one 
research nurse.  Detailed information about NZ ICUs is included in Chapter 2 to provide 
context to the research and results.  There are seven adult and one paediatric Level III ICUs 
in NZ.  One of the adult ICUs was excluded because they did not have a permanent research 
nurse employed at the time this study was conducted.  Although some Level II ICUs employ 
research nurses, the decision to include only Level III ICUs was pragmatic based on likely 
recruitment and volume of data.  This decision was supported by a study about Australian 
and NZ ICU research coordinators, which showed that 84% of the respondents were from a 
Level III ICU (Rickard, Roberts, Foote, & McGrail, 2006).  Starship Paediatric ICU (PICU) 
was excluded because of the perceived different issues for research nurses working with 
paediatric patients compared to those in adult ICUs.  
Key terms 
Research nurse 
The generally accepted definition for a research nurse is a nurse employed for the purpose 
of managing and coordinating clinical trials (Bell, 2009; Jeong, Kang, & Kim, 2007; NZNO 
Critical Care Nurses' Section, 2011).  Research nurses are referred to in various ways in the 
literature, including research coordinators, clinical research nurses, study coordinators, 
clinical trials coordinator and trial coordinators (Bell, 2009; Rickard et al., 2006).  The 
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terms which do not contain the word „nurse‟ in the title refer to positions including, but not 
necessarily limited to nurses.  Throughout this thesis, the original terms used in the literature 
or guiding documents are used.  Unless otherwise stated, they refer to the research nurse 
role which is being investigated.  For the purpose of this study, the generic term „Research 
Nurse‟ and has been abbreviated to ResN.   
 
It is important to distinguish between research nurses (ResN) and nurse researchers, as 
many articles that emerged from the literature were about nurse researchers.  A nurse 
researcher is a nurse conducting their own research in the field of nursing (Gordon, 2008; 
Watmough, Flynn, Wright, & Fry, 2010).  Many ResNs do conduct their own studies, but 
they are mainly employed to conduct clinical trials (Hill & MacArthur, 2006; Rickard et al., 
2006).  ResNs work in a variety of different clinical settings, including oncology, diabetes, 
cardiology, gastroenterology, paediatrics, and ICU (Rickard et al., 2006).  In NZ, the work 
settings are varied but include universities, general practice, hospital and community 
locations in district health boards and private research institutions (Walker, 2009a, 2009b).  
There is no official data about how many ResNs work in NZ.  
Principal investigator 
In this thesis the principal investigator (PI) refers to an intensivist who is the investigator for 
at least one study in their ICU.  In the ICU setting, the PI usually refers to the person who is 
responsible for the conduct of a clinical trial at that site and is usually an intensivist.  This 
differs from the official definition for PI which is the person who has “primary 
responsibility for the design and conduct” (p. 103) of a study, and the person who conducts 
the study at a local site is usually called an „investigator‟ (Ministry of Health [MOH], 2006).  
The PI for a study can be any health professional and as will be revealed in the findings, 
some of the research nurses who participated in this study were PIs for studies.   
Nurse managers and nurses 
The nurse in charge of ICU is known by different titles including Charge Nurse Manager, 
Nurse Unit Manager, and Nurse Manager.  I use the term nurse manager (NM) when talking 
about this role.  The registered nurses who are providing direct clinical care to ICU patients 
are referred to as „bedside‟ nurses as this is what many participants referred to them as.  
Their official title is „staff nurse‟ however „bedside‟ nurse is used to differentiate between 
these nurses and research nurses.  In some cases the research nurses also work as ICU 
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bedside nurses, so the term research nurses is only used when referring to them in their 
research role. 
Other terms 
The terms „role‟ and „work‟ are used frequently throughout this thesis.  Role is defined as 
“the function assumed or the part someone plays in a particular situation” (Oxford 
University Press, n.d.).  „Work‟ is about the tasks that are done.  Other frequently used terms 
are provided in the glossary and further terms specific to the research are explained in 
Chapter 2, which gives an overview of the research process.   
Overview of the thesis 
This chapter has introduced the background to the research question and outlines the rest of 
the thesis.  This thesis consists of seven chapters which collectively aim to describe the role 
of the research nurses working in NZ Level III ICUs.  Chapter 2 gives some clinical context 
about the setting ICU research nurses work in.  It is divided into three sections, of which the 
first gives the reader an overview of the healthcare setting and ICUs in NZ.  The second 
section gives an insight into the process of research, and in particular, clinical trials.  The 
third section brings the ICU and research specialities together to describe this challenging 
environment for conducting research.  A review of the current literature about research 
nurses is presented in Chapter 3 and gaps are identified to frame the research question.  
Chapter 4 outlines the methodology for conducting the research study and describes how the 
research was conducted.  The findings are presented in Chapters 5 and 6.  The focus of 
Chapter 5 is describing the participants and the ICU research departments while Chapter 6 
presents the findings about the work of the ResN, in a thematic way.  Chapter 7 discusses 
the findings, puts them in the context of the current literature and reflects on the study.   
 
A key consideration in reporting the findings was managing confidentiality.  Because the 
ICU research community is very small, and participants and ICUs are likely to be readily 
identifiable, discretion has been used as to when they are named, given code names, and 
when a general term, such as „one research nurse said‟ is used.  For the purpose of 
confidentiality, participants‟ identification numbers (e.g., ResN01) were randomly assigned.  
While it is acknowledged that readers of this thesis from ICUs in NZ may know and 
recognise who the participants are as a group, every endeavour has been made to protect 
individuals‟ views and opinions.  
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Chapter 2     Clinical context 
Introduction  
This chapter contextualises the environment in which NZ ICU research nurses work.  It 
provides a platform for the rest of the thesis by explaining the setting and organisations they 
work within and what is involved in conducting clinical research in NZ ICUs.  This chapter 
has three distinct parts.  It commences with a brief overview about the healthcare system 
and then introduces the reader to the ICU setting, definitions and the documents which 
guide ICU management.  Part 2 introduces basic research concepts, including definitions of 
different types of research, phases of research and key guiding principles.  The third part 
brings the specialty of ICU and research together and discusses considerations for 
conducting clinical research in ICU.  Woven throughout is how the information provided 
links to the ResN. 
Part 1 New Zealand healthcare and ICU 
NZ publicly funded healthcare, including hospitals, is governed locally by 20 district health 
boards (DHBs) (Ministry of Health [MOH], 2010a).  The DHBs were established under the 
NZ Public Health and Disability Act 2000 (NZ Government, 2000).  In addition to publicly 
funded healthcare, there are many healthcare providers and hospitals which are privately 
funded through health insurance or patient self-payment.  
The Treaty of Waitangi 
The Treaty of Waitangi is a significant document in NZ history.  It was signed in 1840 and 
aims to protect the rights and well-being of Maori, who are the indigenous people of NZ 
(Reid, 1999).  This Treaty is essential when discussing research in NZ because Maori must 
be consulted prior to research occurring.  Statistics show that Maori have a higher overall 
mortality than other ethnic groups and are overrepresented in many illnesses (MOH, 2010b) 
so considering Maori health interests is very important.  Healthcare workers and providers 
have an obligation under the Treaty to ensure that Maori are not disadvantaged (MOH, 
2002).  Furthermore, the Nursing Council of NZ (2011) state that the principles of the 
Treaty “require nursing to have a commitment to be responsive to Maori interests, and to 
ensure that these are protected” (p. 12).  
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Intensive care 
Intensive Care is defined by the Intensive Care Clinical Advisory Group (2005) as:  
A designated ward of a hospital that is specially staffed and equipped to 
provide observation, care and treatment to patients with actual or potential 
life-threatening illnesses, injuries or complications, from which recovery is 
possible.  The ICU provides special expertise and facilities for the support of 
vital functions and utilises the skills of medical, nursing and other staff 
trained and experienced in the management of these problems.  (p. 8) 
 
Guidelines for minimum standards for ICUs in NZ and Australia have been developed by 
the College of Intensive Care Medicine of Australia and New Zealand (CICM).  CICM is 
the body which provides training, education and professional development for intensivists 
(CICM, 2012a).  ICUs are categorised into three levels (Level I, II or III) according to the 
complexity of care they are able to provide and the number of patients they are capable of 
admitting annually (CICM, 2010b).  A summary of the capabilities and differences between 
the three levels is provided in Table 1.   
 
Level I ICUs are only required to provide immediate resuscitation and short term cardio-
respiratory support for critically ill patients (CICM, 2010b).  They need to be capable of 
providing mechanical ventilation and simple cardiovascular monitoring for several hours.  
This care could be provided for more than 24 hours but only if it involved failure of a single 
body system and a patient‟s care was discussed with an intensivist at a Level II or Level III 
ICU.  Typically, critically ill patients are transferred to a Level II or Level III unit as soon as 
able. 
 
A high standard of general intensive care under the supervision of an intensivist is expected 
in a Level II ICU.  They can provide “complex multi-system life support, such as 
mechanical ventilation, renal replacement therapy and invasive cardiovascular monitoring 
for several days” (CICM, 2010b, p. 3).  
 
Level III units are often referred to as tertiary referral ICUs, to which lower level units can 
refer their sickest patients.  These units “should be capable of providing comprehensive 
critical care including complex multi-system life support for an indefinite period.  Level III 
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Table 1     Requirements for the 3 levels of Intensive Care Unit in NZ* 
 Level I Level II Level III 
Overview  Immediate resuscitation & short term 
cardio-respiratory support 
High standard of general intensive care Tertiary Referral Unit 
Type of care 
provided 
Simple invasive cardiovascular monitoring 
& mechanical ventilation for several hours 
Invasive cardiovascular monitoring, renal 
replacement therapy, mechanical 
ventilation for several days 
Complex multi-system life support 
indefinitely 
Work 
practice/caseload 
Sufficient ICU beds & admissions to 
maintain clinical skills of medical & 
nursing staff 
Minimum 4 staffed & equipped beds 
> 200 mechanically ventilated patients 
each year 
Minimum 6 staffed & equipped beds 
> 300 mechanically ventilated patients 
each year 
Medical Staff  
Medical director who is experienced in 
Intensive Care Medicine 
Medical director (Fellow of College of 
Intensive Care Medicine) 
Medical director (Fellow of College of 
Intensive Care Medicine) 
Consultant support from a specialist with 
ICU experience 
One other specialist who is a Fellow of 
College of Intensive Care Medicine 
Sufficient specialists so that an ICU 
specialist is always available 
At least 1 medical practitioner exclusively 
rostered at all times 
At least 1 medical practitioner exclusively 
rostered at all times 
At least 1 medical practitioner exclusively 
rostered at all times 
Nursing Staff 
Nurse in charge must have post-
registration qualification in ICU or the 
specialty of the unit 
Nurse in charge must have post-
registration qualification in ICU or the 
specialty of the unit 
Nurse in charge must have post-
registration ICU qualification 
 
Majority of nursing staff have post-
registration  qualification in ICU or the 
specialty of the unit 
Majority of nursing staff have post-
registration  qualification in ICU or the 
specialty of the unit 
Majority of nursing staff have post-
registration ICU qualification 
 
 Access to a nurse educator At least one nurse educator 
All nurses responsible for patient care are 
registered nurses 
All nurses responsible for patient care are 
registered nurses 
All nurses responsible for patient care are 
registered nurses 
1:1 nursing for critically ill patients 
 
1:1 nursing for critically ill patients 
 
1:1 nursing for ventilated or critically ill 
patients 
Minimum of 2 registered nurses in unit at 
all times, when there is a patient admitted 
to the unit 
 Nursing staff available for >1:1 ratio in 
very complex patients 
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*Adapted from College of Intensive Care Medicine. (2010b). Minimum standards for intensive care units (IC-01).  Retrieved 30 November, 2010, from 
http://www.cicm.org.au/cmsfiles/IC-1%20Minimum%20Standards%20for%20Intensive%20Care%20Units.pdf 
 Level I Level II Level III 
Training of ICU 
Specialists 
 May apply for accreditation as a 6 or 12 
month medical training ICU 
May apply for accreditation as a full (24 
month) training medical training ICU 
Operational 
Requirements 
Defined management, admission, 
discharge & referral policies 
Defined management, admission, 
discharge & referral policies 
Defined management, admission, 
discharge & referral policies 
Formal audit & review of its activities & 
outcomes 
Formal audit & review of its activities & 
outcomes & staff who have dedicated time 
to collect & manage data 
Formal audit & review of its activities & 
outcomes & staff who have dedicated 
time to collect & manage data 
Documented orientation programme for 
new staff 
Documented orientation programme for 
new staff 
Documented orientation programme for 
new staff 
Educational programmes for medical staff 
& a formal nursing education programme 
Educational programmes for medical staff 
& a formal nursing education programme 
Educational programmes for medical staff 
& a formal nursing education programme 
An active research programme is desirable 
 
An active research programme is desirable 
 
Must have an active research programme, 
preferably with staff who have dedicated 
time to collect & manage data 
Suitable infection control & isolation 
procedures & facilities 
Suitable infection control & isolation 
procedures & facilities 
Suitable infection control & isolation 
procedures & facilities 
24 access to pharmacy, pathology, 
operating theatres & imaging services 
commensurate with the role of the hospital 
24 access to pharmacy, pathology, 
operating theatres & imaging services 
commensurate with the role of the hospital 
24 access to pharmacy, pathology, 
operating theatres & tertiary-level 
imaging services 
 
Appropriate access to physiotherapy & 
other allied health services when necessary 
Appropriate access to physiotherapy & 
other allied health services when necessary 
Appropriate access to physiotherapy & 
other allied health services when 
necessary 
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units should have a demonstrated commitment to academic education and research” (CICM, 
2010b, p. 1). 
 
Level III ICUs can apply for accreditation to provide medical or registrar training in intensive 
care medicine for six, 12 or 24 months and Level II ICUs for six or 12 months as per the 
requirements outlined in the CICM IC-3 guideline (2010a).  Pertinent to the ResN role, training 
accredited ICUs are required to have:  
Access to an appropriate level of funding for research coordinators to support 
the active research program.  As a minimum, funding to support the full time 
research coordinator position for a Level III Unit (IC-1), and an appropriate 
part-time position in smaller units.  (CICM, 2010a, p. 4, S. 3.5) 
New Zealand ICUs 
The Acute Respiratory Unit at Auckland Hospital, established in 1962 was the first dedicated 
ICU in NZ (Trubuhovich & Judson, 2001).  There are currently 22 adult ICUs in NZ public 
hospitals, and a further three in private hospitals (Table 2).  Many ICUs also admit children, 
and Starship Hospital has a dedicated paediatric ICU.  Neonatal ICUs are not included in this 
table as they are regarded as a separate specialty.  Auckland City Hospital Department of 
Critical Care, Christchurch Hospital, Middlemore Hospital and Wellington Hospital are 
accredited as unrestricted 24 month training ICUs (CICM, 2012b).  Auckland City Hospital 
Cardiovascular ICU, Hawke‟s Bay Hospital, and Waikato Hospital are approved for 12 month 
advanced training, and North Shore Hospital for six months. 
 
There were 18,919 intensive care and high dependency admissions to NZ ICUs in 2008 
(ANZICS Centre for Outcome and Resource Evaluation Database, [ANZICS CORE Database], 
2011).  Of the 10,473 admissions to Level III ICUs in this period, 42% were classified as 
emergency admissions and the remainder were following elective surgery.  The mortality rate 
varies depending on reasons for admissions and admission diagnoses; however the overall 
mortality rate in 2008 for Level III ICUs was 7%. 
 
Due to the severity of their illness, ICU patients are vulnerable in clinical and research terms.  
They are often unconscious or sedated, and therefore unable to speak for themselves.  This is 
referred to as „incompetence‟ and is the (usually temporary) inability of a patient to 
“understand information presented, to appreciate the consequence of acting (or not acting) on 
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that information and to make a choice” for themselves (MOH, 2006, p. 101).  In 2008, 
approximately 52% of patients admitted to Level III ICUs were mechanically ventilated and 
therefore would have been sedated at some point during their admission (ANZICS CORE 
Database, 2011) meaning they were unable to communicate verbally. 
 
Table 2     Summary of New Zealand Intensive Care Units by level* 
Level I Level II Level III 
Gisborne Hospital Hawke‟s Bay Hospital  
Auckland City Hospital 
Cardiovascular ICU 
Grey  Hospital 
Mercy Hospital & Health 
Services** 
Auckland City Hospital 
Department of Critical Care 
Medicine 
Hutt Hospital North Shore Hospital  Christchurch Hospital  
Southern Cross 
(Hamilton)** 
Palmerston North Hospital Dunedin Hospital  
Taranaki Base Hospital Rotorua Hospital  Health Waikato  
Wairau Hospital Southland Hospital  Middlemore Hospital  
Wakefield Hospital** Tauranga Hospital  Starship Children‟s Hospital  
Whakatane Hospital Timaru Hospital  Wellington Hospital  
 Wanganui Hospital   
 Whangarei Hospital   
*Collated from information provided by ANZICS CORE Database (2011)  
** These hospitals are privately funded 
 
Ventilated and critically ill ICU patients are nursed at a 1:1 ratio (one nurse for each patient).  
Patients who are less sick and considered „high dependency‟ may be nursed at a 1:2 ratio 
(Morley, 2005).  Because of these ratios, the bedside nurse constantly monitors and assesses 
the patient‟s condition, makes clinical decisions and provides care for the patient, in 
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collaboration with medical and allied health staff.  In NZ, ICU patients are cared for by a 
registered nurse (CICM, 2010b).   
Part 2  Overview of research principles 
Research is a systematic and methodical process which aims to create new knowledge or 
validate existing knowledge (European Medicines Agency [EMA], 2002; Gillis & Jackson, 
2002; Rischbieth & Blythe, 2005).  There are many different types of research, however 
because most research conducted in NZ ICUs is observational or clinical trial design, these two 
designs are described in more detail to give an indication of the expectations of the ResN in 
such studies. 
 
Observational studies refer to studies which observe current practice, and no intervention takes 
place (National Ethics Advisory Committee [NEAC], 2006).  These studies involve only data 
which can be collected prospectively or retrospectively.  The data are then analysed and can be 
used for quality control, benchmarking current practice and to “add to generalisable knowledge 
about a health issue or disability” (NEAC, 2006, p. 3).  Low risk observational studies are 
eligible for review by an expedited ethical approval process. 
 
A clinical trial is an investigation in human subjects, intended to discover or verify the “safety, 
efficacy or optimum dosage schedule of an investigational product or intervention” (Rischbieth 
& Blythe, 2005, p. 60).  It is usually pre-planned and participants are selected according to 
“predetermined eligibility criteria” (Rischbieth & Blythe, p. 60) and assessed according to 
predefined endpoints.   
 
There are four phases of clinical trials (Coulson & Phelan, 2000; Fowler & Stack, 2007; 
Murray, 2011).  The focus of Phase I studies is to collect safety data and the research drug or 
therapy is used for the first time in healthy humans.  Phase II studies assess whether the agent 
has an effect on the disease (efficacy) in a particular group of patients.  The purpose of a Phase 
II study may be to see if a Phase III study is feasible and warranted.  Because Phase II studies 
have a small patient population and patient outcomes may not show an effect, surrogate end-
points such as biomarkers or hospital length of stay may be used.  Phase III studies gather 
additional safety and efficacy data and aim to show whether the new agent is statistically and 
clinically better than best current practice.  The follow-up tends to be longer, and have a patient 
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based outcome such as mortality or quality of life.  Phase IV studies are long term and done 
when the therapy is licensed and in general use.  Most clinical trials in ICU are Phase II and III. 
Good clinical practice  
Fundamental to all clinical trials is the concept of good clinical practice (GCP).  “GCP is an 
international ethical and scientific quality standard for designing, conducting, recording and 
reporting trials that involve the participation of human subjects” (EMA, 2002, p. 5).  The 
purpose of GCP is to ensure that patients‟ rights are upheld and research studies are conducted 
in an ethical way.  The origins of GCP are in the Declaration of Helsinki which state that the 
individual patient‟s rights take precedence over the interests of a study (World Medical 
Association, 1964).  The risks of a trial must be carefully weighed against the likely benefits.  
Underpinning GCP is patient consent and the concept that the patient has the right to refuse to 
participate in a research trial and is still entitled to receive the best available medical care.  
Responsibilities of those involved in research are outlined in the Guideline for Good Clinical 
Practice (EMA, 2002).  Since January 2011, all clinical trials conducted in NZ have been 
expected to adhere to GCP guidelines (MOH, 2011).   
 
The role of the trial „monitor‟ is to ensure that a study complies with GCP.  This is done by 
checking that enrolled patients met eligibility requirements, consents are filled in correctly and 
that pre-specified data points match source data (EMA, 2002).  Source data are defined as the 
information found in source documents which are the “original records or certified copies of 
original records of clinical findings” (p. 10) such as hospital records, laboratory results, 
radiology results and vital observations (EMA, 2002).  The sponsor is the research organisation 
“who take responsibility for the initiation, management and financing of a clinical trial” (EMA, 
2002, p. 10).   
Protocol 
The process of conducting a clinical trial begins with recognising an issue or problem that 
needs to be investigated.  The protocol is the document which outlines all information about a 
trial.  It provides the statistical and clinical background, rationale based on previous studies and 
literature to conduct the trial, specifies treatments to be performed, the data to collect and 
safety information, including the course of action if a patient is put at risk, (EMA, 2002).  The 
protocol is developed and refined by the investigator and/or management committee, which is a 
group of interested and suitably qualified individuals.  The protocol is submitted for approval 
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by an ethics committee, along with any written study material, including information sheets, 
consent forms and advertising information.  Adherence to the protocol ensures that procedures 
are carried out consistently and safely by multiple participating sites.  
 
Protocol violations (or deviations) are events which are not in accordance with the study 
protocol.  They may or may not be harmful to the patient, but may put the results of the study 
in jeopardy, by diluting the statistical effect.  An example of a protocol violation would be if a 
study was investigating the efficacy of two different resuscitation fluids and a patient was 
given the incorrect fluid, not the one they were randomised to receive.  This type of violation 
requires reporting to the sponsor.  Serious adverse events (SAEs), on the other hand, are events 
that may have put the patient at risk, and may or may not be related to the study treatment.  
EMA (2002, p. 10) defines SAEs as: 
Any untoward medical occurrence that at any dose: 
 results in death, 
 is life-threatening,  
 requires inpatient hospitalization [sic] or prolongation of existing 
hospitalization, results in persistent or significant disability/incapacity, or  
 is a congenital anomaly/birth defect. 
 
A data monitoring committee (DMC) is responsible for the safe conduct of the study and 
unlike the management committee they can review unblinded data while the study is in 
progress.  A DMC consists of “a group of independent experts external to a study assessing the 
progress, safety data and, if needed critical efficacy endpoints of a clinical study” (EMA, 2005, 
p. 3).  If the trial does not have a DMC, the PI must report any SAE to the ethics committee as 
soon as able (New Zealand Health and Disabilities Ethics Committees [HDEC], 2010).  If a 
trial is overseen by a DMC, SAEs are reported to the ethics committee for NZ patients only if 
the SAE is unexpected, not defined by study end-points, and if the study code must be 
unblinded (HDEC, 2010).   
Conducting research and clinical trials in New Zealand  
In addition to GCP, researchers must also adhere to the ethical requirements for NZ.  Changes 
to the NZ Health and Disability Ethics Committees (HDEC) became effective on 13 June 2012 
while this thesis was in the final stages of being written up (HDEC, 2012).  Because data 
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collected about the ResN‟s role in ethics were collected in 2011, the ethical review 
requirements in effect at the time of the interviews are discussed below, not the new guidelines. 
NZ ethical review process 
Ethical review is the approval of research by an external body to determine whether the 
research being proposed has an acceptable risk to the patient compared to the likely benefit to 
society.  In NZ, six regional and one multi-regional ethics committees (MREC) were 
established in 2004, under Section 11 of the NZ Health and Disability Act 2000 (NZ 
Government, 2000) and operate under the MREC Committee Terms of Reference (HDEC, 
n.d.).  The primary purpose of ethical review is to ensure “that the rights and interests of 
participants in research and innovative practice, and consumers of health and disability 
services” are protected (MOH, 2006, p. 2).  MREC review allows for a single ethics 
application, submitted by the „lead site‟, when a study is being conducted at more than one site 
in NZ. 
 
If multiple ICUs are participating in a study, it is my experience that the research staff at one of 
the ICUs volunteers to be the lead site.  Staff at the lead site complete the full ethics application 
and create generic consent forms and information sheets for the NZ setting.  These forms and 
sheets are either adapted from a template sent by the sponsor or developed independently.  The 
documents from all other sites are collated by the lead site and submitted to MREC together.  
The approvals necessary from each site are evidence of consultation with Maori, signed 
locality assessment, and a signed declaration by each PI (called a „Part 4‟).  Evidence of 
consultation with, and support from Maori is completed according to the local hospital process.  
The locality assessment is a declaration that the proposed locality is appropriate and has 
sufficient resources, including personnel, for the trial to take place (MOH, 2006).  The Part 4 
declaration is a statement signed by the PI and senior manager stating that the PI understands 
the protocol and ethical considerations have been made.  
 
If a drug is a „new medicine‟, approval must first be given by the Standing Committee on 
Therapeutic Trials (SCOTT) under Section 30 of the Medicines Act 1981 (MOH, 2011).  The 
purpose of SCOTT approval is to assess the scientific and clinical validity and risks of the 
proposed trial.  Additionally, SCOTT reviews the merit of clinical trials being submitted for 
Health Research Council funding (Health Research Council of New Zealand, 1993). 
18 
Hospital research departments 
In planning this study, I presumed that most hospitals or DHBs had a research department or 
policy to ensure that the DHB is protected from risk (including financial) when research is 
conducted within the hospital.  The hospital I work at has a register of research being 
conducted within the hospital.  The budget and clinical trials agreement are assessed prior to 
the commencement of any research. 
Study funding 
Generally, a „per patient‟ payment for each patient enrolled into a study is paid by the sponsor 
to the site.  The „per patient‟ payment aims to recompense the costs of the study, including 
ResN time, consumables, therapeutic substances, and laboratory, pharmacy and radiology 
costs.  Study funding is an important consideration for this thesis because in NZ ICUs, funding 
received from studies contributes to the cost of ResNs‟ salaries.  Specific details about this are 
discussed in Chapter 5. 
Commercial studies 
Commercially sponsored studies are those where a clinical trial is “conducted principally for 
the benefit of the manufacturer or distributor of the medicine or item being trialled” (HDEC, 
2012, p. 52).  Commercial studies tend to be drug trials which may be experimental in nature 
or assessing a new use, different doses or side effects for an existing drug.  Sites are paid by 
pharmaceutical or other healthcare companies.   
Investigator-initiated studies 
Investigators initiating their own studies can apply for grants from research organisations such 
as the Health Research Council (HRC), private trust funds and special interest groups or 
collaboration may be sought from commercial companies, to provide an unconditional grant.  
Anecdotally, investigator-initiated, grant-funded studies tend to be less well funded than 
commercial studies, and sometimes the „per-patient‟ payment may not cover the costs incurred.  
Observational studies are usually investigator-initiated and may attract little or no funding.   
Part 3 Bringing two specialties together – research in the ICU setting 
Research has been a part of ICU for almost as long as ICU has existed in NZ.  While it is 
difficult to say exactly when research started in ICUs, when „New Zealand‟, „Intensive Care‟ 
and „Critical Care‟ are searched in Medical Literature On-Line via ProQuest (Medline) and 
Cumulative Index to Nursing and Allied Health Literature (CINAHL), the earliest NZ 
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publication was an article published in 1967 titled „The Intensive Care Unit in Tauranga‟ 
(Fergus & Watts, 1967).  The intensivists profiled in „Intensive Care in New Zealand – a 
History of NZ Region of ANZICS‟ (Trubuhovich & Judson, 2001) talked about conducting 
research at their ICUs throughout the 1980s and 1990s.  NZ ICUs have also been involved in 
many recent multicentre international studies (Cooper et al., 2011; NICE Study Investigators, 
2009; The ANZIC Influenza Investigators, 2009).  
What is known about the research nurse role? 
The ResN role is relatively new and the first nurse employed specifically as a ResN in a NZ 
ICU was in 1997 in Auckland Hospital Department of Critical Care Medicine (L. Newby, 
personal communication, June 15, 2010).  The exact number of ResNs working in NZ ICUs is 
unknown, however all but one Level III ICU employed at least one ResN prior to this study. 
Trial selection 
The process of studies being selected by an ICU relies on a belief of „equipoise‟ within the 
ICU.  Equipoise is where there is genuine uncertainty about a treatment (Murray, 2011).  The 
protocol will be assessed by ICU personnel to establish the feasibility of conducting the study 
in their ICU.  Who is involved in this decision in the participating ICUs is revealed in Chapter 
6.  Determining feasibility involves estimating the number of patients a site could recruit and 
can also include consideration of the costs which will be incurred.  Usually one of the 
intensivists will become the PI for a trial, or for observational studies, this may be a ResN or 
other doctor such as a registrar.  Sites are selected by the sponsor based on the ICU‟s ability to 
recruit patients into a study and their research experience.   
Considerations when conducting research in ICU 
ICU patients are a vulnerable cohort and there are many ethical and clinical considerations 
when conducting research in ICU.  With approximately half of all admissions being classified 
as emergency (or unexpected) admissions, ICU can be a frightening experience for the patient 
and their family.  ICU patients can be extremely sick and many will die of their illness either in 
ICU, or soon after (Hicks & Mackle, 2010).   
Consent 
Consent is the process by which a patient decides whether to participate in a trial or not.  This 
process involves explaining the patient‟s condition, the specifics of the study treatment and 
potential risks and benefits of the study.  The information must be given to the patient in a way 
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they can understand.  This is usually in the form of a „plain language‟ information sheet and the 
option of an impartial interpreter if required.  Fundamental to upholding patients‟ rights, the 
patient must consent without “manipulation, coercion, inducement or any other undue 
influence” (MOH, 2006, p. 7).   
 
As ICU patients are frequently unable to consent to participate in clinical trials for themselves, 
special provision is provided in Research involving unconscious participants (Appendix 3) of 
the Operational Standards for Ethics Committees (MOH, 2006).  Unconscious patients can be 
enrolled into studies either using a „delayed consent‟ option or after consultation with their 
family (assent) (Table 3).  „Assent‟ is a term used by some ICU researchers and refers to 
obtaining permission from the patient‟s family to enrol a patient into a trial.  In NZ law, there is 
no allowance for consenting by proxy (unless the patient has a legal representative), so when 
research is discussed with family, they are asked if they think the patient would want to 
participate in a study.   
 
Table 3     Types of consent used in the ICU setting 
 Consent (patient) Assent (family) 
Prior Prior consent from the patient is the 
usual practice when conducting 
research.  This is obtained from the 
patient before any treatment begins. 
Assent is where the family agrees to 
their family member participating in a 
trial prior to study treatment beginning.   
Delayed If no family is immediately available, 
the patient may be enrolled into an 
approved study without consent.  Once 
the patient is able to consent, they 
consent to continuing with the study.  
This may be following assent from the 
family or from the patient alone. 
If no family is immediately available, 
the patient may be enrolled into an 
approved study and assent sought from 
the family after the study treatment has 
begun.   
 
Delayed consent allows the patient to be enrolled into some trials without prior consent or 
consultation with the family.  The use of delayed consent is applied for on an individual trial 
basis as part of the ethics application and is used only when the family is not immediately 
available.  This request is made for trials where delaying enrolment into the trial until the 
family had been spoken to, would mean that many patients were not able to be enrolled.  An 
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example of this is for a study investigating fluid resuscitation, where treatment must be given 
immediately.  Assent to continue with study treatment is sought from the family, until the 
patient is competent to decide for themselves.   
 
Whichever option is used, consent to continue with the study is sought from the patient when 
they are competent and they still have the right to decline any further study treatment or 
follow-up, without affecting their medical treatment.  If the patient does not recover enough to 
consent, or dies, the ethics committee can give permission for the trial data to be used. 
 
The decision about who can obtain consent from a patient is trial-specific and would generally 
be decided at the beginning of each study, and documented in a „delegation of duty log‟, which 
is authorised by the PI.  Depending on the study, they may perform all of the tasks themselves, 
or delegate them to someone else.   
Other considerations 
The timeframe for putting a patient into an ICU clinical trial is often very short.  While all 
clinical trials are scientifically justified and ethically approved, the full effect of study 
treatment is unknown; therefore there is always a risk.  All potential risks and benefits of a 
study are explained to the family (or patient) and they have the opportunity to ask questions.  
Many ICU studies are „blinded‟, which means none of the staff know if the patient will receive 
the treatment or if they are in the control group.  Part of the consent process includes 
explaining to families that clinical trials are only conducted when it is not known if one 
treatment is more beneficial than another in this group of patients.  The family are asked to 
consider the risks and benefits and make the decision about allowing the patient to participate.  
This can be a burdensome decision to make in an already stressful situation as their family 
member is critically ill and they are in an unfamiliar environment, perhaps without their usual 
support networks.   
Supporting organisations 
Australia New Zealand Intensive Care Society Clinical Trials Group 
The Australia New Zealand Intensive Care Society (ANZICS) is a professional body for 
intensivists (ANZICS, 2010) of which the ANZICS Clinical Trials Group (CTG) is a 
subcommittee (CTG, 2011a).  Established in 1994, the CTG is a group of intensivists and 
researchers, whose members are committed to collaborating to produce high quality research 
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(CTG, 2010a).  The CTG is funded by ICUs paying an annual fee and eight NZ ICUs are 
members (CTG, 2011a).  Three scientific meetings are run by the CTG each year and are open 
to all staff including PIs, other doctors and ResNs.  The largest meeting runs over three days in 
March and is held in Australia.  At all of the meetings, there are presentations about studies at 
all stages of development, updates about current studies and results from studies which have 
been completed.  When new studies are presented, there is an open forum for feedback about 
the design, potential problems and feasibility, which anyone present can contribute to.  
 
Although the CTG does not conduct studies itself, investigators can seek „CTG-endorsement‟ 
for their studies.  The process of CTG-endorsement involves the investigator presenting the 
study at a CTG meeting and submitting documentation about the study, which is then assessed 
by the CTG executive committee.  Relevant to the ResN role, a condition of CTG-endorsement 
it that “the study management committee must include at least one individual employed as an 
ICU Research Coordinator [sic] for the duration of the study” (CTG, 2011c, p. 8).  Many 
multi-centre studies have been endorsed by the CTG, and several publications in international 
medical journals have resulted (Cooper et al., 2011; NICE Study Investigators, 2009; The 
ANZIC Influenza Investigators, 2009; The Blood Observational Study Investigators on behalf 
of the ANZICS-Clinical Trials Group, 2010).  An example of an ongoing CTG-endorsed 
observational study is the „point prevalent‟ programme which ICUs across Australia and NZ 
can participate in once or twice a year.  As well as reporting a „snapshot‟ of patients who are in 
the ICUs on the specified days, point prevalent days are also used to assess current practice 
about pre-defined topics, how many patients are enrolled in research trials and feasibility of 
future research projects.  These point prevalent studies are also used to see whether research 
findings have been translated into clinical practice (Finfer et al., 2010).  Researchers can apply 
to have questions included in a point-prevalent study (CTG, 2010b). 
 
It is unknown if enrolling patients concurrently into more than one study, known as co-
enrolment, is common practice in other clinical areas.  For CTG-endorsed studies, co-
enrolment is encouraged and outlined in the CTG Co-enrolment Policy (CTG, 2011b) to ensure 
that trials are completed as quickly as possible “allowing results of potentially beneficial 
interventions to be available earlier” (p. 1).  The management committee for each study decides 
which studies it is safe to co-enrol in, without compromising patient safety or potentially 
affecting the study outcomes.  There is also a CTG Competing Studies Policy which prioritises 
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studies which are CTG-endorsed and funded by large funding bodies such as the HRC in NZ or 
National Health and Medical Research Council (NHMRC) in Australia, to ensure trials are 
completed on time (CTG, 2008).   
Intensive Care Research Coordinators Interest Group (IRCIG) 
The Intensive Care Research Coordinators Interest Group (IRCIG) is a collaborative network 
for research coordinators and is a sub-group of the CTG (IRCIG, 2011, 2012).  IRCIG was 
formally established in 2000 and was originally called the Intensive Care Research Nurses 
Interest Group.  The name was changed in 2001 to incorporate people doing the research role, 
who were not nurses (B.L. Roberts, personal communication, 16
th
 April, 2012).  The title 
Research Coordinator (RC) is used throughout Australia, and includes, but does not refer 
exclusively to nurses (Rickard et al., 2006).   
 
IRCIG aims to provide support for RCs, promote the role of RCs and to enable communication 
between them.  A significant aim is to ensure that CTG-endorsed studies receive input from 
RCs through representation on the committees that develop the studies (IRCIG, 2011).  IRCIG 
coordinates a regional mentoring programme for RCs throughout Australia and NZ, with one 
representative in NZ.  IRCIG has a one-day workshop the day before the main CTG meeting 
which has guest speakers and offers educational and professional development talks.  ResNs 
are encouraged to present their own research work.  It also provides an opportunity for ResNs 
to network with others in the same position.  It was at one of these annual workshops that the 
idea of starting a NZ based network for ICU ResNs began.  There are few NZ based ICU 
ResNs, compared to Australia and it was recognised that NZ needed a collective voice.  
New Zealand Critical Care Clinical Research Nurse Group 
In August 2009, the NZ ICU Research Nurses Group was started with a meeting in Wellington.  
This first meeting had two invited speakers, speaking about ethics and the role of the ResN.  
Each of the nine ICU ResNs present spoke about the projects they were currently involved in.  
Information about the member units, including the studies they were participating in, contact 
details and ResN full-time equivalence (FTE), was collated at this meeting, and updated with 
the second meeting at Middlemore ICU in 2010.  In 2010, the ICU ResNs became the first 
subgroup of the Critical Care Section of the NZ Nurses Organisation, and became known as 
the NZ Critical Care Clinical Research Nurse Group.  A position statement about the role of 
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the research nurse in ICU was released in January, 2011 (NZNO Critical Care Nurses' Section, 
2011). 
Summary  
This chapter has outlined healthcare and ICU in NZ, research concepts and given some 
background about the way research is incorporated into ICU in NZ.  Challenges of conducting 
research in the ICU setting have been outlined, as well as organisations which support research 
and ResNs working in ICU. 
 
By providing this background to conducting research in NZ ICUs, a base has been provided, on 
which the international literature, choice of methodology and ultimately the findings of this 
theses can be built.  The next chapter builds on contextualising the research by analysing the 
international literature about the role of the ResN.  
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Chapter 3     Literature review 
Introduction 
A review of the literature was conducted to see what was already known about the role of the 
ResN internationally, to assess whether it was reflective of the NZ setting and to identify gaps 
in current knowledge.  This chapter begins with an outline of the search strategy and inclusion 
criteria.  An overview of the literature and its quality is then provided, following which the 
findings and an analysis of relevant international literature are presented.  The themes that 
emerged and were considered significant include the development of the role, the „work‟ of 
ResNs, their role preparedness and job satisfaction.  The gaps in the literature are identified in 
the conclusion, paving the way for the topic of this thesis.   
Search strategy 
A literature review was conducted at the outset of this study in 2010, and updated again in 
2012.  Four significant studies were published between the initial and final review.  The 
literature review was conducted using CINAHL, Medline and PubMed databases, and Google 
Scholar search engine.  Various combinations of the search terms “research nurse”, “research 
coordinator”, “study coordinator”, “clinical trials coordinator”, “clinical research nurse” and 
“trials coordinator” were used as keywords.  These results were combined with the term „role‟ 
and limited to articles in the English language, published from 2000 - 2012.  Publications these 
articles cited were also reviewed, as were significant articles cited in other literature (Figure 1).  
This resulted in a total of 21 articles, which were reviewed in depth.  These articles were based 
on 16 individual studies; three of the studies involved  more than one publication (Mueller, 
2001; Mueller & Mamo, 2000, 2002; Rickard et al., 2006; Rickard, Roberts, Foote, & McGrail, 
2007; Roberts, Eastwood, Raunow, Howe, & Rickard, 2011a, 2011b; Roberts, Rickard, Foote, 
& McGrail, 2006).  A review article (Becze, 2010) which summarised the article by Nagel, 
Gender and Bonner (2010) was not analysed separately as it contained no new information. 
 
Studies were only included if they had an empirical study component.  Articles were excluded 
if they were about nurse researchers or had no information about the role of the ResN.  The 
hierarchy of evidence and research in Moule and Goodman (2009) ranks „expert opinion‟ and 
„experiential accounts‟ in the lowest two positions.  While experiential accounts give a 
valuable insight into the „day-to-day‟ work that ResNs do and are often cited in publications, 
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CINAHL
  
43 
 
Medline 
(ProQuest) 
83 
PubMed 
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Google 
Scholar 
21 
Initial search 
Pre-defined search terms 
Limited to English 
Published 2000-2012 
Excluding articles not about 
the role of the research 
nurse 
34 Unique 
articles 
Including relevant articles 
from other sources 
42 Unique 
articles 
Literature 
Reviews 
3 
Experiential 
Accounts 
8 
Expert 
Opinion 
10 
Figure 1 Search strategy 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
they have been excluded from this literature review because of this low ranking.  Likewise, 
although there was useful background information in expert opinion articles they were not 
analysed in isolation.  Three articles were excluded from the final analysis because they were 
literature reviews (Bell, 2009; Bird & Kirshbaum, 2005; Raja-Jones, 2002).   
Overview of literature 
The majority of studies about the role of the ResN are from the United States of America 
(USA) (n = 9), one of which included participants from Canada.  There are also studies from 
Australia (n = 6), Italy (n = 1), South Korea (n = 1), Spain (n = 1) and United Kingdom (UK) 
(n = 3).  Five of the Australian publications involved NZ respondents.  The publications most 
relevant to this thesis are five articles, based on two separate surveys, which are set in 
Australian and NZ ICUs (Rickard et al., 2006, 2007; Roberts et al., 2011a, 2011b; Roberts et 
al., 2006).  In some sections of this review, these studies have been analysed separately from 
the rest of the literature.  Studies which relate to clinical areas other than ICU have been 
included in the overall analysis of the literature, to position the role in a more general context. 
  
Empirical 
studies 
21 
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In all except one study (Catania et al., 2012), the ResNs were predominantly female (85 - 
100%), with an age range of 21 - 65 years.  Age was recorded using either a range or the mean.  
Where a mean age was provided, this ranged from 30.9 - 45.8 years.  Where the information 
was collected, ResNs were well educated and experienced nurses, although it is not clear 
whether this was a prerequisite for the role or if there was an expectation (either formally or 
informally) to attain these qualifications once in the role.  
 
Eight studies which included non-nurse research coordinators in the cohort have been reviewed 
because they contribute to what is known about the role.  The non-nurse study coordinators 
came from a variety of backgrounds including general sciences, public health, genetic, 
physiotherapy, and social work (Anderson, 2008; Davis, Hull, Grady, Wilford, & Henderson, 
2002; Loh, Butow, Brown, & Boyle, 2002; Rickard et al., 2006, 2007; Rico-Villademoros et 
al., 2004; Roberts et al., 2006).  Table 4 summarises the method, participants, findings and 
relevance to this study.  In this table, unless otherwise stated, the participants are nurses.  
Methods used for data collection included survey (n = 13), focus groups (n = 3), one-to-one 
interviews (n = 3) or a combination (n = 1).  The method was not articulated for one study 
(Gordon, 2008).  All but one of the studies examined information from the viewpoint of the 
ResN only.  The remaining study surveyed ResNs and research doctors (investigators) about 
the role of the research nurse (Jeong et al., 2007). 
 
Rickard et al. (2006) reported that out of the 49 respondents in a study of intensive care (ICU) 
research coordinators (RCs), there were 21 different job titles, and 31% had no job description.   
Few studies surveyed the structure of research departments, or analysed the reporting lines for 
ResNs.  The RCs reported most commonly to an intensivist (53%), nurse manager (16%) or 
both (18%).  Hill and MacArthur‟s UK study (2006) reported 17% of ResNs had a clinical 
nurse line manager.  These authors reported that a significant number of respondents (65%) 
were on fixed-term contracts and although 72% of participants had a job description, only 50% 
considered it accurately reflected their duties.  Concerns were raised about short-term contracts 
and having to recruit patients in order to pay for their wages by Hill and Macarthur.  This was 
echoed by Rickard et al. who found that 37% of respondents “would remain in the role until 
the funding runs out” (p. 236), although this was not an issue for other respondents.   
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Table 4     Summary of relevant literature about the role of research nurses 
Reference Country Method 
Participants and 
setting 
Research aim Findings in relation to this study 
Anderson  
(2008) 
USA Survey Study Coordinators 
(nurses, n = 35;  
 non-nurses, n = 55) 
 
Gene therapy 
Describe characteristics of 
sample study coordinators 
 
Determine difference between 
nurse and non-nurse 
coordinators 
 
Identify qualifications and role 
preparation 
Study coordinators learn about gene therapy research „on 
the job‟, by physicians and lack formal training 
 
Nurse coordinators were not certified in clinical research 
trial management 
 
Perceived high degree of collaboration between 
coordinators and PIs 
 
Top ranking priority skill identified as „protection of 
research participants‟ 
Bevans et al. 
(2011) 
USA Survey Clinical Research Nurses 
(CRN), Research Nurse 
Coordinators (RNC), 
Nurse Practitioners 
(NP) 
(n = 412) 
 
Large biomedical research 
institution 
Describe frequency and 
perceived importance of study 
activities 
 
Delineate differences between 
CRN and RNCs 
Two distinct roles identified (CRN and RNC) 
 
CRNs worked more in the „clinical practice‟ domain and 
significantly less in „study management‟, „care 
coordination‟, subject protection‟, and „contributing to 
science‟ 
  
RNCs more focussed on „coordinating‟ patient care and 
research activities and tended to be linked to one study or 
PI 
Catania et al. 
(2012) 
Italy Survey 
(CTNQ) 
Clinical Trials Nurses 
(CTN) (n = 30) 
 
Oncology 
Assess the role of CTN 
 
Evaluate the quality of the job 
performed 
Italian CTNs mostly focussed on trial activities, including 
„consent process‟, „implementation and evaluation of 
protocol‟ and „investigational product management‟ 
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Reference Country Method 
Participants and 
setting 
Research aim Findings in relation to this study 
Davis et al.  
(2002) 
USA Focus Group Study Coordinators 
(nurses, n = 31;  
non-nurses, n = 14) 
 
Academic medical centre, 
federal research centre, 
private organisation 
Compare whether there was a 
difference in protection of 
research subjects, depending on 
workplace 
Study coordinators balance 3 advocacy roles; patient, 
subject and study 
  
Some difference found between the balance of the 3 
advocacies depending on the workplace 
Duane et al. 
(2007) 
USA Survey Clinical Research 
Coordinators (CRC) 
(nurses, n = 101;  
non-nurses, n = 104) 
 
Members of Association 
of Clinical Research 
Professionals (ACRP) 
Describe the CRC work tasks, 
percentage of time spent on each 
task and perceptions of CRC 
work experiences 
On the job training (56%) 
 
Obstacles identified as multi-tasking, recruitment, 
interruptions and inadequate compensation 
Gordon 
(2008) 
UK Not stated Clinical Research Nurses 
(CRN) (not stated) 
Pilot data about amount of time 
spent on various study tasks 
Majority of time spent on clinical tasks and administration  
Hill & 
MacArthur 
(2006) 
UK Survey (2) 
Focus Group 
Research Nurses  
(Study 1, n = 72; Study 2, 
n = 50, Study 2a, n = 16) 
 
Lothian University 
Hospital National Health 
Service Trust 
To develop a profile of research 
nurses working for the Trust 
 
Explore professional issues 
related to their role 
Most on fixed term contracts (65%).  72% had job 
descriptions, half of which were accurate.  Line manager: 
doctors (43%), directorate manager (40%), nursing 
manager (17%) 
 
Majority reported „isolation‟.  Concerns raised regarding 
lack of support and being ethically compromised 
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Reference Country Method 
Participants and 
setting 
Research aim Findings in relation to this study 
Jeong et al. 
(2007) 
Korea Survey Clinical Research Nurses 
(CRN) (n = 79) and 
Investigators (n = 71) 
 
Hospitals, pharmaceutical 
companies and contract 
research organisations  
Determine the standard roles, 
proficiency and qualifications of 
CRNs from CRN and 
investigator perspective 
Important role components identified by both CRNs and 
investigators:  communication, completing CRFs (data) 
and obtaining informed consent 
 
Statistically significant different perception between 
CRNS and investigators: 
 CRNs > Investigators: „recruiting subjects‟ and 
„screening subjects‟  
 Investigators > CRNs: „preparing for monitoring 
and inspection‟ and „scheduling subjects‟  
Loh et al. 
(2002) 
Australia Focus Group Data Managers  
(nurses, n = 14;  
non-nurses, n = 7) 
 
Large teaching hospitals 
Explore views of data managers 
and compare their role to 
physicians in obtaining consent 
3 roles identified in informed consent process: 
 Information provision 
 Quality assurance  
 Ongoing support during the trial 
Mori et al. 
(2007) 
USA Survey 
(CTNQ) 
Clinical Research Nurses 
(CRN) (n = 109) 
 
General Clinical Research 
Centres (GCRCs) 
Describe the role of CRN to 
inform development of CRN 
professional organisation and 
certification programme 
CRNs primarily focussed on clinical implementation of 
trials. 
 
Recommended standardising through certification to 
promote consistency in education, adherence to standards 
and professionalism. 
 
CRNs had high job satisfaction, autonomy, but also stress 
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Reference Country Method 
Participants and 
setting 
Research aim Findings in relation to this study 
Mueller 
(2001) 
 
Mueller & 
Mamo 
(2000) 
 
Mueller & 
Mamo 
(2002) 
USA Interviews Nurse Trial Coordinators 
(Study 1, n = 32; Study 2, 
n = 24, Study 3, n = 24) 
 
Hospital-based medical 
centres (public and 
private clinical trials) 
Examine work of nurse 
coordinators and occupational 
processes. 
 
Career contingency 
 
Job satisfaction 
Trial coordination activities delegated „down‟ from 
doctors to nurses (sociological context) 
 
Development of the role, and the way nurses became trial 
coordinators varied 
 
Identified positive aspects as more in-depth relationship 
with patients, enhanced relationship with physicians, 
clinical skill and knowledge, and autonomy 
 
Negative aspects were  uncertainty about funding, 
professional isolation,  workload stress, paperwork, too 
specialised and lack of recognition on publications 
 
Nagel et al. 
(2010) 
USA & 
Canada 
Survey 
(CTNQ) 
Clinical Research Nurses 
(CRN) (n = 85) 
 
Paediatric oncology 
Describe the roles and 
responsibilities of CRN 
Most common roles identified were consent process, 
implementation of study protocol, professional nurse role 
performance, data management and protocol planning 
 
High levels of competence, satisfaction but also stress 
reported 
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Reference Country Method 
Participants and 
setting 
Research aim Findings in relation to this study 
Rickard et al. 
(2006) 
 
Rickard et al. 
(2007) 
 
Roberts et al. 
(2006) 
Australia 
& NZ 
Survey Research Coordinators 
(RC)  
(nurses, n = 46;  
non-nurses, n = 3) 
 
 
Intensive Care Units 
Describe demographics, 
education and work experience 
of ICU RCs 
 
Describe the current role and 
structure of RC positions 
 
Job satisfaction 
Mostly female nurses, aged 30 - 50 years, with 
postgraduate qualifications, working in Level III ICUs 
 
Role content included ethics submissions, liaison with the 
healthcare team, data collection, assess patient‟s condition 
and education 
 
Satisfaction about flexibility and hours of work, 
autonomy, making a difference to patients, intellectual 
stimulation and working with multidisciplinary team 
 
Dissatisfaction about remuneration and on call, isolation, 
stress, lack of professional recognition and career 
pathway, high workloads, protocol requirements, tension 
with nursing and senior management 
Rico-
Villademoros 
et al.2004 
Spain Survey Clinical Research 
Coordinators (CRC) 
(nurses, n = 14;  
non-nurses, n = 23) 
 
Oncology 
Determine standard tasks CRCs were mainly involved in trial activities involving 
administering the protocol 
 
Most CRCs were extremely or very satisfied with their job 
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Reference Country Method 
Participants and 
setting 
Research aim Findings in relation to this study 
Roberts et al. 
2011a 
 
Roberts et al. 
2011b 
Australia 
& NZ 
Survey Research Coordinators 
(RC) (n = 56) 
 
Intensive Care Units 
Describe demographics, role and 
responsibilities 
 
Map professional development 
priorities 
 
Job satisfaction 
 
Compare results to earlier 
survey 
Mostly female nurses, aged between 30 - 50 years, with 
postgraduate qualifications.  Long-term experience in ICU 
research 
 
Maintaining ethical standards highest priority.  Highest 
ranking study duties: ethics submission, protocol 
adherence, screening patients, education, data collection, 
regulatory and ethics matters 
 
Satisfaction about autonomy, making a difference, 
intellectual stimulation, variability and peer support 
 
Dissatisfaction about work hours, lack of support, 
recognition and job security 
Spilsbury et 
al. 
2008 
UK Focus Group Clinical Research Nurses 
(CRN) (n = 9) 
 
Pressure area care trial 
conducted in 6 National 
Health Service Trusts 
Explores scope and potential 
contribution of CRN role to 
clinical trials of a nursing-
specific topic 
Describes challenges associated with training and 
management of research nurses 
 
Identified role conflict of researcher vs nurse, and 
challenges getting nurses to comply with study protocols  
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Quality of the literature 
The overall quality of the literature ranged from single centre, pilot studies to large, well-
designed validated surveys.  The „Strengthening The Reporting of Observational Studies in 
Epidemiology‟ (STROBE) criteria have been used as one tool in assessing the quality of the 
literature reviewed (von Elm et al., 2007).  The STROBE statement consists of 22 individual 
components (Appendix A) important to the reporting of observational studies.  Each 
component is either „present‟ (Y) or „absent‟ (N), with the total number of components 
present used for rating the quality of the publication (Covic et al., 2009).  Using the criteria 
of a low score (≤10 items), moderate (11 - 16 items), or good (≥17 items) identified in 
Covic et al., there were one poor, six moderate and 14 articles of good quality.  The lower 
ratings tended to be due to using non-validated questionnaires, not including the method in 
the title, not stating bias, not outlining the statistical method used and/or not reporting on 
limitations. 
 
It is acknowledged that the STROBE criteria are better suited to assessing the quality of 
reporting of research, than the actual research itself (von Elm et al., 2007).  However, it has 
been used here as a helpful way of highlighting potential weaknesses when assessing the 
literature.  Other criteria used were; critiquing of sampling frames, data collection 
techniques and quality of findings reported which are described throughout the literature 
review.  The STROBE score generally aligned with the overall analysis of the studies.     
Development of the research nurse role 
Sociologist and Professor of Nursing, Mary-Rose Mueller, was the lead researcher in a 
series of studies based on in-depth semi-structured interview data conducted between 1992 
and 1999 (Mueller, 2001; Mueller & Mamo, 2000, 2002).  The objectives of these studies 
were to examine the role of the nurse trial coordinator, the activities they perform and 
explore their career development (Mueller & Mamo, 2000) using the conceptual framework 
of the sociology of occupational development (Mueller).  
  
The interviews were performed in two regions of the USA, using a convenience, snowball 
sampling approach.  Thirty nine interviews were audiotaped, transcribed verbatim and 
coded with recurrent patterns and themes.  The number of participants‟ interviews used for 
each of the three studies differed according to the objective of the particular study.  Six 
interviews were not included in the final analysis as the audiotapes were lost or incomplete.  
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An identified limitation of the studies was that the interviews were conducted over a long 
period of time (1992 -1999) (Mueller & Mamo, 2002).   
 
Mueller (2001) examines the path of nurse trial coordinators being delegated duties by 
doctors to it becoming a fully-fledged specialty of nursing.  She states that tasks which may 
previously have been performed by doctors for clinical trials were now routinely performed 
by nurse trial coordinators.  Potential contributing factors included an increase in clinical 
trials, recognition of the randomised controlled trial as the „gold standard‟ and physicians 
becoming too busy with other duties to perform the tasks required in clinical trials.  Mueller 
argues that delegation occurs along socially stratified lines, from higher status occupational 
groups (doctors) to lower status groups (nurses).  She also states that nurses enjoyed the 
“status enhancement” (Mueller & Mamo, 2002, p. 38) that this new position had.  Nurses 
embraced the responsibility delegated to them, and frequently acted independently.  In some 
examples of their work in clinical trials, nurses themselves resolved issues which arose with 
patients on trials; however in situations they were less sure about, they would refer to the 
principal investigator.  Making the decision to resolve independently or in collusion with 
medical staff highlighted the extensive nursing knowledge, skills and decision-making that 
experienced nurses make all the time.  She recognised that trial co-ordination was a 
combination of work which was perceived as partly medical and partly nursing.  Mueller 
questioned whether the job of coordinating clinical trials could be fulfilled by occupational 
groups, other than nurses.  She challenged research nurses themselves to prove that their 
skills and knowledge were more valuable to clinical research than those from other 
occupational groups.  
Role and work of the research nurse 
Publications quantifying and „delineating‟ the role of the ResN began to emerge from the 
USA in the mid-2000s, and several have been published since.  These international studies 
point to a clearly defined role for the research nurse of managing clinical trials and ensuring 
the study protocol is adhered to, in order to produce good quality research.  
 
Three of the studies examining the role of the ResN used the clinical trials nursing 
questionnaire (CTNQ) (Catania et al., 2012; Mori, Mullen, & Hill, 2007; Nagel et al., 2010).  
The CTNQ was developed by a working group for the Oncology Nursing Society in the 
USA to „delineate‟ the role of the ResN (Ehrenberger & Lillington, 2004).  The literature 
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indicates that it was developed in response to Mueller‟s challenge to produce empirical 
evidence about the role of the ResN.  The process of developing the CTNQ included an 
extensive literature review, which enabled generation of items for the questionnaire, using 
the Nursing Role Effectiveness Model as a framework (Irvine, Sidani, & Hall, 1998).  The 
tool was initially validated by way of an expert panel, focus group testing, reviewed and 
finalised by the working group.  The tool itself consists of 154 items and 12 sections (H. 
Deininger, personal communication, 21
st
 August, 2010).  Respondents were asked to 
indicate the frequency and importance of the predefined items within their role.  When the 
CTNQ was used to quantify the role of the research nurse, it was criticised as being too long 
by respondents.  This is supported by the low return rate of 39.5% (Mori et al.) and a high 
number (19%) of incomplete surveys (Nagel et al.).  Despite this limitation, the CTNQ was 
subsequently translated into Italian and validated using the same methodology as the 
original English version (Catania, PoirÃ¨, Dozin, Bernardi, & Boni, 2008.  It was used to 
study the clinical trials nurses in Italy (Catania et al., 2012).   
 
A two part study conducted in a Scottish research trust aimed to develop a profile of the 
research nurses working in the trust and explore professional issues (Hill & MacArthur, 
2006).  The first part of the study used a non-validated postal survey which focussed on 
employment issues, such as line accountability and job descriptions.  A second postal survey 
explored research nurses‟ knowledge, professional issues, support and educational 
opportunities.  The focus group explored these issues in more depth. 
  
Rickard et al. (2006, 2007) and Roberts et al. (2006) developed the self-reporting Rickard-
Roberts-Research Coordinator Survey (RRRCS) to conduct a cross-sectional survey of 
Australian and NZ ICU RCs in 2004.  It consisted of 33 questions related to demographics, 
education, employment history, role structure and role components.  It can be assumed that 
RRRCS was not validated, as no reference to validation is made.  The second part of the 
questionnaire used a modified, previously validated McCloskey/Mueller Satisfaction Survey 
(MMSS) to assess job satisfaction, and MMSS Importance survey so that comparison could 
be made between tasks that were done and how important they were.  Two open-ended 
questions asking respondents to list the best and worst things about being an RC were 
included and are discussed in the job satisfaction section of this review.  The survey tool 
was adjusted slightly and used again in 2009 (Roberts et al., 2011a, 2011b). 
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Both the 2004 and 2009 questionnaires were web-based and IRCIG members were invited 
to participate by email.  Reminder emails were sent between three and four weeks, and 
again at six weeks.  At the time of the first survey, the authors considered that most 
Australian and NZ ICU RCs would have been members of IRCIG.  There was a 71% 
response rate to the survey in 2004 (n = 49), of whom 44 were Australian RCs and five were 
from NZ.  The response rate dropped to 54% (n = 56) when repeated in 2009 and the 
number of NZ respondents was not specified.  The data were collected anonymously, by 
using an electronic data collection system and descriptive analysis was undertaken.  
 
Over the decade, there was consistency within the literature about the tasks research nurses 
performed for clinical trials.  The most frequently reported components of the role were 
clinical skills/patient monitoring, managing the study protocol, educating staff and 
patients/relatives, treatment administration (drug or other), collecting specimens and other 
research specific data, completing the case report form (CRF), monitoring for and treating 
adverse events, ensuring informed consent, monitoring of protocol adherence and reporting 
non-compliance or protocol deviations (Bevans et al., 2011; Catania et al., 2012; Davis et 
al., 2002; Jeong et al., 2007; Mori et al., 2007; Nagel et al., 2010; Rickard et al., 2006; Rico-
Villademoros et al., 2004; Roberts et al., 2011b).  One UK study categorised the work of the 
ResN in Newcastle, England citing unpublished pilot data from Newcastle Clinical 
Research Facility (Gordon, 2008).  Research nursing activity was examined for one week 
and found that 31.3% of time was spent doing clinical activities such as venepuncture, 
intravenous cannulation, study visits and study treatment administration.  A further 30.6% 
of time was spent on administration, with the remaining time divided between other study 
related activities.   
 
A role component considered significant to the NZ situation is protocol planning and 
development.  Rickard et al. (2006) and Roberts et al. (2011b) reported 67% and 73% 
respectively of study respondents identified protocol development as part of their role.  
About half of ResNs in four other studies were involved in protocol planning and in three 
cases it was rated with a high importance although a low frequency (Catania et al., 2012; 
Hill & MacArthur, 2006; Mori et al., 2007; Nagel et al., 2010).  Nagel et al. conducted a 
comparative analysis which revealed that the more qualified a clinical research nurse (CRN) 
was, the more likely they were to participate in protocol assessment, subject recruitment, 
obtaining informed consent, data management, and performance of the professional nursing 
38 
role.  No statistically significant association was found between the number of years worked 
in clinical research and any role components.   
 
The work of two separate research-related nursing roles was delineated in a recent USA 
study set in a large research centre (Bevans et al., 2011).  This study consisted of a survey 
based on a validated conceptual framework, which once again rated frequency and 
importance of tasks performed.  Separation between the roles of research nurse coordinator 
(RNC) and CRN was identified.  The focus of the CRN was more about delivering patient 
care of research participants, while the RNC was more focused on study management, and 
overseeing of care to research participants.  The role of nurse practitioners (NP) was less 
clear but incorporated educational, administrative and research roles 
 
In the only study that researched the viewpoint of research doctors as well as research 
nurses about the research nurse role (Jeong et al., 2007), there was a statistically significant 
difference between the perceptions of investigators and CRNs in four tasks.  CRNs rated 
„recruiting subjects‟ (χ2 4.23; p<0.05) and „screening subjects‟ (χ2 6.83; p<0.01) as important 
components of their role, more than the investigators did.  Conversely, investigators rated 
„preparing for monitoring and inspection‟ (χ2 6.08; p <0.01) and „scheduling subjects‟ (χ2 
8.99; p<0.05) significantly higher than CRNs.  The standard deviations were not provided in 
this publication.  The CRNs and investigators both rated „communicating with 
investigator/sponsor‟ and „completing CRFs‟ in their top five roles.  This Korean study used 
a non-validated questionnaire, purposeful selection of respondents and weighted the 
findings of the investigators more highly than the CRNs in its conclusions.  However, it 
highlights the different perception about the role between the investigators and ResNs.  
Roberts et al. (2011a) also highlighted participant and management perceptions as an area of 
future investigation. 
 
Communicating with and educating staff was highlighted as a very important aspect of the 
research nurse role and was identified as a major factor contributing to protocol adherence 
(Rico-Villademoros et al., 2004; Spilsbury et al., 2008).  Some studies described the ResN 
as being a „hub‟ who liaised with investigators, research companies, patients and their 
families, clinical staff and other clinics or departments (Davis et al., 2002; Rickard et al., 
2006).   
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Spilsbury et al. (2008) used the opportunity which arose from conducting a large, multi-
centre randomised controlled trial about pressure area care across six National Health 
Service Trusts in the UK to study the role of the CRN.  They conducted a focus group to 
explore the experiences of being a CRN, and hear their observations of care related to trial 
and clinical practice.  Out of the potential 16 CRNs, nine participated in the focus group.  
The participants were guided towards the aims of study, with the facilitator encouraging 
more in-depth discussion of inconsistencies amongst the group.  The focus group discussion 
was recorded, as well as field notes being made, then transcribed verbatim and analysed 
using QSR NVivo v.2 – a software package for analysing qualitative data.  The data were 
grouped into themes for content analysis which was performed by more than one team 
member to ensure trustworthiness.  One of the challenges the CRNs voiced was ward 
nursing staff not complying with the study protocol.  In some cases if the RC didn‟t 
administer the treatment, which in this case was putting the correct mattress on a bed, then it 
didn‟t get done.  The CRNs reported that staff just didn‟t understand the trial process.  Often 
relevant paperwork was not completed or was poorly completed, making it difficult to 
understand things that had happened with regards to the trial.   
 
Managing trial budgets featured as a major role in the latest study by Roberts et al. (2011b), 
in which 86% of ResNs were now responsible for this task, compared to only 47% in their 
previous study (Rickard et al., 2006).  Although few respondents in Mori et al.‟s 2007 study 
about role delineation prepared study budgets on a frequent basis, 72% rated it with high 
importance. 
 
Developing nursing research was not generally formal component of the ResN role.  Hill 
and MacArthur (2006) reported that only 15% were involved in developing studies to 
examine nursing practice.  Of the 61 ResNs not already involved in nursing research, 52% 
expressed an interest in doing so and 59% of those considered that it would be possible.  
Rickard et al. (2006) reported that 36.7% (n = 18) of RCs were conducting their own 
studies, although this did not seem to be as part of their role as RCs.  A higher proportion of 
those who were studying towards or already had masters level degrees, conducted their own 
research.  It was not discussed whether the research being conducted was solely for the 
purpose of attaining a qualification or to answer a research question.   
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Ethics, patient advocacy and consent 
Ethics was discussed in several studies, where the ResN held a key role in ensuring that 
ethical principles were upheld.  An important study of study coordinators, of whom 68% 
were nurses, by Davis et al. (2002) was set in three different work settings (an academic 
medical centre, federal research institution and private organisation) in the USA.  Seven 
focus groups were conducted where participants were given different vignettes about the 
roles and skills of study coordinators, and then study recruitment.  Transcripts of the focus 
groups were coded using NUD.IST version 5.  Their findings indicate that study 
coordinators balance patient advocacy and welfare with the rights and welfare of a patient as 
a research subject (subject advocacy) and advancing research goals and ensuring that the 
right patients were recruited and the study protocol adhered to (study advocacy).   
 
Preparation of ethics submissions was considered part of the RC role by 96 - 100% of 
respondents in Rickard et al. (2006) and Roberts et al. (2011b).  Respondents in Mori et al. 
(2007) rated this as a role component which was performed infrequently, however was of 
high importance.  Although other studies cover ethics issues, these were the only studies 
where ethics submissions were listed as a major role component.  The reason for this is 
unknown, however may be related to differing ethics systems internationally. 
 
Involvement in the consent process was a major component in many studies.  In some 
studies, it was unclear whether ResNs obtained consent or just ensured it was obtained 
(Catania et al., 2012; Mori et al., 2007; Nagel et al., 2010).  Bevans et al. (2011) articulated 
this as “facilitate the ongoing informed consent/assent process” (p. 424).  The terminology 
about consent changed between the first and second survey of Australian and NZ RCs from 
“Request consent” (p. 238) in 2004 to “Obtain consent” (p. 264) in 2009 (Rickard et al., 
2006; Roberts et al., 2011b).  The number of respondents for whom this was part of their 
role however, remained high at 78% and 80% respectively.  Another Australian study 
conducted a focus group about ethical issues for data managers, two thirds of whom were 
trained nurses (Loh et al., 2002).  The data managers had a role in obtaining consent, and 
rated upholding ethics by ensuring that consent was informed as important.  Hill and 
MacArthur (2006) highlighted a lack of training to obtain informed consent, even though 
this was part of the ResNs‟ role.   
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Job satisfaction 
Nine of the 21 studies examined job satisfaction of ResNs as a component of a larger study.  
Most reported that ResNs were generally very satisfied with their role.  The long period of 
time ResNs tended to stay in their positions was also construed as an overall indicator of job 
satisfaction (Mueller & Mamo, 2002; Roberts et al., 2011a).  Two UK-based studies 
reported more negative components than positive, highlighting in particular the sense of 
isolation ResNs experienced (Hill & MacArthur, 2006; Spilsbury et al., 2008).   
 
Two studies used the previously discussed CTNQ tool to assess job satisfaction (Mori et al., 
2007; Nagel et al., 2010).  The CTNQ contains a section titled „professional nursing role 
perception”, and asked respondents to rate 10 statements about stress, satisfaction, 
competence, recognition and support on a five point scale (Strongly Agree, Agree, 
Undecided, Disagree, Strongly Disagree) or “not applicable”.  Mori et al. reported that the 
majority (88%) of respondents felt competent in their current role, 82% experienced job 
satisfaction and 79% experienced autonomy and independence.  These results were 
reinforced by Nagel et al. (2010) where the majority (94%) of respondents felt competent, 
satisfied (90%) and experienced autonomy and independence (89%).  This was similar to 
the results of the Spanish Lung Society study in which most (83%)  CRCs  expressed job 
satisfaction and believed they played an important role in oncology clinical trials (Rico-
Villademoros et al., 2004).  
 
Positive aspects of the role which consistently featured in the studies included autonomy, 
flexible and social working hours, and intellectual stimulation (Rickard et al., 2007).  
Mueller and Mamo (2002) analysed the “benefits and drawbacks” of the nurse trial 
coordinator role, using a sub-sample of 24 from their original 39 semi-structured interviews 
conducted.  Participants identified benefits of the position as autonomy, daytime social 
hours, different, more intense relationships with patients and a more „equal‟ relationship 
with physicians including more respect from physicians.   
 
Negative aspects of the role included working in isolation, lack of recognition, 
administration, heavy workloads, stress, and uncertainty about the security of on-going 
employment in the position (Hill & MacArthur, 2006; Roberts et al., 2006; Spilsbury et al., 
2008).  The drawbacks cited by Mueller and Mamo (2002) included lack of recognition on 
publications, physicians‟ lack of urgency in dealing with matters, no back-up when trial co-
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ordinator is on leave, position insecurity (grant-dependent), isolation from other nurses and 
paperwork and the inability to actually change the outcome of diseases such as AIDS in 
particular patients.  
 
Most significant to NZ, was the job satisfaction of the cohort of 49 Australian and NZ ICU 
RCs (Rickard et al., 2007; Roberts et al., 2006).  The results of the open-ended questions 
were clustered into four themes; how the job is structured, worth of the job, what the work 
involves and who I work with.  All of these categories had statements for the best and worst 
aspects.  High on the list of best aspects of the role were flexibility and work hours, 
autonomy, making a difference to patient care, intellectual stimulation and working with the 
multidisciplinary team.  Negative comments included being on-call, poor pay, isolation and 
stress, lack of recognition, protocol requirements, dealing with ethics committees, workload 
and nursing colleagues and senior management.  There were more positive statements 
(60%) than negative statements (40%) in 2004.  When the study was repeated in 2009, while 
there were still more positive (52%) than negative statements (48%), the overall findings 
were more negative than the previous study.  The 2009 findings rated „lack of support or 
recognition in general‟ highest in the negative themes, followed by working unsociable 
hours and lack of job security (Roberts et al., 2011a).  The best aspects of the role were 
autonomy, peer support and variability. 
 
The MMSIS component of the study consisted of 31 points about specific aspects of 
satisfaction and importance about the role (Rickard et al., 2007).  Respondents were asked 
to select a number from 1-10 with one being not satisfied or important to 10 being very 
satisfied or important.  The questionnaire was formatted so that respondents answered the 
questions regarding satisfaction, followed by the same points listed for importance.  The 
study found that RCs were generally satisfied with their position with a score of 3.84 (out of 
5).  The aspects which RCs felt most satisfied with, and had a mean satisfaction score over 
4.3 were working social (normal) hours, flexibility, weekends off, level of responsibility and 
level of control over work.  Things that RCs were least satisfied with a level satisfaction 
level ≤ 3.25 were compensation for working weekends, child care facilities, other aspects of 
remuneration package (e.g., no cellphone or laptop provided), salary level and lack of 
opportunities for career advancement.  The open-ended questions were in the middle of the 
questionnaire, before the predefined points, so to some extent they validated the findings 
from the questionnaire. 
43 
 
Rickard et al. (2007) also rated the same role components for importance.  Items which 
rated with the highest importance were level of control over working conditions, level of 
input into decision making and level of control over work, with 100% of RCs rating these as 
very or moderately important.  The least important aspects were membership of 
departmental committees, social contact with colleagues outside work and convenient 
childcare facilities.  The area the authors highlighted as concerning was where an item 
received a high importance score and a low satisfaction score.  The top five of these were 
compensation for working weekends, salary level, recognition by ICU management, career 
advancement opportunities and research processes in unit.   
 
A sense of isolation featured in almost every study.  Hill and MacArthur (2006) found in 
one of the questionnaire components of the study that 58% of ResNs expressed a feeling of 
isolation within their jobs.  The feeling of isolation was reiterated in the focus group 
component of the study.  Focus group participants were also asked for strategies to deal with 
this sense of isolation.  Responses included discussion with clinical colleagues (69%), 
contact with other ResNs (48%), support from manager (14%) and 10% found it difficult or 
could not find a strategy.  They also reported that ward nurses didn‟t understand their 
feelings of isolation and thought they had an easy job because of the social hours, and didn‟t 
see the rest of the job, which in some cases included unsociable hours.   
 
This sense of isolation was also one of the themes that emerged from the study by Spilsbury 
et al. (2008).  The findings of this study were generally quite negative, which the authors 
attributed, in part, to recall bias as the focus group was conducted after the study had 
finished.  CRNs experienced hostility from ward staff, even though ward management had 
agreed to participate in the trial.  A strategy to overcome this was to help staff in clinical 
areas to gain their cooperation in research.  However, the CRNs experienced role conflict 
between their role as CRN and their role as a clinical nurse and reported that there was an 
over-reliance by ward staff to provide clinical expertise beyond the scope of the research 
project.  This included asking staff asking them questions about non-research specific 
pressure area care.  The CRNs in this study also expressed that they were regarded 
„differently‟ to CRNs working on medical trials because their trial was nursing research, 
although the reason for this was not discovered.    
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In contrast, many studies reported support from other staff.  In the CTNQ „perception‟ 
section, 66% experienced acceptance and support from non-research nurses, 85% support 
from physicians and 83% experienced support from administrative staff (Mori et al., 2007).  
Nagel et al. (2010) reported similar results with 75% reporting they had support of non-
research nurses in their role as CRNs, more than 90% experienced physician support and 
more than 70% had administrative support.  Nagel et al. reported that CRNs had a dual role 
of nurse and researcher in the oncology setting.  Some of the findings were contradictory 
such as enjoying learning new skills and knowledge required, but perceiving the specialty as 
„too narrow‟, or being a speciality within a specialty (such as research within the oncology 
setting) (Mueller & Mamo, 2002).   
 
A high rate of stress was reported by many ResNs.  Mori et al. (2007) reported that 67% of 
CRN respondents experienced stress related to their workload.  This was even higher in 
Nagel et al. (2010) at 81%.  Stress related to role ambiguity was also reported by 43% of 
CRNs in Nagel et al.‟s study.  Duane et al. (2007) found CRCs considered the number of 
studies they managed was more than they thought was a reasonable number.  Multi-tasking, 
recruitment, interruptions and inadequate compensation were cited as the four main (over 
50%) obstacles to completing work tasks.  Twenty percent of the respondents in the study 
stated they worked more than 50 hours per week.  This was confirmed by Anderson (2008) 
who reported 11% of study coordinators worked 41 - 50 hours per week, and another 11% 
working more than 50 hours per week.  Heavy workloads were also reported by 24% of 
respondents in Roberts et al. (2006).   
 
Many studies suggested strategies to overcome drawbacks of the roles or identified it as an 
avenue for future research (Mueller & Mamo, 2002).  Some strategies included 
establishments of a network, establishing a research nurse database and permanent contracts 
to increase job security (Hill & MacArthur, 2006).   
Role preparedness, career pathways and professional development 
A common theme throughout the literature, from all countries is that ResNs had learnt how 
to do their work, “on the job” (Anderson, 2008; Hill & MacArthur, 2006; Mori et al., 2007; 
Mueller, 2001).  Mori et al. reported that 80% of respondents reporting that they were self-
taught.  This was backed up by Hill and MacArthur who reported that only 44% of 
respondents had been specifically orientated to their research role, although most of the rest 
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felt this would have been useful.  Ninety percent however, had access to continuing 
professional development although few took the opportunity to use it.   
 
A significant study examining the role preparedness of gene therapy research coordinators 
aimed to compare the nurse and non-nurse respondents (Anderson, 2008).  This study was a 
web-based validated survey of study coordinators in the USA.  The focus was particularly 
about ethical preparedness, considering the contentiousness of gene therapy research and 
likely ethical situations which may arise.  The study found that despite study coordinators 
feeling strongly prepared for their role, few of them actually had formal training in this 
specialty.  Non-nurse study coordinators lacked clinical knowledge, skill and expertise in 
gene therapy, physiology, disease pathology, pharmacology or adverse events, while the 
nurse study-coordinators lacked knowledge and experience about research ethics and 
scientific misconduct.   
 
Research nurses commonly learnt from the Principal Investigators (25%) and from other 
study coordinators (25%) (Anderson, 2008).  They also learnt through monitoring visits, by 
making mistakes, from meetings, and networks.  The reasons for learning this way appeared 
to be partly due to the lack of specific formal training for research nurses and perhaps the 
lack of career structure (Rickard et al., 2006).  Roberts et al. (2011a) built on this theme by 
examining the RCs‟ perception of professional development.  They found that RCs rated 
“protection of research participants” (p. 132) as the most important priority for professional 
development.  This was followed by communication skills and organisational, planning and 
management skills. 
 
According to Mueller and Mamo (2000), career development was determined by a number 
of related factors, rather than following a predefined career pathway.  They called this 
concept “career contingencies” (Mueller & Mamo, 2000).  Mueller and Mamo (2001) report 
that there was no single route for nurse to become clinical trials nurses, but rather it was a 
number of contributing factors which led to this being an advantageous career for a nurse.  
During the time these interviews were conducted, there was no official training for clinical 
trials nurses and the nurses had a tendency to “learn on the job” (Mueller, 2001, p. 185).  
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Summary and areas for further research 
There was a predominance of literature about the „tasks‟ ResNs performed for research trials 
and a major finding from the literature was that the primary role of the research nurse was 
the management of clinical trials.  The most commonly identified tasks were about 
administering the study protocol.  The „sociology‟ studies indicated that study tasks had 
been delegated „down‟ from doctors to nurses, and the work could be seen as both nursing 
and medical.  Was this the case in the ICU setting, where patients are so ill, and families 
stressed?  The Australian literature which was set in ICUs showed a significant number of 
ResNs were also involved in protocol development – was this role also a feature for NZ 
ResNs, given the collegial relationship through the organisations identified in Chapter 2?  
While „identifying study tasks‟ cannot be identified as a gap in the international literature, it 
was not known whether NZ ResNs shared this role with their counterparts internationally.   
 
Job satisfaction featured in many studies, with ResNs generally being satisfied with their 
role.  Areas of dissatisfaction identified were:  Lack of recognition, poor remuneration, no 
career pathway, high levels of stress, high workloads, lack of job security and a sense of 
isolation.  Because much was already written about job satisfaction, this shaped the type of 
questions asked in the ResN interviews, as will be seen in Chapter 4.  Isolation was a 
significant feature for many ResNs internationally.  NZ is a small, low populated country 
with relatively few, geographically distant ICUs who employ a ResN.  It was unknown 
whether NZ ResNs also experienced a sense of isolation, and if so, the strategies they had 
found to overcome it.  The role of ResNs has already been identified in Chapter 2 as 
relatively new – had that led to a sense of professional isolation?  Other challenges faced by 
the ResNs in NZ were also unknown.   
 
Research nurses tended to be well-qualified and experienced, but undertrained in clinical 
trial management.  The literature indicated that learning „on the job‟ was the predominant 
way of being orientated to the ResN role.  Given the newness of the role in NZ ICUs, how 
did the ResNs learn what to do, and given that there are so few, who taught them?  There 
was little written about the management structures ResNs work within.  The two studies 
which did examine lines of accountability reported that most ResNs reported to PIs, with 
others reporting to nursing and other managers.  It was unknown if there was any similarity 
amongst who NZ ResNs report to, and the structures they work within compared to other 
international settings.  These same studies identified job security as a problem, and ResNs 
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were often employed on a „contract‟, rather than as a permanent position.  Given the CICM 
requirements identified in Chapter 2, would this also be the case in NZ ICUs?  I had some 
prior knowledge of funding sources, and together with the literature about job security, I 
identified this as information which needed to be gathered, when examining the role. 
 
Patient advocacy was a significant feature in only one study (Davis et al., 2002), yet ICU 
ResNs work in a setting in which patients are extremely vulnerable.  Describing the ResN 
role in balancing the demands of the study with those of the patients, was clearly described 
in this study.  Logically, balancing these demands in the ICU setting could be even more 
important, given the vulnerable population.  This Davis et al. article had a significant impact 
on my study as I sought to explore whether ResNs also had an advocacy role in the ICU 
research setting.  
 
A significant feature of the literature was that by far the most commonly used method was a 
survey design.  This finding was important when designing this study because while survey 
gave an excellent overview of the demographics of the ResNs, and the tasks they performed, 
it lacked depth.  An example was that ResNs were identified as being involved in the 
consent process, yet it was unclear whether they obtained consent, or just ensured that a 
consent form was completed by a member of the research team.  Additionally, although 
participation in ethics submission was noted in three studies, this process was not described.  
The ethics system in NZ is very robust, and whether ResNs are involved is significant.  
 
Much of the literature was set in the USA, where the healthcare system differs greatly from 
NZ.  While the literature set in Australian and NZ ICUs was robust, NZ ResNs accounted 
for only 10% of the cohort and their accounts have not been analysed separately.  All but 
one of the studies explored the role of the ResN from only the ResN perspective.  It wasn‟t 
known if this view aligned with other members of the multidisciplinary team they work 
with.  This had significant influence on the research question and overall design of my 
study, as I sought to describe the role from the ResN, PI and NM perspective.  
 
Despite the increasing volume and quality of literature about ResNs, two major omissions 
were identified.  These are; „what is the ResN role in the NZ setting?‟ and „what are the 
perspectives of those they work with?‟  These findings and unanswered questions lead on to 
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the next chapter which describes how this study was undertaken to fill some of these gaps in 
knowledge. 
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Chapter 4     Methodology 
Introduction 
The primary aim of this study was to describe the role of the ResN in NZ Level III ICUs, 
from the perspective of the ResN, PI and NM.  The secondary aim was to describe the 
structure and funding of the research departments in the context of the ResN role.  This 
chapter commences with describing the methodological approach used to answer the 
research question and the rationale for choosing the qualitative descriptive approach.  The 
overall study design is then reported in depth, including the method used, use of analysis 
tools, sample selection and recruitment.  The chapter also reports on ethical issues 
encountered, the process of analysis and how rigour was ensured. 
Qualitative Description 
The function of the methodology is the “strategy, plan of action, process or design lying 
behind the choice and use of particular methods” (Crotty, 1998, p. 3) which will answer the 
research question.  Broadly speaking, the considerations when selecting the methodology 
for this study included the ability to answer the research question, a rigorous approach, 
collect good data, feasible to do in the time frame, good recruitment of participants and 
produce results which would add to the body of literature.  The research question could have 
been answered in a number of ways, and survey and case study methodologies were 
explored and eliminated before selecting the qualitative descriptive approach.  As an insider, 
the methodological approach also had to be „safe‟ for me as I was researching my 
colleagues, who I rely on for advice and support.  
 
The overarching approach to this study is qualitative description.  Qualitative research can 
be defined as research that explores and seeks to interpret social or human behaviour 
(Creswell, 2009; Gillis & Jackson, 2002).  There is a focus on verbal rather than numerical 
data.  Accurately defining qualitative description is challenging.  Even Sandelowski (2010), 
who has been attributed as identifying qualitative description as a methodology describes it 
as “naming that that has no name” (p. 80).  Qualitative descriptive studies aim to accurately 
describe a particular phenomena or aspect of society (Gillis & Jackson), in this case, the role 
of the ResN.  While the interpretation in qualitative description is less in-depth than other 
qualitative methodologies, some interpretation is still required (Milne & Oberle, 2005; 
Sandelowski, 2000).  According to Sandelowski (2000) this lower lever of interpretation 
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enables the voice and meaning of the participants to be presented as intended.  It reflects the 
views of the people whose behaviour is being described, through rich verbal data, as well as 
the interpretation of the data by the researcher (Gillis & Jackson).   
 
Qualitative description was the best approach to answer this research question because the 
study aimed to describe the ResN role and understand what was already happening in NZ 
ICUs.  Critical discourse was not required as I did not aim to find which interpretation of the 
role was the right one but to gain an understanding.  This included establishing what was 
happening in the ResNs‟ role, who they were, what they do and how they do it.  Qualitative 
description allowed me to describe patterns, see if there was consensus or variability about 
the role and whether there was shared understanding amongst the key informants and 
amongst ICUs.  If there were differences, what aspects were different and what underpinned 
those differences?  I presumed that the role was shared throughout NZ but I didn‟t know if 
all components were shared, or what influenced any differences or similarities.  
 
One methodological approach which was considered was survey design using a 
questionnaire.  A survey approach would have been appropriate for gathering data to 
describe the role of the ResN and the literature review revealed that this methodology had 
been used to answer similar questions, with some success (Bevans et al., 2011; Mori et al., 
2007; Nagel et al., 2010; Rickard et al., 2006, 2007; Roberts et al., 2011a, 2011b; Roberts et 
al., 2006).  Existing questionnaires (G. Eastwood, personal communication, 6
th
 April, 2010, 
H. Deininger, personal communication, 21
st
 August, 2010) could have been adapted to 
incorporate the PI and NM participants.  The limitations of the survey method include that 
the sample size would have been very small for this approach and a poor return rate would 
have resulted in incomplete data.  Poor response rates is a common problem with survey 
with Gillis and Jackson (2002) reporting that response rates between 50 and 75% are good. 
However, even a response rate of 75% would possibly have meant the question was not 
fully answered.  The ultimate reason a survey design was eliminated was that the findings 
generated would be too similar to a study conducted in Australian and NZ ICUs by Rickard 
et al. (2006) using a survey methodology. 
 
Case study was also considered as a way of reporting about the role in each ICU.  Case 
study is defined as an in-depth analysis of a case (Stake, 1995; Tellis, 1997).  The single 
case can refer to a “program [sic], event, activity, process of one or more individuals” 
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(Creswell, 2009, p. 13).  Case study is most useful when you know little about a group or 
community.  Studying „role‟ as a phenomena in case study would have been difficult 
because the information being studied was too general (Stake).  Case study would have 
worked better if I was studying one ResN or one ICU.  The issue with case study is that it 
wasn‟t going to enable sufficient description about role of the ResN across the ICUs.   
Overall study design 
Semi-structured interviews with three sets of key informants were chosen as the overall 
design.  Although usually referred to in ethnography, key informants are those people who 
know the most about the phenomena (Crabtree & Miller, 1992; Gillis & Jackson, 2002).  
The key informants identified for this study were the ResNs, PIs and NMs.  Analysis was 
planned for within the whole dataset, within key informants‟ groups and within ICUs.  As 
part of the analysis, a responsibility assignment matrix (RAM) was used to determine who 
had responsibility for key research tasks.  The matrix is discussed in more detail later in this 
chapter. 
Semi-structured interviews 
The data were gathered via semi-structured interviews.  Qualitative research has an 
emphasis on verbal descriptions and the most commonly used method for obtaining such 
data is the semi-structured interview (Whiting, 2008).  Semi-structured interviews are one-
to-one interviews which are conducted with some pre-defined open-ended questions, whilst 
also allowing for themes to emerge (DiCicco-Bloom & Crabtree, 2006).  They differ from 
other forms of interview in that unstructured interviews are usually used in conjunction with 
other data collection methods and are non-directive in nature (Ryan, Coughlan, & Cronin, 
2009).  Structured interviews have an explicit interview schedule which asks the same 
question in exactly the same way to all participants (Ryan et al.).   
 
Semi-structured interviews were decided as the most appropriate method for this study 
because it was possible to direct the course of the interview to gather data needed to answer 
the research question.  It also allowed the participants to initiate other topics and expand on 
specific things if they wished.  There were also other, more pragmatic reasons for 
conducting interviews including the increased likelihood of participants to keep a pre-
arranged appointment for an interview than respond to a questionnaire.  Given the likely 
sample size, semi-structured interviews of the three participant groups were considered 
feasible and likely to elicit enough data to describe the role of the ResN.   
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One of the considerations, which never arose, was that not all participants would agree to 
being interviewed.  While it was already known that the ResNs were enthusiastic about the 
study and keen to participate, the likely reaction of PIs and NMs was initially unclear.  The 
nature of this design meant that a comprehensive perspective from each of the sites was 
required.  To off-set the risk of low recruitment of PIs and NMs, a more in-depth interview 
schedule for the ResNs was developed.  
 
Prior to commencing the interviews, a pilot interview was conducted in April 2011 with a 
nurse who had previously worked as an ICU ResN, to test the ResN interview schedule and 
recording equipment.  Their feedback was sought and no significant changes were made to 
the schedules.  It was not thought necessary to test the PI and NM interview schedules as 
they were derived from the ResN schedule which had the most detailed questions. 
Other methods considered 
Other methods that were considered included focus groups, document review and self-
observation by way of a time-and-motion diary and a combination of these.  Focus groups 
are a form of interviewing or group discussion where a group rather than an individual is 
interviewed (DiCicco-Bloom & Crabtree, 2006).  Focus groups are facilitated by a 
moderator (Plummer-D'Amato, 2008), who relies on the group interacting  with each other 
to elicit rich “interactive data” (Lambert & Loiselle, 2008, p. 229). The moderator needs to 
encourage participants to talk about the topic with each other, rather than using probing 
questions that might be used in individual interviews (Gillis & Jackson, 2002).  An 
advantage of focus group as a method is the perceived ease of only conducting one 
„interview‟.  However, for the purposes of this study, two main limitations were identified.  
The ResNs worked in six different ICUs around NZ which would have made it logistically 
difficult to get them together.  Secondly, in focus groups, strong-willed individuals may 
influence the group discussion and therefore the data gathered (Gillis & Jackson).  While I 
am unable to say whether this was a possibility for the sample I had selected, I knew that the 
ResNs had varied levels of experiences and length of service.  It was important to capture all 
of their views and it was possible that more experienced ResNs could dominate a focus 
group.  I was uncertain that as a novice researcher and interviewer, I would be able to 
manage this situation.   
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A time-and-motion study would have been an appropriate method to gather some of the data 
required (Harrison & Nixon, 2002; Lindquist et al., 2011) and I considered asking the 
ResNs to keep a diary of their work activities, hourly.  An advantage of this method is that it 
would have given an accurate reflection of the work ResNs did for that timeframe.  It was 
my own personal experience which eventually discounted the idea.  As part of my role, I 
have to allocate hours to particular clinical trials and projects which is a task I find 
burdensome and sometimes time-consuming.  I also find it disruptive to complete at the 
time, and often do it retrospectively.  Asking ResNs to account for every hour over the 
period of one or two weeks was therefore considered to be unrealistic given their usually 
very busy job.   
 
Conducting a document review of the ResNs‟ position descriptions was also considered to 
complement the interviews.  When I was developing my own position description, I found it 
very difficult to obtain position descriptions from other hospitals, as they are confidential to 
the hospital.  To replace this, and partly address this issue, a question was included in the 
ResN interview schedule asking if they had a position description and whether this was 
indicative of the work they did. 
Interview schedules  
Interview schedules were developed for the three participant groups.  This was necessary 
because I recognised that each group would have different levels of knowledge about 
aspects of the role.  The ResNs‟ interview schedule was the most detailed, incorporating 
questions about all aspects of the role, finances and the structures of the departments 
(Appendix B).  The PI interview schedule focussed on finances, structures and their 
understanding of the roles and responsibilities of the ResN (Appendix C).  In addition to 
this, more focus was placed on nursing management in the NM interview schedule 
(Appendix D). 
 
The interview schedule is recognised as a key element in successful data collection through 
semi-structured interviewing (Baumbusch, 2010; DiCicco-Bloom & Crabtree, 2006; Ryan et 
al., 2009).  The progression of the interview schedules was designed to establish rapport 
with the participants by initially asking closed ended, non-threatening questions before 
progressing to more open-ended questions about structures and various aspects of the ResN 
role.  The NM and PIs were not well known to me so establishing rapport was important for 
me as well as the participants.   
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All of the interview schedules began with an introduction and then consisted of five sections 
which aligned with a mixed analysis approach.  These sections were background, 
accountability and funding, ResNs role and responsibilities, processes around studies and 
future development of the ResN role.  The order of the sections and questions was adapted 
for the individual interview schedules, and as the interviews were semi-structured, the order 
was adjusted, depending on the flow of the interview. 
 
The „background‟ section of the ResN schedule consisted of a collection of closed questions 
including demographic data about their hours of work, length of service, qualificat ions, and 
how they were orientated to the role.  The PI and NM interview schedules began with 
closed-ended questions about their role in the research department in relation to the ResNs 
and clarification of the studies the ICU was participating in. 
 
The accountability and funding section consisted of a series of closed and open-ended 
questions, with prompts.  The data I wanted to elicit from this section was how the ResNs‟ 
positions were funded, and what the structure within the department was.  The NMs and PIs 
were also asked more specific questions about the financial situation in the research 
department, including the mix of studies they participated in.  All groups were asked 
whether the ResNs were seen as „senior nurses‟ within ICU, and also about the expectation 
of them in relation to resource allocation when the ICU was short-staffed.  Specific 
questions were asked about the CICM guideline requiring tertiary level ICUs to fund a 
research coordinator (CICM, 2010a), and necessity of, and funding for ResNs to attend 
work-related meetings. 
 
Questions about the ResNs‟ role consisted of open-ended questions, with a series of prompts 
which were used if necessary.  ResN participants were asked to recall what they did the last 
day they worked as a ResN.  The only prompts they were given was to think about 
everything they did, including interruptions.  They were then asked if this constituted a 
typical day and if it was, what would be different about an atypical day, and if not, then 
what a typical day was.  This question was included as an alternative to the time-and-motion 
diary and was used for content analysis as well as to inform the RAM.  One benchmark 
question was included in this section asking all participants about the expectation of the 
ResN if a clinical emergency arose while they were with a patient in a research capacity.  To 
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give context to two questions, the participants were told some background information from 
the literature about patient advocacy and a sense of isolation.  Participants were also told 
that in one study, 4% of research coordinators in Australasian ICUs were not nurses, then 
asked if they thought it was necessary for ResNs to be nurses in the ICU setting.  When it 
came to analysis, I realised that one important question which emerged in some ResNs‟ data 
had not been asked of all participants.  This was whether there was pressure to do further 
study.  For the participants who had asked to review their transcript, I asked them this 
question in the cover letter accompanying their transcript.  For the others I contacted them 
by email to ask what their highest qualification was, and whether there was any pressure to 
do advanced study.  
 
The „processes around studies‟ section was the most structured set of questions and was 
designed to populate the RAM.  This section consisted of a mixture of open and closed 
questions.  The closed questions were about who does specific pre-defined tasks. 
 
The final section consisted of open ended questions regarding the development of the ResN 
role, and specific questions about the CTG recommendation that there always be a research 
coordinator on CTG-endorsed management committees.  PIs were asked more specific 
questions about the future role of the ResN in regards to management committees.  The 
ResNs and NMs were also asked about their knowledge of a consultation paper about 
developing a generic competency framework for ResNs in NZ  (Walker et al., 2010).  The 
interview was then closed with an invitation to make any other comments.   
Responsibility assignment matrix  
Prior to the interviews, I gave a 30 minute presentation about my proposed study to 
approximately 70 Australian and NZ ResNs and RCs at the IRCIG Research Coordinators 
Workshop, in Australia, in March 2011.  The presentation was about my experience when I 
was a novice ResN, the background to why I wanted to conduct the study and basic themes 
of the international literature.  Information delivered about the interviews was selective, 
outlining broad areas of questions, because only some of the potential ResN participants 
were at this presentation.  Much positive feedback was given from the ResNs present, many 
stating that my story resonated with them.  One of the other guest speakers, Dr Andrew 
Giddy from the Victoria Ethics and Governance Board approached me during a break 
(personal communication, 10
th
 March, 2011).  He suggested using a “RACI Chart” to assess 
whether the different occupational groups agreed about the actual tasks that ResNs 
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performed.  RACI is an acronym for the four levels of responsibility; Responsible, 
Accountable, Consulted and Informed and is one form of a responsibility assignment matrix 
(RAM).  It seemed like a good suggestion and I explored its use on the internet and in 
project management books (Project Management Institute, 2008; Smith & Erwin, 2007; 
Williams, 2008). 
 
RAMs are used in project management as a way of managing tasks and resources for 
projects (Project Management Institute, 2008).  There are several variations of RAM which 
show levels of responsibility related to activities, decisions or tasks and articulating an 
individual‟s role in a project (Smith & Erwin, 2007; Williams, 2008).  As can be seen in 
Table 5, in RAMs, staff have various levels of responsibility for individual tasks.  When 
RAMs are used prospectively, the purpose is to plan levels of responsibility assigned, in 
order to allocate resources accordingly (Williams).  Using a RAM retrospectively allows the 
user to analyse problem areas in projects.  For example if more than one person has overall 
accountability for a task, or if no-one has accountability for a task, this may make decision-
making difficult (Smith & Erwin).   
 
Table 5     Levels of responsibility in responsibility assignment matrix* 
 Level of Responsibility Description 
Responsible The person who actually does the task 
Accountable The person who has overall accountability for ensuring 
that a task is carried out 
Consult The person who may be consulted for advice or 
information (characterised by 2 way communication) 
Inform The person who is informed after decisions have already 
been made and who may be required to take action as a 
result (characterised by 1 way communication) 
*Adapted from “Role and Responsibility Charting”, by Michael J. Smith & James Erwin, 2007, Retrieved 
from http://alliancebestpractice.co.uk/downloaddoc/RACI%20Explanation.pdf on 31st March 2012.  
 
I decided to use a RAM as an analysis tool.  This was developed prior to the interviews, so 
that relevant questions could be included in the interview schedule.  The individual RAM 
charts consisted of a list of study tasks on the Y axis (Figure 2).  These study tasks were 
developed using the literature and personal experience.  The X axis consisted of different 
ICU health professionals, who I thought would be involved in the study tasks.  I left spaces 
on the Y axis to include study tasks which I hadn‟t thought of.  The spaces were filled in 
with „R‟, „A‟, „C‟ or „I‟ (Table 5), to indicate the level of involvement (if any), the different 
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roles in ICU had for study tasks.  The responsibilities could also be combined, so if 
someone had overall accountability for ensuring the task was done, and also did the task, 
this would be written as „A/R‟. 
 
Figure 2 Sample responsibility assignment matrix used for this study 
 
 
 
 PI RC ResN Other 
Intensivist 
NM Registrar ACNM Bedside 
Nurse 
Other 
Feasibility (patients)          
Feasibility (budget)          
Final decision          
          
 
 
Initially I planned to fill in the RAM during the interview.  However, this was too 
distracting so I introduced the matrix at the beginning of the interviews and explained that 
part of the interview schedule was directed at completing the matrix afterwards.   
Sample selection 
Level III ICUs were selected based on the CICM guideline, and my own knowledge that 
most of these ICUs employed a ResN.  While the line manager for NZ ResNs was not 
known prior to the study, the literature indicated that PIs and NMs, along with the ResNs, 
were the most likely to be the most knowledgeable about the ResN role.  Including all of 
these participant groups allowed me to evaluate if there was consensus about the role of the 
ResN and therefore enable some triangulation.  Triangulation is a way of using more than 
one dataset to corroborate findings and gain a greater understanding of the phenomena being 
studied (Creswell, 2009; Gillis & Jackson, 2002).  
 
The inclusion criteria for the study (Table 6) were selected to ensure that the data collected 
were an accurate reflection of current practice in ICU research.  I determined that gathering 
full data on at least three level III ICUs would be the minimum necessary to describe the 
ResN‟s role as I already knew that different ICUs operated in different ways and had 
different funding structures.  I also endeavoured to interview ResNs who had a variety of 
Healthcare professionals who perform study tasks 
Study 
tasks 
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length of service and experience to add depth and richness to the data collected.  The PI 
selected needed to have a current active role in research and a working relationship with a 
ResN.  Articulating this was difficult because some ICUs had several PIs involved in 
research, while others had one who was in charge of research.   
 
Table 6     Inclusion criteria for participants 
Inclusion Criteria Rationale 
Research Nurses 
Currently employed as a ResN in 
an adult Level III ICU 
To gather information which is about the current 
situation for ICU ResNs in NZ, their knowledge 
and experience needs to be current. 
ResN for > 6 months 
Questions being asked will require ResNs to call on 
their experiences and give examples.  It is unlikely 
they would have sufficient depth of experience in 
less than 6 months. 
Principal Investigator 
PI for at least one ICU study, or 
have been a PI for a study within 
the previous 6 months 
The literature determined that most ResNs reported 
to an intensivist and it was known from personal 
experience and anecdotal accounts that the PI 
worked closely with ResNs. 
Nurse Manager 
Overall management of nursing 
staff and budgets in the ICU 
Based on the literature and personal experience, an 
assumption was made that the ResNs would have 
some level of accountability to the NM.  At a 
minimum, the NM would have knowledge about 
the role from managing the nursing staff. 
 
Eleven ResNs were identified as meeting the criteria of being employed in their position for 
six months or more.  As all 11 ResNs were aware of this study, once ethical approval was 
gained, they were all approached individually by email inviting them to participate.  This 
invitation was accompanied by the information sheet (Appendix E) and consent form 
(Appendix F).  The information sheet outlined the intent of the study, and positioned 
confidentiality and identifiability.  This email elicited a 100% agreement to participate, and 
enquiries were made by phone and email to determine the ResNs‟ availability for 
interviews.  Because of the logistics of interviewing in six different ICUs, interviews were 
grouped together where possible.  
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I planned to interview all of the ResNs prior to the PIs and NMs.  The reason for this was 
twofold.  Firstly, it meant that I could gather information about specific studies the ICUs 
were participating in, get an overview of the structure and also identify any issues which 
needed to be explored further in the PI and NM interviews.  Secondly, as a novice 
interviewer, it was easier for me to interview people who were well known to me before the 
challenge of interviewing senior ICU staff, who I did not know. 
 
The names of PIs and NMs were sought from the ResNs.  Asking the ResNs for the contact 
details of the PI was most appropriate way of selecting a PI for each ICU.  This had the 
potential to introduce some bias however, was not considered a problem as in four cases, the 
PI selected was in charge of research.  Of the remaining two, one ResN selected the PI who 
was most involved on a daily basis.  In the other case, both PIs were considered appropriate 
by the ResN and I contacted both in advance, with the final decision being made based on 
their availability on the day of the interview.  As each ICU only had one NM, no decision 
had to be made about appropriateness. 
 
An email of introduction explaining who I was and the purpose of my study was sent 
individually to all potential PI and NM participants, along with the consent form (Appendix 
F) and relevant information sheet (Appendix G).  All PIs and NMs already knew about the 
study as they had been informed by the ResNs and all responded that they were agreeable to 
participating.  Further liaison was required to ensure their availability.  In some cases, an 
exact time for the interview was not able to be booked, but the day or days I would be in 
their hospital was confirmed.  A PI and the NM from all six ICUs agreed to be interviewed. 
Setting for interviews 
Logistically, the easiest place for the interviews to take place was in the participants‟ own 
ICUs.  An empty office was sought to conduct each of the interviews.  This was their own 
office for three of the ResNs and all of the PIs and NMs.  While it has been suggested that 
participants choose where the interview takes place (Clarke, 2006), the participants in this 
study were not seen as vulnerable and there was not thought to be a power imbalance.  In 
fact many of the participants would be perceived as my seniors.   
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Interviews 
Interviews were conducted over 11 individual days between May and July 2011.  While not 
ideal to conduct too many interviews in a short space of time, given the location of these, a 
pragmatic decision was made to conduct up to three interviews a day.  The order of ICUs 
was also pragmatic, based on participant and flight availability.  The interviews at my own 
ICU were conducted last, as I wanted to be immersed in the study, and more skilled at 
interviewing by the time I interviewed staff who I worked closely with.  Because of 
scheduling, not all interviews were conducted in the planned order but in all cases, at least 
one ResN in each ICU was interviewed before the PI and NM.   
 
Before the interview commenced, participants were asked if they had read the information 
sheet, offered the opportunity to have any questions clarified and were then asked to sign 
the consent form.  Most participants stated that they had already read the information sheet, 
although none had printed it out or signed the consent form.  Agreement was sought about 
clarifying data gathered, and in particular the RAM, after the interview if necessary.  A copy 
of the interview schedule was not sent in advance of the interview.   
 
The interview schedule was used as a guide, and field notes were made on the pre-printed 
individualised interview schedules throughout the interview.  People were asked to provide 
evidence or examples to demonstrate their views, as opposed to just their opinions.  At 
times, participants pre-empted questions when talking about other issues, in which case the 
questions weren‟t asked.  The interviews were digitally recorded with two digital recorders 
and all recorded files were downloaded and backed up on-site.  I kept an electronic log of 
the date, time and length of the interviews.  
Difficulties encountered with the interviews  
Only minor problems were encountered with the interviews and were symptomatic of 
working in a busy environment such as ICU.  Twelve of the interviews were interrupted by 
phone calls (n = 4) and/or other staff entering the office (n = 9).  The interruptions were 
more common in ResN interviews than the other participant groups (ResN, n = 9; PI, n = 2; 
NM, n = 1).  The interruptions ranged from a staff member mistakenly entering the room to 
lengthy work-related phone calls.  The location of one interview had to be moved after it 
had started due to other staff needing the office.  In one ICU, construction work was taking 
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place outside, resulting in poor (but decipherable) recording quality, and the ICU intercom 
was disconnected in another ICU as it was disrupting the interviews.   
 
Two PIs were only available for a limited time for the interview, due to other commitments.  
One of these interviews was quite rushed and I made a pragmatic decision to prioritise 
asking questions I considered essential.  The PI offered to meet again at a later time or for 
me to phone with any additional questions or clarification of answers.  As I had obtained all 
of the key material, this was not considered necessary, and the offer was not taken up.  
 
In another case, the PI was working from home on the day I had arranged to interview them.  
The ResN organised for this PI to be interviewed by phone.  This opportunity was accepted 
as I did not have plans to return to this ICU and I wanted to ensure the views of all 
stakeholders in the unit were heard.  The interview was conducted by landline using a 
speakerphone and the interview was recorded and transcribed as the others had been.   
Analysis 
In qualitative studies, data analysis begins even as data is being collected (Creswell, 2009; 
Miles & Huberman, 1994; Silverman & Marvasti, 2008).  While the data were collected 
using only semi-structured interviews, a mixed approach was used for the analysis.  Several 
authors talk about a systematic approach to analysing qualitative data (Creswell; 
Sandelowski, 1995; Thomas, 2006).  These processes typically included; data preparation, 
reading the data „as a whole‟, analysing for common themes (coding) and interpretation of 
the data.  I was initially guided by the work of Creswell, who described a six step process.  
The steps I took for data analysis are shown in Table 7. 
Interview transcripts 
The first step after gathering the data was to ensure the data were accurate and presented in 
a way which could be analysed.  The interviews were transcribed verbatim, initially by the 
researcher (n = 8), and then when the enormity of the task and time involved was realised, a 
grant was obtained from Victoria University of Wellington to pay a professional transcriber 
to complete the transcriptions (n =15).  The transcriber signed a confidentiality agreement 
(Appendix H).  The transcriptions were then checked for accuracy against the recording.  
For the six participants who had elected to view their transcripts, these were sent with a 
cover letter and a relatively short time-frame for review.  All but one of the reviewed 
transcripts were returned with minor changes, and some had additional information. 
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Table 7     Steps for data analysis 
Step Task 
1 Organise and prepare data 
2 Read through all transcripts as a whole 
3 Extract „concrete‟ data from transcripts 
4 Open coding 
5 Synthesis and identification of grouping and patterns 
6 
Re-analyse transcripts for consensus about identified 
themes 
7 Group data by ICU 
8 Group data by role 
9 Interpretation of data 
 
Each of the transcripts was then read through in their entirety to get a sense of likely themes 
(Step 2).  The „concrete‟ data, including demographics and background information about 
the ResNs and ICU structures, were extracted (Step 3).  The written transcripts were then 
read through line by line, and multiple themes identified (Step 4).  At this point, the answers 
to specific questions in relation to the pre-defined topics were analysed.  For the first two 
transcripts, my supervisor also analysed the transcripts line by line.  The multiple themes 
were clustered with similar themes and labelled with a code (Step 5).  Where themes were 
identified in some transcripts, all transcripts were then re-analysed for that specific theme, to 
see if there was consensus, if there were data which didn‟t comply and to find a good 
example of identified themes (Step 6).  The data were hand coded and collated using 
spreadsheets and a notebook to record specific data.  The final steps including grouping the 
data by ICU and by role for triangulation (Steps 7 and 8) and the data were then interpreted 
(Step 9).   
 
The data for this study were analysed in five distinct parts, which were aligned with the 
interview schedules and have been analysed in different ways (Figure 3).  Although the 
methodology for this study is qualitative, the nature of the question necessitated collection 
of some demographic data to provide context to the role.  The demographic data about the 
ResNs and the structures of the individual ICUs required no interpretative analysis and were 
summarised in table form in the results chapter. 
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Figure 3 Analysis by section of interview schedule 
 
 
 
 
 
Data about the role of the ResN and future development of the role were analysed 
thematically.  Qualitative data analysis requires familiarity and immersion in the data, and 
continuous reflection on the data from the time it is gathered (Creswell, 2009; Gillis & 
Jackson, 2002).  An interpretive approach has been applied to these data.  Interpretation of 
the data involves reading what was said, who said it and what it means.   
 
Defining themes is controversial with DeSantis and Ugarriza  (2000) arguing that there is no 
clear definition of theme.  For this study, a theme has been defined as “some level of 
patterned response or meaning with the dataset” (Braun & Clarke, 2006, p. 82).  Prevalence 
has been expressed using words such as „many‟, „most‟ or „few‟, and where appropriate, 
numerically.  This approach has been used for this study to add clarity and justification for 
some findings.  The ResNs‟ transcripts were analysed first, then the PIs and NMs.  Each 
dataset was analysed separately, then triangulation across the whole, then triangulated 
across the unit (Figure 4). 
 
 
Background Organise and prepare data 
Summarised in 
table of 
demographic 
data 
Structures and 
Funding 
Organise and 
prepare data 
Collated by ICU 
Summarised by 
ICU in table form 
Research Role 
and 
Responsibilities 
Organise and 
prepare data 
Thematically 
analysed 
Process around 
Studies 
Organise and 
prepare data 
Populated 
responsibility 
assignment 
matrix 
Analyse by ICU 
and professional 
group 
Future 
Development of 
Role 
Organise and 
prepare data 
Thematically 
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Figure 4 Order transcripts were analysed 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Responsibility assignment matrix 
The research tasks (processes around studies section) were analysed using a RAM chart.  
The purpose of using the matrix for analysis was to find out what study duties ResNs did, if 
all of the participants agreed and if the nurses didn‟t do the tasks, who did?  As described 
earlier, individual RAMs were completed based on the specific and generic interview 
questions.  Once the individual charts had been completed, they were returned to 
participants as described in the „member checking‟ section below.   
 
The individual RAMs were then collated in an excel spreadsheet by ICU, by participant 
group and then all combined, to see similarities and differences between ICUs and 
participants (Figure 5).  A column for „Unknown‟ was added because some aspects of the 
role were not well understood by some participant groups.  The results have not been 
displayed as a whole, to protect the identities of participants; however, they are referred to 
in the results section, with examples provided as evidence.  To protect the identity of 
individual ICUs and therefore individual participants, where more than one ResN in an ICU 
participated in this study, the most common level of responsibility reported is shown.  When 
the analysis was done, all views were recorded.  The matrix was amended at the analysis 
stage, to ensure that all tasks talked about by the participants were captured.   
  
Research 
Nurse 
Nurse 
Manager 
Principal 
Investigator 
Unit A 
Unit B 
 
Unit C 
 
Unit E 
 
Unit D 
 
Unit F 
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Figure 5 Sample of analysis using Responsibility Assignment Matrix 
 
 
 
Person who 
does task →  
Principal 
Investigator 
Research 
Nurse 
Intensivist 
Nurse 
Manager 
Registrar ACNM 
Bedside 
Nurse 
Other Unknown 
As reported 
by → RN PI NM RN PI NM RN PI NM RN PI NM RN PI NM RN PI NM RN PI NM RN PI NM RN PI NM 
Task ↓ Unit 
↓ 
 
A                            
B                            
C                            
D                            
E                            
F                            
 
 
 
 
 
Rigour 
Rigour and trustworthiness are demonstrated throughout this study and are summarised in 
this section.  The purpose of rigour is so that readers can trust the findings of the research 
(McBrien, 2008; Silverman & Marvasti, 2008).  Rigour strategies employed in this thesis 
include reflexivity, triangulation, member checking, and audit trail while evidence of data 
are provided by appropriate use of quotes to give examples of findings (Crabtree & Miller, 
1992; Creswell, 2009; Liamputtong, 2009; McBrien; Sandelowski, 1994) 
Reflexivity 
Reflexivity is the process by which researchers have self-awareness of their perspective in 
the research (McBrien, 2008; Patton, 2002).  Recognising how our own values may 
influence the findings of a study is important for the credibility and rigor of a study (Jootun, 
McGhee, & Marland, 2009).  Throughout this study, I have had an insider‟s perspective.  I 
am studying a role I work in, interviewing colleagues I know and interpreting the data 
myself.  At all stages of the study I have endeavoured to put my knowledge and experience 
„aside‟ and rely on the data as presented.  This process of „putting aside‟ one‟s own 
Healthcare professionals who perform study tasks 
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knowledge and values about the subject being studied is called „bracketing‟ (Silverman & 
Marvasti, 2008).  As a novice researcher, I need to acknowledge that despite my best efforts, 
I was probably not able to do this 100% of the time and this influence would have been 
present unconsciously throughout the study.   
 
There are advantages and disadvantages to being an insider.  Advantages include; access to 
and trust of the group and shared understanding of terminology (Bishop, 2005).  The ResNs 
and PIs understood my questions, why I was asking those questions and I understood what 
they were talking about.  The disadvantages included; the potential for bias and participants 
not always giving full answers because they thought I knew what they meant.  To overcome 
this, participants were asked to give examples where possible, or follow up questions and 
open-ended questions were used.  Insider knowledge and bias were not considered problems 
for this research because this study was about what ResNs do and what participants 
understood their role to be in research, and their answers were quite „concrete‟. 
 
Despite being an insider, I remained open to interviewees‟ perspectives.  I took the stance 
when interviewing that no answer was considered right or wrong.  I did not challenge 
people‟s interpretation of their view of the role; that if a participant said it was true then it 
was true.  During the analysis phase, I did not rank one participant‟s perspectives above or 
below others and have tried to present them with equal weighting, unless otherwise 
reported.  The aim of this study was to obtain different stakeholders views, even if they 
differed from each other‟s and my own.  Likewise, the study was not about testing 
participants‟ knowledge about the role.  Where appropriate, if I already had information 
about something factual such as studies they were participating in, this was more of a 
statement requiring confirmation, than a question in the PI and NM interviews.   
 
To help with bracketing during the interview process, I used the interview schedules with 
pre-defined prompts.  Although it is inevitable with semi-structured interviewing that topics 
outside of the schedule arise, I endeavoured to follow the pre-defined interview questions 
where possible.  I was careful not to engage in critique or offer information about other 
people or roles to the participants.  
Triangulation 
The term triangulation comes from the fields of navigation and surveying where having 
more than one landmark assists you to verify your bearings (Gillis & Jackson, 2002; Patton, 
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2002).  Triangulation in research allows the researcher to verify their findings by using 
different data sources, investigators, theories or methodologies (Creswell, 2009; Patton).  
This study achieved some degree of triangulation by gathering data from the different 
practitioners, and additionally by analysing data thematically and using the RAM.  Where 
findings from the key informants are incongruent, this has been highlighted in the findings 
section. 
Member checking 
Member checking is the process of checking the accuracy of the data collected with the 
participants (Liamputtong, 2009).  Member checking is generally considered essential to the 
credibility of data (Creswell, 2009; McBrien, 2008), although Sandelowski (1993) 
controversially argues that by seeking clarification, the participants may change the data.  
This was less of a risk in this study, because the interview topic was not controversial, 
interview schedules were quite structured, examples were constantly sought and participants 
were unlikely to change their stance.   
 
All participants were offered the opportunity to see their transcripts – four ResNs, one PI 
and one NM took this opportunity.  In all cases, only minor changes were made.  For 
participants who did not wish to view their transcript, I contacted them by email to check 
data I was unsure of, or that required clarification.  Member checking afforded this study the 
cleanest possible data, and people elaborating or changing their transcripts did not result in 
significant changes to the final data.   
 
Once the transcripts had been analysed and the information used to populate the individual 
RAMs, these RAMs were returned to participants for confirmation.  This was to ensure the 
accuracy of my interpretation about study tasks.  Of the 14 (ResN =10; PI=2; NM=2) who 
returned the RAMs, 13 made changes, which reinforced the need to member check when 
determining details about responsibility and accountability on a series of activities.  
Audit trail 
McBrien (2008) describes the use of an audit trail as essential for documenting decisions 
made about data kept and discarded.  When the transcripts were initially analysed, notes 
were made on printed copies of these.  Then multiple themes were collated in an excel 
spreadsheet, and handwritten notebook.  The audit trail of information which was kept and 
discarded has been kept electronically, and thoughts about potential themes were recorded 
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in a research diary.  Audit trail in qualitative research ensures that even though another 
researcher may have a different interpretation of the same data, the process by which the 
findings were arrived at is clear.   
Ethical issues 
Ethical approval was sought and obtained from the Victoria University Human Ethics 
Committee (Appendix I).  Several ethical issues were identified in this study.  The main 
issue, which was recognised from the outset, was that the participants were from a select 
and small group from within the broader ICU community.  De-identification will work in 
the main for people outside of the environment, but given the size of NZ, anyone who is part 
of the ICU research community may be able to identify the participants involved.  Every 
endeavour has been made for individual quotes to be kept confidential by way of using a 
randomly assigned coding system for participants.  The plural „ResNs‟ has been used even if 
only one ResN was interviewed to prevent identification of the ICU they work in.  Tables in 
Chapter 5 (Findings) have been designed so that cross reference between ResN 
demographics, ICU structures and quotes is not possible.   
 
Recordings of interviews were only heard by me, and the transcriber, who was bound by a 
confidentiality agreement.  Some written transcripts were viewed by my supervisor to assist 
with early coding.  I have undertaken to keep the recordings and written transcripts 
confidential and they will be destroyed two years after the completion of this thesis.  Care 
will be taken that any presentations about the results of the study are done in a forum where 
no one group has privileged information.  
 
Much of the information about the ICUs themselves, such as how many studies they are 
participating in, was considered to be relatively low risk and readily available to anyone 
who asked.  Information about structures and funding would be relatively easy to obtain 
within the ICU community and has been discussed in various forms in the public domain. 
 
„Third party critique‟ was identified as an issue inherent in a study of this kind.  The nature 
of the study topic and the method of semi-structured interviewing meant that participants 
were talking about other people, or their role, both positively and negatively.  While I 
wanted to hear what people said as it related to the study, I did not take responsibility for the 
interview to become a „venting‟ process.  I took a stance in the interviews not to talk about 
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individuals or share information and was careful not to engage if participants were critical 
of other people.  This stance was important to make the research safe for everybody 
involved.  
 
There were two ethical issues which arose at the interviewing stage, which were not 
anticipated.  The first was a desire from many ResNs to know what their particular PI or 
NM knew about what they did.  This was borne out of a feeling that many NMs, in 
particular, did not know what ResNs did.  Obviously this information could not be passed 
onto the ResNs, but I consider that the findings of this thesis will help inform them, as well 
as their managers what their role is. 
 
Related to this issue was a desire by PIs and NMs to know how things worked in other 
ICUs.  In most cases, I answered this question with an example of what we do in the ICU I 
work in.  I believe that the findings of this study will enable the information to be presented 
across ICUs, in a form which PIs and NMs find useful for their own departments.  I found 
this curiosity interesting in such a small community and country where this information 
could easily be obtained with a phone call or email.  I think interviewing the PIs and NMs 
may have provoked this interest. 
 
One ethical issue which I didn‟t overly address was that participants may not have had the 
freedom to decline participation in this study.  While I did not coerce people into 
participating, the ResNs may have felt pressure from their colleagues.  It is also possible that 
when the ResNs told the PIs and NMs about this study, they influenced their decision about 
participating.  This study is not controversial and I am satisfied that participants would have 
voiced if they did not wish to participate.  ICU and research departments in particular, have 
a philosophy of participating in research so this may have influenced their decisions.   
 
Another ethical issue was that I had to interview my own colleagues, including fellow 
ResNs, PI and NM who is my line manager.  I elected to interview these colleagues last so 
that my interviewing skills were better than at the beginning.  A risk to the data in 
interviewing colleagues was their desire to give the „right‟ answer.  At the time of the 
interviews and on reflection after reading the transcripts, I believe they answered with 
honesty and integrity.  I made a conscious decision prior to the interviews to present myself 
as a „researcher‟ and remain professional throughout the interviews.  I believe I achieved 
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this but on reflection think it would have been desirable to either omit the ICU I work in, 
which would have made the data incomplete or engaged another interviewer to interview 
them.  It was challenging interviewing my work colleagues and the interviews were 
probably more structured, more closely aligned to the interview schedule, and less free-
flowing than some others. 
Summary 
This chapter has described the methodology and methods employed to conduct this 
research.  Rationales have been provided about these decisions and how they will ultimately 
answer the research question.  The sample and setting have been described and strategies 
that were employed to ensure the rigour and trustworthiness of the research have been 
outlined.  Ethical issues which were anticipated and encountered have been summarised. 
 
This chapter, along with the preceding chapters will assist the reader to understand the 
findings which are presented in the next two chapters. 
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Chapter 5     Findings: Research participants, departments and 
supporting structures 
Introduction 
The findings of this research are presented in Chapters 5 and 6.  In Chapter 5, the findings 
about who the ResNs are, their background and where they work are presented, while 
Chapter 6 is about the work they do.  Specifically, the first part of Chapter 5 introduces the 
three participant groups.  The ICU research departments are then described in terms of the 
ResN; including the management structures they work within, how their positions are 
funded, and their functional relationships.  Finally the demographics, background and 
working conditions of the ResNs are reported.  While it is unusual to present the findings for 
the secondary objectives first, it has been done for this thesis, so that the reader knows more 
about the context of the ResNs‟ work which is important for understanding the thematic 
findings presented in Chapter 6.   
Research participants 
The 23 people interviewed for this study included between one and three ResNs (n = 11), 
one PI (n = 6) and the NM (n = 6) from each ICU.  The interviews took place between April 
and July 2011.  The mean length of the ResN interviews was 74 minutes (range 50 - 101), 
the PIs 47 minutes (range 30 - 69) and the NMs was 39 minutes (range 33 - 48).   
Research nurses 
All of the ResNs interviewed were female.  As seen in Table 8, they had worked in their 
current ResN positions for a mean of 6.1 years (range 1 - 14), and had worked in an ICU 
setting for a mean of 17.8 years (range 4 - 33).  Two had worked in research prior to their 
current position.  The ResNs‟ past nursing experience also included working in cardiac care, 
emergency department, general wards, health education, home care, neurosurgery and 
paediatrics.  They had worked in a variety of positions including charge nurse, duty 
manager, educator and staff nurse.  Several had worked internationally, including Australia, 
England, Hong Kong, Saudi Arabia and Zimbabwe.   
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Table 8     Research nurse participants' demographics* 
Research 
FTE 
ICU FTE 
Time in ICU 
Research 
Nurse role 
(years) 
Previous 
Research 
experience 
(years) 
ICU 
experience 
(years) 
Highest qualification 
0.4 0.2 5.0 0.5 17 Post Graduate Diploma 
0.4 0.6 5.0 None 10 Post Graduate Diploma 
0.8 0 9.0 None 20 Post Graduate Certificate
**
 
1.0 0 14.0 None 33 Masters (coursework) 
0.6 0.4 1.5 None 10 Masters (coursework) 
0.6 0 1.2 None 17 Post Graduate Certificate
**
 
0.6 0.4 7.0 None 24 Post Graduate Diploma 
0.5 0 12.0 None 29 Masters (by thesis) 
0.8 0.1 6.0 None 18 Masters (by thesis)  
0.9 0.1 3.0 None 14 Post Graduate Certificate
**
 
0.5 0.5 1.0 5.0 4 Post Graduate Diploma 
*No names or codes have been included in this table because it would make the ResNs readily identifiable 
when quoted later in the thesis 
** Refers to an ICU specific qualification.   
Principal investigators 
All of the PIs were doctors (male n = 5; female n = 1).  They had been actively involved in 
research in their current ICU for a mean of 9.7 years (range 0.3 - 19), and all had experience 
working with the ResNs on large, multi-centre clinical trials.  Three of the PIs had a title as 
the head of the research department, and a further two considered themselves to be in charge 
although they didn‟t have a formal title.  Two PIs were also the clinical director of the ICU 
they worked in. 
Nurse managers 
Of the six NMs, five were female and one was male.  Five reported that the ResN had some 
line management accountability to them and in the sixth, the ResN reported directly to the 
PI.  This sixth NM‟s involvement with research was as part of their ICU research 
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management group.  Three NMs stated that they were unsure how much they knew about 
the ResN‟s role.  The reasons given were that the ResNs managed their own research 
workload (n = 2), the NM was relatively new to their position and sorting out research had 
not been their top priority (n = 2) and they were fully occupied with their own operational 
workload (n = 1). 
Research departments - structure and funding  
In two ICUs there was not shared understanding, amongst the participant groups, about the 
structure and management of the research departments.  In one of these ICUs, the PI was 
uncertain who the ResNs‟ line manager was and thought it may have been the clinical 
director or administrator, while the ResN and NM thought it was the NM.  In the other ICU, 
there was disagreement amongst the ResNs, NM and PI about overall accountability and 
professional accountability.  Where there was not consensus, I have weighed the evidence 
and based the displayed models in Figure 6 on the majority view, which in all cases 
included at least one ResN.  This figure shows the four identified models of line 
management structure within the research departments.  The most common line 
management model was Model A (n = 3), with all other models being present in one ICU 
each.  Professional, trial and operational (or financial) accountabilities are shown, based on 
the participants own descriptions.  The bold lines on this figure show the official lines of 
accountability, while the dashed lines indicate unofficial accountability.  In Model D, the 
day-to-day management of research had been delegated to the PI and research nurse 
coordinator, who worked collaboratively as a team.  Model B shows the ResN has 
accountability to a service manager, which was identified as a nursing management role. 
Structure and lines of accountability 
The ResNs line manager was the NM (n = 8), service manager (n = 2) or PI (n = 1).  In 
addition to this formal line of professional accountability, all of the ResNs had some 
operational research accountability to the PI.  “It‟s probably officially [NM], but I would 
only report to [PI] really” ResN01 (L. 506 - 507).  This was generally informal and the 
ResNs reported that they worked more closely with the PI than the NM and subsequently 
the PI had a better understanding of the role.  Three ResNs referred to the PI as „the boss‟.   
ResN09 found the dual accountability confusing and reported “there‟s no structure for your 
job or reporting or management and you lie in-between … you have two bosses” (L. 213 -
214).  
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Figure 6 Reported line management models for research nurses 
Research 
Nurse 
Nurse Manager 
Principal 
Investigator 
Research 
Nurse 
Nurse 
Manager 
Service 
Manager 
Principal 
Investigator 
MODEL A 
 
MODEL B 
 
MODEL C 
 
MODEL D 
Research 
Team  
Research 
Nurse 
Coordinator 
Nurse 
Manager 
Clinical 
Director 
Principal 
Investigator 
Research 
Nurse 
Research 
Coordinator 
Principal 
Investigator 
Research 
Nurse 
  
 
 
Key 
           = Professional accountability 
           = Clinical Trial accountability 
           = Operational accountability 
           = Delegated to 
 
Dashed lines indicate an informal 
accountability 
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PI04 was unsure whether the ResNs being accountable to the NM was an appropriate 
structure.   
It‟s a little bit complicated in terms of the staffing because professionally they 
have to report through the nursing hierarchy, which I have to say is a bit 
inappropriate I think, but that‟s the way it is … and their professional 
accountability seems to go up through the nursing hierarchy whereas I‟m a 
kind of a business manager I guess for that part of the business rather than 
the professional manager.  (L. 85 - 91) 
 
The ResNs were responsible for the day-to-day research work, and this is discussed further 
in the next chapter.  All of the NMs confirmed this, three with the rationale that the nurses 
were senior nurses who had been delegated this responsibility and were expected to manage 
their own workload.  NM03 quipped that “no news was good news” (L. 461 - 462).  
 
In five ICUs, there was an intensivist in charge of research from a medical perspective, or 
who had research as a „portfolio‟, in addition to their clinical duties.  The remaining PI 
stated that the PIs in their unit worked as a team and no one in particular was in charge of 
research.  The ResNs (n = 4), PIs (n = 5) and NMs (n = 5) often referred to the ResNs and 
PIs as „the research team‟, who collectively worked together to incorporate research into 
ICU patient care.  In Model D (Figure 6), where the Research Nurse Coordinator (RNC) and 
PI managed research together, the RNC was still accountable to the PI for study activities 
which had to be signed by a doctor. 
 
Three ICUs had one main PI who was PI for all of the multi-centre studies.  While Table 9 
shows that all ICUs have more than one intensivist as a PI for research studies, the majority 
of the research workload fell to one PI, who had a particular interest, or was „in charge‟ of 
research in ICU.  Within these units, other intensivists were the PI for their own studies, 
which distorts the numbers given in the table.  These other studies tended to be small, 
single-centred studies, which required little or no involvement from the ResN.  In two ICUs, 
all intensivists were sub-investigators for all studies, and took an active role in recruiting 
patients into studies.  More than one intensivist took the lead in the multi-centre studies in 
three ICUs.  
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Table 9     Summary of principal investigators and studies for each ICU 
ICU
*
 
Number of PIs Number of current studies 
 Intensivist 
Research 
Nurse 
PhD 
Investigator 
initiated** 
Commercial 
Ongoing 
Observational 
Nursing 
Unit  2 1  8 (4) 1 2  
Unit  2 1  7 (3) 2 2  
Unit  2 1  8 (2) 1 2  
Unit  3 1  1 (1) 1 1 1 
Unit  3 2 1 9 (6) 1 2  
Unit  4 1  4 (3) 1 2  
* ICUs have not been given codes in this table so that cross-reference cannot be made when findings are 
described later in Chapter 5 and 6 in order to preserve the confidentiality of participants. 
**CTG-endorsed studies shown in brackets (CTG, 2010a) 
Hospital research department 
There had been significant changes to many hospital research departments in recent years 
and generally the role of these departments was not well articulated.  Three PIs described 
these changes as a rationalisation of trust accounts because in the past, multiple trust funds 
existed within the hospital, sometimes with large sums of money in them, donated from past 
patients, or in the case of research, earned from participating in well-funded studies.  As a 
result of these changes, there was variance amongst the participants about whether the 
hospital research department fulfilled their expectation (ResN; n = 2, PI; n = 3) or not 
(ResN; n = 4, PI; n = 0).  The remaining participants were uncertain either because they had 
nothing to do with the research department or the department was too new to assess, and one 
hospital did not have a research department.   
 
The term „overheads‟ refers to the costs associated with running a business.  In research, it 
is the amount paid by the ICU to conduct research within the hospital, and contributes to 
running the hospital research department.  As can be seen in Table 10 there was variation in 
the amount of overhead payments that ICU research departments paid.  This is important for 
ResNs as the financial viability of their position is related to the robustness of their finances.  
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Tasks which were identified as involving the hospital research department and would have 
incurred costs included hospital research office staff, statistician, legal consultation, 
accountants and Maori consultation.  A ResN from the hospital which did not have a 
research department said they were working towards a system where they were “supposed 
to actually pay our own overheads” to recompense the hospital for costs incurred.   
 
Table 10 Summary of ICUs’ funding streams, research nurse FTE and overheads 
ICU
*
 
Research 
Nurse 
FTE
**
 
Research Nurse 
Funding 
Hospital Overheads 
Unit  0.9 0.9 FTE studies 25% Research Nurses‟ Salary 
Unit  1.0 
0.5 FTE studies 
0.5 FTE ICU budget 
Nil 
Unit  1.2 1.2 FTE studies 
Commercial studies 15 - 20% of income 
Grant funded studies Nil 
Unit  1.5 
0.5 FTE studies 
0.5 FTE ICU budget 
0.5 FTE commercial sponsor 
Commercial studies 15% of income 
Grant funded studies 10% of income 
Unit  1.9 
1.4 FTE studies 
0.5 FTE ICU budget 
Tiered structure, depending on type of study: 
Fixed fee of $1500 - $6500 plus 0 - 20% of 
income 
Unit  3.2 
1.2 FTE studies 
1.0 FTE commercial sponsor 
1.0 FTE grants 
Tiered structure, depending on type of study: 
Fixed fee of $1500 - $6500 plus 0 - 20% of 
income 
* ICUs have not been given codes in this table so that cross-reference cannot be made when findings are 
described later in Chapter 5 and 6, in order to preserve the confidentiality of participants. 
** The FTE of ResNs within an ICU shown in Table 10 does not always match the number of ResNs 
participants listed in Table 8.  This is because three ICUs had staff working in research who did not meet the 
inclusion criteria of working in the position for more than six months.  In some cases, they were employed on 
a short-term basis for a specific trial. 
Funding 
Funding is essential for research, and the ability of an ICU to participate in, and produce 
research relies on funding.  This directly affects the ResNs as a large part of the cost of 
research in ICU is paying staff to manage studies.  Table 10 shows that all of the ResNs‟ 
positions were at least partially funded by the income from studies and in two ICUs, this 
was the only income.  The 0.5 FTE from the ICU budget in a third ICU, was deemed to be 
for operational data collection, so the ResN role was actually also funded solely from 
studies.  Two ICUs were additionally funded by an unconditional grant from a commercial 
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sponsor and three ICUs had some portion of the ResN FTE funded from the ICU operational 
budget.  NM06 stated that they had only been able to establish the ResN position if it was 
not funded from the ICU operating budget.  This was by agreement with “the CEO [chief 
executive officer] that it was a cost neutral position that was funded from the research trust 
fund” (L. 58 - 59), and it had been self-supporting since.  Funds for research departments 
were administered via a trust account, which was kept separate from the ICU operating 
budget.  The trustees were generally a triumvirate consisting of a selection of people 
including the clinical director, ex-ICU administrators, ex-ICU nurses, ICU administrators, 
ICU doctors, NM and PI.  
 
Only one PI stated they were fully funded for their research position and had a formal 0.5 
FTE research role which was funded by an external commercial sponsor.  Another PI said 
they were allocated 2½ hours per week for research and the other four managed their 
research responsibilities around their clinical duties.  This lack of time was reported by PI02 
as one reason for needing ResNs.  “I often find … my clinical duties just take me away and I 
wouldn‟t have time on a daily basis to keep things going” (L. 92 - 94). 
 
As can be seen in Table 9, most ICUs participated in more grant-funded or unfunded 
investigator-initiated studies, than commercial.  All participants were asked whether they 
preferred a certain mix of studies to maintain the research departments from a financial 
point of view.  Four PIs were pragmatic about the need to do commercial studies and stated 
they needed to do them to support the rest of the research they undertook.  The two who 
stated they did not need to do commercial studies had ongoing unconditional grants from a 
commercial sponsor which supported the research positions.  They thought this was a good 
position to be in, because there was no pressure to recruit into studies, or to seek well-
funded studies.  Amongst the ResNs, five thought they needed to do a commercial study, 
and the remaining six thought their ICU had a preference for CTG-endorsed studies.  In five 
of the ICUs, their current commercial study was due to finish shortly after the interviews 
took place, and all were actively assessing a new commercial study.  NMs had a limited 
knowledge about the different types of studies and four did not know if the fee was a 
consideration when deciding on studies.  
 
Participants were also asked if they would consider unfunded or poorly funded studies if it 
was an area of research that the unit was interested in.  Five PIs responded that they would 
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definitely consider this situation and assessed each study on its merits, and likelihood of 
improving patient outcomes.  Four PIs stated a preference and commitment to CTG-
endorsed studies, even though these studies only “broke even” at best.  PI04 stated that their 
ICU was “very conscious of cost-recovery” and “had only a limited capacity to do 
unfunded studies” (L. 169, 179).  Six ResNs said they thought their ICU would participate 
in low-funded studies, with most stating they already were.  Many PIs and NMs talked 
about studies being at least “cost neutral”.   
College of Intensive Care Medicine guidelines 
Participants‟ responses to the question that according to the CICM guideline “Level III 
ICUs have sufficient funding for a full time Research Coordinator to fund an active research 
programme” (CICM, 2010a) revealed that most of the ResNs thought their position should 
be at least partially funded.  Over half (n = 8) thought the position should receive some 
funding from the ICU, hospital, DHB or government.  The remaining three, all of whom 
worked in research departments funded by an external commercial sponsor, thought it 
should be funded but didn‟t know who would fund it.  Reasons given for at least partial 
funding included increased job security (n = 2), research being an inherent part of patient 
care in large Level III ICUs (n = 2) and because other senior nurse positions which are part 
of the CICM guideline, such as nurse specialists were funded (n = 1).  Most participants 
however, thought that it was unlikely that DHBs would fund research.  There were other 
benefits to the guideline and ResN08 speculated that it was probably the only reason “we 
have a research unit here” (L. 975).   
 
Three of the PIs expressed that the research role should be at least partially funded through 
the DHB.  Of the remaining three PIs, two worked in ICUs where the ResN position was 
already partially funded from the ICU budget.  One of these was new to the position and 
was looking at other sources for funding to support their research department.  The other PI 
stated that the “holy grail is to have enough grant money to fully fund research trials” 
(PI01, L. 686).  PI03 had mixed views about whether funding was a good idea, stating “you 
lose a bit of autonomy potentially” (L. 1157).  Most PIs (n = 4) thought it was unlikely that 
their ICUs would get more or any funding for the research position because “hospitals don‟t 
see their role as funding research”, or because they were already self-sufficient so they 
thought hospital management perceived that they didn‟t need funding.  PI03 commented 
that the CICM recommendation may help an ICU without existing funding for ResNs to 
“get leverage” but if the role was already supported through other means, it was unlikely to 
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help.  PI02 stated that it could potentially be used as a “bargaining tool” to get hospital-
funded ResNs.  A cited advantage to hospital-based funding was that it provided security for 
when study recruitment was low.  PI01 observed that the recommendation was more about 
recognising the need for ICUs to participate in research. 
I think it recognises that to be a training unit at a top level, part of training is 
that we can‟t make progress without doing research, so the trainees need to 
be exposed to the idea that patients will be involved in research and that it‟s 
part of our job to do that and obviously so if you‟re in this unit as trainee 
registrars they need to be exposed to that.  So I think it is important.  And 
practically you can‟t do research without [ResNs].  (L. 663 - 668) 
 
Four of the NMs expressed outrage that the intensivists‟ training organisation would make a 
recommendation and that it had no financial attachment to it.  This was described in various 
ways including that the guideline “had no teeth” (NM05) and “CICM don‟t do anything for 
me” (NM02) and “they [CICM] should fund it” (NM04).  Four NMs also expressed that 
although they would like to see the research position funded there was no surplus in the 
hospital system, and they were not optimistic about getting funding.  NM06 stated that if 
there was more money available it would be “more likely to go to operational and service 
budgets” (L. 355) and for NM02 they “would rather have another nurse on the floor than a 
research person” (L. 262 - 263).  NM01 already funded some ResN FTE from the ICU 
budget and thought that funding was vital to maintain the position.   
Sense of security 
Security about the research departments‟ finances by PIs and NMs was attributed to both 
existing funds in their trust accounts and ongoing funding streams.  In three ICUs neither 
the NM nor PI were concerned about their finances, and stated they had enough money 
saved in the trust account to pay the ResNs‟ salaries for a “long” period of time, even if 
funding streams were discontinued.  One NM said they were not concerned about finances 
because if study recruitment was too low, one of the ResNs was aware that their tenure 
would be discontinued. 
 
In the remaining three ICUs, either the PI, NM or both were concerned about the financial 
situation of their research department.  In one of these, the NM and PI were very concerned 
about ongoing funding and the NM expressed concern that the ResNs may have to reduce 
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their hours which didn‟t give them a sense of job security.  The PI stated that they were 
“always running on empty”.  
  
The ResNs‟ sense of security depended both on the culture of the ICU they worked in and 
the way their position was funded.  Most (n = 10) thought that unless their particular 
funding stream decreased or was discontinued, their position would be secure.  Responses 
ranged from “I don‟t think my job is secure anymore” to “really secure”, with the most 
frequent response being “as secure as anything [in the DHB] is”.  ResN09 and ResN11 
stated that the research ethos was so strong in their ICUs, particularly among the doctors, 
that even if their funding ran out, this ethos added security to their positions.  In contrast, 
ResN02 stated although there was always plenty of work to do, the security of their position 
was dependent on funding being available.   
Physical department 
All six of the ICUs had a research department office within the borders of the ICU.  Four 
had a dedicated office only for ResNs, one shared their office with the ICU registrars and 
the other shared with a nurse educator.  The ResNs from two ICUs had only recently moved 
to the ICU, having previously had their research office located in another department some 
distance from the ICU.  ResN06 reported that being located in the ICU was “much more 
productive” (L. 24).  The most often discussed advantages to having an office within the 
ICU were “visibility” and feeling like “part of the ICU team”.  A dedicated research office 
also provided the necessary space to store the large amount of paperwork that accompanies 
research, confidentiality, easy access to patient charts and a place to “concentrate”. 
Relationship of research department to ICU 
Although the research department was physically within the confines of the ICU, where 
research and ResNs were in the overall ICU structure was less clear.  The participants in all 
but one ICU thought the research department was seen as being slightly separate to the ICU 
with the most frequently used phrase being “to the side”.  This finding was as common in 
ICUs where some of the ResN salary was funded from the ICU operating budget as those 
where it wasn‟t.  A reason research was seen as separate was because of the financial 
independence from the ICU operating budget.  NM06 articulated this as 
we like to think we have a small business that we‟re running and we‟re the 
directors of that small business and we have the final sign off and approval 
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for all expenditure and also the vision and direction of the research 
department.  (L. 82 - 85) 
 
There were perceived advantages and disadvantages to being a considered a separate 
department.  The main advantage to this financial independence was that the ResNs hours 
were protected from short-staffing within the ICU clinical area.  Another advantage cited by 
ResN08 was that the research department was protected from restructuring which had 
affected other senior nurse positions.  The PIs were more likely (n = 5) than the NMs (n = 2) 
to say that research hours were protected and PI02 summed this up by saying that “research 
has to be viewed with some degree of importance” (L. 172 - 173).  Of these five PIs, four 
thought the nurses could help in the ICU if it was short-staffed, only if they chose to and by 
negotiation.  The NMs were more likely to think the nurses should help out if the ICU was 
busy or short-staffed (n = 4) but acknowledged that research was also important and three 
stated that there were other options such as nurse specialists and educators before the ResN 
would be called upon.  The ResNs were divided on whether they would help in the unit if it 
was short-staffed.  Six stated that they didn‟t help, four would help and one had never been 
asked.  Reasons given for not helping including separate funding (n = 3), clinical 
unfamiliarity (n = 1) and “if you started, you would always be helping” (n = 1).  Of the four 
who helped with lunch breaks or short-staffing, they thought it was a valuable opportunity 
to educate and good for their relationship with clinical staff.  They suggested this was 
important because of the extra workload clinical staff sometimes had because of research. 
 
Negative aspects of being seen as a separate department included a lack of research culture, 
visibility, ResN credibility, and a sense of isolation or “not being part of the team” 
(ResN10, L. 18 - 19).  Only three ResNs reported feeling isolated, as articulated by ResN09 
“So I thought it would be following patients and enrolling patients.  I didn‟t envisage how 
isolated you‟d be and how you‟re seen as the bottom of the pile.  Yep and your manager 
doesn‟t understand” (L. 208 - 210).  The remaining ResNs stated they did not feel isolated 
because they felt like they were either part of a team of several ResNs or part of a larger NZ 
network.  ResN02 didn‟t view professional isolation a problem because she “was ready to 
step away from the bedside” (L. 930). 
 
This difficulty in positioning where the research department belongs and finding the balance 
was summarised by ResN08. 
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We are a separate bubble in so many ways.  And that‟s quite good because 
we don't necessarily want to be part of the senior team because of a lot of 
things that have gone on over the last few years.  So it is good to be our own 
separate bubble; however you don‟t want to be too separate and you still 
need to be seen as part of the unit and everything that goes on and – that‟s 
one of the reasons that we‟ve really resisted moving offices outside the unit 
and things like that because we are a part of the unit and if you move too far 
out then you will be seen as something completely separate.  (L. 916 - 924) 
Research nurses 
Background 
The ResNs‟ job titles included research nurse (n = 5), speciality nurse research (n = 3), 
nurse coordinator for ICU research (n = 1), research coordinator (n = 1) and research nurse 
coordinator (n = 1).  In one ICU, the research nurse coordinator was a position senior to a 
specialty nurse research position. 
Our official hospital title is Research Nurses…It‟s slowly changing to Nurse 
Specialist Research… But I put myself down as the Research Coordinator 
when I‟m talking to everyone except patients and families.  Because that‟s 
what I do – I coordinate research.  But when I‟m talking to patients and 
families, I will call myself a Research Nurse, so they know where I‟m coming 
from.  (ResN02, L. 23 - 29) 
 
Four of the ResNs in four different ICUs were the first appointed to the ResN role in their 
ICU.  Three were in positions established specifically to assist with clinical trials while the 
fourth began with a mandate to “get nurses interested in research” (ResN06, L. 236).  
Generally, the ResN role had developed in response to ICUs or PIs becoming involved in 
research studies which the PIs did not have time to manage themselves.  
 
There was no single reason nurses became ResNs.  Five reported they had been in ICU 
clinical nursing for a long time and were looking for a new challenge, yet had a desire to 
stay in the ICU environment.  A motivating factor for two ResNs was “getting off night 
duty” and for another two, the hours and flexibility were appealing.  Many (n = 8) expressed 
a prior interest in research through their own tertiary level study or thought it might be 
interesting because they liked numbers or data, or gaining a greater understanding of critical 
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illness.  Most ResNs (n = 10) stated they still enjoyed the job, citing reasons such as 
autonomy, intellectual stimulation, variety and „making a difference‟ to long-term patient 
outcomes. 
I‟ve stayed in it because I like the autonomy.  I like the work.  Now that I have 
a greater understanding and realise that there can be positives and negatives.  
But I do like it and I do like to think I‟m making a difference by doing what 
the results have shown may necessarily save lives, and I quite like that.  And I 
like the fact that I can help teach people on the floor about research and 
support them through research.  I can do my own research and it‟s very 
supported for you to do your own research.  (ResN04, L. 241 - 247) 
 
All 11 ResNs had applied for advertised positions, which were generally only advertised 
within the ICU.  ResN04, ResN07 and ResN11 were seconded to the position from their 
ICU staff nurse position prior to obtaining a permanent position.  All but two had not 
actively sought a position in research, but when the position was advertised, thought it 
sounded interesting.  One of the two ResNs who actively sought a role in research had 
worked in research prior to working in ICU, while the other had seen ResNs working in 
ICU. 
I have always been a little bit interested in research because I like to know 
the „why‟ and when I started in the ICU there were research nurses and I 
thought they were so cool.  They were doing really cool jobs and … obviously 
having saw what they did on the clinical side of things and all the fun stuff 
didn‟t actually see all the data collection and the data input and you know all 
the nightmarish stuff that you have to do or writing ethics applications, all 
that [stuff] and I thought that would be really cool.  (ResN04, L. 209 - 216) 
 
The majority of the ResNs (n = 8) had no real understanding or expectation of what the role 
would entail prior to working in it.  The work was busier and more stressful than they 
expected (n = 4), and they hadn‟t realised the amount of information they would need to 
know or tasks that weren‟t seen by other staff, such as ethics applications (n = 4).  The 
responsibility weighed heavily on some ResNs and ResN10 reported “Absolutely, it‟s 
always there.  When you go on holiday you‟ve got stuff building up that‟s going to have to 
be done when you get back.  It doesn‟t go away and it keeps me awake at night” (L. 145 - 
147). 
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ResNs were either „self-taught‟ (n = 6) about their role or learned from more experienced 
ResNs within their ICU (n = 5).  Where they were self-taught, they had learned “on the 
job”,   through “trial and error” (n = 2), from study monitors (n = 3), reading protocols (n 
= 2), attending meetings (n = 1) and from ResNs in other NZ ICUs (n = 3).  The learning 
process was described as “a steep learning curve” (n = 2), “felt like a fish out of water” 
(ResN07) and “thrown in the deep end” (ResN11).  Although the PIs were considered 
supportive, none had assisted with orientating the ResNs.  ResNs learnt about GCP 
guidelines through formal training courses (n = 6), in-hospital seminars (n = 2) and the 
remainder through peers, study start up meetings and study monitors.   
Qualifications 
The ResNs were well qualified, and all had a post-registration qualification (Table 8).  One 
nurse was currently studying towards a doctorate and a further three expressed that they 
were likely to work towards a Masters degree in the future.  When specifically asked 
whether there was pressure to undertake advanced study in their role, all but one ResN 
stated that there wasn‟t.  For ResN09 there was a contractual expectation to work towards a 
Masters degree because her role was a senior nurse role.  ResN04 and ResN08 said although 
there was no pressure to study, working in the role presented an excellent opportunity to 
study and they would be well-supported to do so.  ResN11 said her PI had offered her 
support to do her Masters degree.  Two ResNs were conducting their own research studies; 
one towards a PhD, and the other was conducting an observational study, which was not 
towards a qualification.  A third ResN was leading a nursing study about ICU patient 
communication at her site. 
Working conditions 
As shown earlier in Table 8, 10 of the ResNs held part time research positions (0.4 - 0.9 
FTE), and one worked full-time.  For seven ResNs, their contract was permanent, with a 
further three due to become permanent shortly after the interviews, while the 11
th
 had a two 
year renewable contract.  All worked variable hours between 0700 - 1800hrs, Monday - 
Friday.  Reasons given for working part-time in research were; funding restrictions (n = 2), 
personal preference (n = 2), poor pay in research (n = 1), and the position had historically 
been part-time (n = 1). 
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In addition to their research role, seven of the ResNs also worked within ICU as a staff 
nurse (n = 6) or charge nurse (n = 1).  One spent most of her allocated staff nurse time doing 
the staff roster for her ICU.  ResN01 and ResN03 reported that the balance they had 
between research and clinical was „just right‟ and ResN04 would work more in research if it 
paid better. 
 
There were personal, research and clinical reasons for working clinical shifts.  Personal 
reasons were about remuneration (n = 2) that included needing a full-time income (n = 1) 
and better pay doing clinical shifts (n = 1).  Clinical reasons were equally divided between 
maintenance of clinical skills (n = 5) and credibility with staff (n = 5).  Clinical credibility 
was not always about clinical competence but was described as being important to be 
“seen” by the bedside nurses.  Research reasons were that working clinical helped with 
recruitment for studies (n = 2), increased research profile (n = 2), funding restrictions (n = 2) 
and compulsory part of contract (n = 1).  “Good for the staff to see you out there doing the 
stuff as well, not just always sitting in an office.  And you find heaps more patients when 
you‟re on the floor, than when you‟re sitting in your office” (ResN01, L 30 - 32).    
 
The four ResNs who did not work clinical had worked in the research role for a mean of 9.6 
years (range 1.2 - 14).  While all acknowledged that working clinically had advantages, the 
reasons they didn‟t included; they had worked in ICU as a nurse for so many years and saw 
no need to continue doing clinical (n = 4), the research job was busy enough (n = 2) and it 
was logistically difficult to fit in (n = 2).  Three of the ResNs who didn‟t work clinical had 
initially worked both, but as the workload for research increased, they found it increasingly 
difficult to balance the requirements of both jobs.  These three all thought it was good to 
have someone on the research team, who still regularly worked clinically.   
 
Working clinically had its problems.  When ResNs worked as bedside nurses, most reported 
doing research duties such as screening for potential patients and enrolling them into 
studies, while also having sole care of a critically ill patient.  ResN02 commented that she 
“spent my lunchtime screening or doing other [research] stuff” (L. 934).  ResN02 also 
reported previous charge nurses rostering her for afternoon or night shifts in the middle of 
the working week, making research difficult to do during the expected hours for the research 
role.  ResN10 had encountered this problem just prior to the interview, and considered that 
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this type of rostering indicated a lack of understanding by charge nurses about the 
requirements of the research role.   
 
None of the PIs thought it was an absolute necessity for the ResNs to do clinical shifts, but it 
depended on the individual ResNs‟ level of clinical experience and familiarity to staff.  PI06 
stated that “even in the [research role], you‟re still doing some nursing” (L. 117).  However, 
many of the PIs saw advantages to working clinical, including; enhancing communication 
and relationships (n = 3), raising the profile of research with a view to increasing 
recruitment into studies (n = 2), maintaining their skill level (n = 1) and understanding the 
work of the bedside nurse (n = 1).  This dual role was seen as advantageous by some PIs and 
ResNs who saw it as a way of getting greater value for the research department.  “The plus 
for me is that obviously if [they‟re] on clinical then I can get some free research time out of 
them if we get a patient in a trial.  So it increases our coverage a little bit” (PI01, L.97 - 
99). 
 
The NMs generally favoured the idea of ResNs doing clinical shifts (n = 5) although three 
thought it depended on the individual nurse and the length of time they had already worked 
clinically.  Only two of these NMs were from ICUs where all of the ResNs did clinical 
shifts.  NM04 ventured that having to do clinical was not important and was “an old 
notion” (L. 241).  The reasons NMs gave for ResNs doing clinical were; to maintain their 
skill level (n = 3), to have credibility with patients, family and staff nurses (n = 3) and to 
have a presence on the unit (n = 1).  NM06 thought requiring ResNs to do clinical was an 
“idealistic, rather than practical expectation” (L. 242). 
 
All participants were asked a benchmark question of what they would expect the ResNs to 
do if an emergency arose while they were with an ICU patient doing research duties.  The 
examples given were that the patient had a cardiac arrest, or was trying to pull their endo-
tracheal (breathing) tube out.  All but one participant responded that the ResNs should 
intervene to their level of experience and ability.  NM06 stated that as a registered nurse, 
that was their “duty of care”.  In contrast, NM05 stated that the ResNs should not get 
involved as it was no longer their area of expertise.  
Remuneration 
All of the ResNs were on a senior nurse salary scale of the Multi-Employer Collective 
Agreement (MECA) (DHB/NZNO, 2012).  Of the seven who shared which level they were 
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on, five were on Grade 2 and two were on Grade 3.  Three ResNs volunteered that their 
research position was re-scoped between five and 10 years ago, which resulted in their pay 
scale not only being lowered but also their pay rate remaining the same for many years.  
I was on level three and I went down to grade two and basically haven‟t had 
a pay rise for years, well not a proper one.  So that was quite a sore point 
because I was regarded as the same level as an educator and suddenly it was 
a demotion, and that was quite a contentious time for me as well, by the then 
manager.  (ResN06, L. 86 - 90) 
There was discontent about the pay scale (ResN; n = 7, PI; n = 2) and frustration that it was 
lower than ACNMs and educators despite similar levels of responsibility.  “The salaries are 
on the nursing scale and we can‟t seem to get out of that” (PI04, L. 88). 
 
The lack of a career structure was also a frustration and the research staff from one ICU has 
addressed this situation by introducing a career pathway.  PI03 expressed the difficulty they 
experienced in securing this.   
The organisation wanted everyone in research [in the hospital] on the same 
„speciality clinical nurse research‟ position description and there was a big 
fight to get them to agree that that was inappropriate because you‟ve got 
different people with different responsibilities and different experience.  (L. 
261 - 263) 
After hours availability and pay 
There were very different expectations and remuneration for the nurses being „on call‟ as 
seen in Table 11.  Two ICUs had a formal, paid „on call‟ system which meant they were 
expected to be available.  In a further three ICUs, the ResNs were not paid to be on call, but 
were phoned if a patient needed to be recruited after the normal working day.  The sixth 
ICU had no clinical trials running at the time of this study which required a ResN to be 
called in after hours.   
 
One of the ResNs who was paid to be available commented that the on-call system was 
underutilised by ICU staff but conversely, if it was utilised more, their job would be even 
more demanding than it currently was.  ResN09 said it was unclear how available she was 
expected to be, because she wasn‟t paid to be on-call and no formal system was in place.  
She commented that she was being called “more and more” and the expectation needed to 
be reviewed.  If she was called in, she was paid at a higher call-back rate.  NM01 thought 
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the ResNs were expected to be available after hours to enrol patients if necessary, however 
the ResNs in this ICU stated that although they were usually available there was no on call 
roster and no obligation to come in.  They were given „time in lieu‟ rather than extra pay for 
being called back or working overtime, an arrangement made because of funding 
restrictions and FTE limitations.  ResNs for another ICU were not paid to be on call and 
received extra pay at a normal rate if they came in to recruit a patient.  Although not paid to 
be on call, ResNs from this ICU had experienced pressure from a PI to come and recruit 
patients after hours. 
 
Table 11 On call and call back payments for ICU research nurses by ICU 
 Unit * Unit Unit Unit Unit Unit 
On call times Unsure 0600-2200 
Only if 
available 
At all 
times 
Only if 
available 
Not 
required 
On call 
payment 
Unpaid MECA  Unpaid MECA Unpaid 
Not 
required 
Call back 
remuneration 
MECA 
Call back 
rate 
MECA 
Call back 
rate 
Time in 
lieu 
MECA 
Call back 
rate 
Normal 
time 
Not 
required 
* ICU codes have not been included in this table to prevent the identifiability of ICUs and individual 
participants 
 
 
Six of the ResNs volunteered they were available to be phoned after hours for advice.  Many 
would also regularly phone the ICU to check that trial activities had been done correctly and 
on time.  This out of hours work was recognised as important by the ResNs.   
Fortunately I was rung at 11 o‟clock at night and [gave advice] and I was 
very thankful to the doctors in that case ringing because as I have said many 
times a quick phone call would help solve issues or protocol violations.  
(ResN11, L. 638 - 642) 
Job descriptions and performance appraisals 
Seven ResNs said they had a job description, two were unsure and two said they didn‟t have 
one.  Of the seven who had a job description, only three thought it was a true reflection of 
their role, and ResN11 stated that as she wrote hers, she was confident that it was correct.  
ResN06 had written hers many years prior when the role was quite different so although she 
was happy with the original job description, she no longer thought it was an accurate 
reflection of her role.  In contrast, ResN02 stated that hers was a generic senior nurse job 
description, and not reflective of her research role and ResN09s included activities such as 
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audit, which were not possible in the FTE she was employed for.  ResN08 was in the 
process of having hers updated and ResN05 had never read her job description.   
 
Performance appraisals were current in five of the ResNs, although one stated this was 
mainly for her nursing role.  Two others had received a recent informal appraisal and 
ResN01, ResN09 and ResN11 had never had an appraisal for their research position.  These 
ResNs had been in their research position between one and nine years, and two of them had 
a job description.  ResN09 wondered how she would be appraised because “no one knows 
what you do” and “no one actually really knows what you would appraise” (L. 534, 537 - 
538).  ResN06 commented that she hadn‟t had a performance appraisal for many years 
because there had been several changes of manager during that time.  Two ResNs who had 
had an up-to-date performance appraisal volunteered that it was done in consultation with 
staff they worked with including monitors, doctors and hospital research staff.  This was 
called a “360 appraisal” and the ResNs thought it was done well.   
 
All of the ICUs had more than one ResN working in a research role.  Only one had a formal, 
tiered structure and career pathway for the ResN, with the senior nurse being called a 
research nurse coordinator.  This was finalised around the time this study was conducted.  In 
another, ResN11 said she was considered the senior in the department and delegated tasks to 
more junior ResNs.  In addition, ResN09 reported that when staff worked in the department 
on secondments, they would be considered her junior and work would be delegated 
accordingly.  The ResNs and PI in one ICU expressed a perception that the longer a ResN 
was in the role, the more senior they were, although this was not formal and all ResNs had 
the same title and pay.  Two ResNs who had been in the role for a relatively short time 
regarded the experienced ResN as their senior, despite them being paid the same and sharing 
the same title.  ResNs from three ICUs reported they were responsible for ICU staff who 
occasionally helped with research activities while they were on „light duties‟ after an 
accident.  
Senior nurses 
ResNs were senior nurses as evidenced by their pay being on the senior pay scale of the 
MECA.  However, many thought that the research role was not regarded as being a senior 
position within their ICU.  Of the seven ResNs who saw themselves as seniors, three 
thought this was related to their ICU experience rather than being a ResN.  The four who 
didn‟t think they were viewed by others as senior related this to the separateness of research 
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from ICU.  Of these four, three described themselves as “just the research nurse” and one 
as a “nurse with another job”.  
I think our role is that of a senior nurse but we‟re not involved in the 
operations of the unit so we wouldn‟t influence the development of the unit.  
It‟s a really bizarre role I think because you are a senior nurse but there‟s no 
senior nurses I think within this ICU apart from us that don‟t influence the 
day to day running of the unit.  (ResN09, L. 659 - 663) 
 
This uncertainty about where ResNs were placed in the nursing hierarchy was reinforced by 
NMs and was articulated by NM06 “It‟s separate, it‟s still got the job title, the role 
description, the responsibilities, however I don't believe staff at the bedside considers them 
their senior” (NM06, L. 148 - 149).  This ambiguity was expressed by NM05 as: 
Senior nurses here we would call charge nurses and the senior nursing team 
and then staff nurses, the senior staff nurses are all our level fours and very 
experienced and we‟ve got a good core of them.  I think that they [ResNs] 
would be seen from the floor as somewhere in-between.  I don't think they‟re 
seen as part of the senior nursing team of the department because it‟s like 
that‟s more a management team.  (L. 72 - 77) 
 
These views were in contrast to the PIs, five of whom definitely thought that ResNs were 
senior nurses because of their speciality research and ICU knowledge.  The sixth PI did not 
think they would be seen as senior nurses because of the separateness of research from the 
ICU. 
 
Clinical Trials Group meeting attendance 
The vast majority of PIs and NMs (n = 11) agreed that attending the main CTG in Australia 
was an essential part of the role and it was almost guaranteed that at least one ResN would 
attend.  Attendance was considered important because of networking opportunities (n = 7), 
to learn about and participate in discussion about studies (n = 6) and find out study results (n 
= 2).  Networking was regarded as important as other ResNs and RCs could serve as role 
models, and share experiences about specific trials, funding, and engendering a “research 
culture”.  Knowing about studies enabled ResNs to participate in local discussions about 
which studies an ICU could participate in and enhanced the ResNs work.  Both NM05 and 
PI01 commented that the nurses always came back “enthusiastic”, and this was an element 
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essential to involving other staff in research in the ICU.  In contrast, one NM regarded 
attendance as a privilege that should be used as a reward for the ResNs doing their job well.  
The significant cost of attending research meetings overseas was acknowledged, and most 
were funded from the ICU research trust funds.  Others applied to education funds within 
their hospitals to assist with paying for attendance and some ResNs had personal education 
fund allowances.  Some ResNs attended other CTG meetings; however these were generally 
rated as less important than the main one. 
 
The 10 ResNs who regularly attended the CTG meeting thought it was beneficial, that it 
assisted them to do their job well and was “part of the job”.  They identified similar reasons 
to the PIs and NMs including the opportunity to network with their Australian and NZ 
colleagues (n = 5), learning about upcoming trials (n = 6) and getting the results of trials 
they had contributed to (n = 2).  Two ResNs did not like having to travel to Australia for the 
meetings and ResN09 stated that the usefulness of the CTG meeting was variable depending 
on the content.  Two other ResNs regarded the RC Workshop as a good professional 
development opportunity, ResN09 stating there were few such opportunities for ResNs. 
Without that [main CTG meeting] I wouldn‟t still be in the role… it reaffirms 
why I‟m doing it … I learn so much from it and its great knowing you‟ve got 
a group of colleagues and that you are part of something that matters.  If I 
was just here and not going to [CTG meeting] - just working here on my own, 
then I may as well just be entering data.  (ResN10, L. 818 - 827) 
 
Summary 
This chapter has described the three groups of participants.  Detailed information about the 
ICU research departments has helped to contextualise the structure the ResNs work within, 
and given a sense of how the role is perceived by those they work with.  The ResNs 
demographics, background, qualifications and contractual working conditions have shown 
that the ResNs are experienced in ICU and well-qualified.  Elements of dissatisfaction 
emerged around pay structures, job security and line management. 
 
The next chapter presents the thematic findings drawn from the interviews and focuses on 
the work the ResNs do, to fulfil their role expectations.  
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Chapter 6     Findings:  Research nurse role 
Introduction 
This second findings chapter is about the actual work of the ResNs.  There were three 
distinct areas which emerged from the thematic analysis about what was important about the 
role.  The first is about the role of the ResN as project manager and reports their role in 
every aspect of trial management.  Secondly, is the ResN role as a patient advocate, which 
focuses on the balance between patient and trial advocacy, and the ResN role in the consent 
process.  The third area is about ResNs bridging knowledge gaps through their dual 
specialty and communication skills.  This theme also identified skills and attributes 
important to being an ICU ResN.  While job satisfaction was not a primary focus of this 
thesis, challenges experienced by the ResNs did emerge from the interviews and are 
presented in this section.  Parts of their role were straight-forward such as the tasks that need 
to be performed for the safe conduct of clinical trials, while others such as communication 
and patient advocacy were more complex.  Incorporated throughout this chapter are 
summary findings from the responsibility assignment matrix (RAM) which shows where 
there is consistency amongst participant groups and amongst units.  When talking about the 
RAM, „accountability‟ refers to the person who has the overall responsibility for a task, 
while „responsibility‟ refers to the person who does the task.  There was generally consensus 
about who did tasks within individual ICUs, however, RAM did highlight areas that 
participant groups within the same ICU didn‟t agree on a specific task.  Areas where there 
was not agreement are highlighted in the text.  
Research nurses as project managers 
A responsibility which emerged over and over was that the ResN was a project manager or 
„coordinator‟.  This role covered the different stages of managing clinical trials including 
design, selection, set up, maintenance, or day-to-day management, and trial closure.  ResNs 
had involvement at every stage of the process and when ResNs didn‟t do the task 
themselves, they often facilitated it.  The extent of their role within each stage varied 
depending on the skills required, how experienced they were and the complexity of the 
study.  Some of the tasks were shared between the ResN and PI. 
There are two main areas.  One is in the initiation of a study, so there is a 
whole lot of setup type stuff and depending on skill sets the PI could do more 
or less or the nurse could do more or less but there are all of the ethics 
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issues, all the paperwork that goes on with that, the contractual side of things 
and the reporting requirements that go along with that, both to the sponsor 
and to ethics and so on, so there‟s all that stuff that goes on in the setup and 
the background while the study is running and I think that‟s one area that‟s 
quite important and the other one is the actual operation of the study, where 
there is the screening and the support of recruitment consent and supporting 
whatever‟s required in terms of intervention in the bed space.  (PI04, L.60 - 
68) 
 
Most of the ResNs described their last day working in research as „typical‟.  It was 
extremely busy with many interruptions and they had to multi-task several activities 
simultaneously.  There were similarities amongst the descriptions and all of the nurses had a 
basic daily routine which typically commenced with screening patients for trials, checking 
on patients who were already in studies and obtaining or facilitating consents.  They then 
did a variety of other study duties, depending on what was outstanding and “dealing with 
what‟s thrown at you” (ResN09, L. 316).   
 
An atypical day was mostly described by ResNs as one where they were either very busy or 
very quiet.  If the ICU was really busy, many patients would be eligible for studies, 
including difficult studies which took all day to enrol one patient into.  Other hallmarks of 
an atypical day included where study treatments didn‟t get administered correctly (protocol 
violations) and SAEs.  An atypical day was also one where they “had no patients [in trials]” 
(ResN01, L. 331) or had “no interruptions and sitting in the office and able to do a full 
eight hours work, minus your coffee breaks” (ResN04, L 555 - 557). 
 
It was widely acknowledged that PIs didn‟t have time to do most of the work for clinical 
trials, because of their clinical commitments as intensivists, and most of them weren‟t 
funded for research.  PIs generally had a good understanding of what was involved to 
manage clinical trials within the ICU, and there was a sense of the nurses working alongside 
the PIs to manage the studies, however the day-to-day management of studies fell 
predominantly to the ResNs.  The role had not been delegated in that PIs did not direct the 
work ResNs did daily, rather the ResNs took responsibility for their own work priorities.   
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The ResNs in five ICUs were responsible for some part of the research finances, including 
maintaining budgets, writing invoices for patient payments or facilitating this process.  
Administration work included checking emails, looking for medical records, updating study 
folders, archiving, computer training and invoicing.   
Study duties 
Trial design 
Five ResNs reported that they were currently a member of a management committee or had 
been in the past, which meant they had direct input into the trial design and protocol 
development.  Additionally, two ResNs stated that they had been invited to be part of a CTG 
reviewing committee which meant they reviewed and had input into trial documents before 
being released to the wider research community.  All participants thought it was important 
for ResNs to be on management committees and involved at the design stage because they 
had a good understanding about the practicalities of conducting the research, and impact on 
patients and nursing staff.  Additionally, improving case report form (CRF) development 
and data dictionaries made their and other ResNs daily work easier.  All ResNs working in 
ICU had the opportunity to review and contribute to CTG-endorsed studies, by way of 
attending CTG meetings.  The ResNs reported much of their workload was for CTG-
endorsed studies.   
Trial selection 
Trial selection refers to deciding which trials an ICU participates in and has been included 
because ResNs are actively involved in this decision (Figure 7).  When a study was being 
considered, the protocol was generally disseminated and discussed within the research team 
(ResNs and PI) before being sent to the other intensivists or a unit-level research committee 
for discussion.  Scientific validity, equipoise, practicality, financial viability, clinical 
relevance and interest were taken into account when a study was being considered.  
Although the other specialists in the ICU were generally consulted, the interviews revealed 
that this was often a limited consultation.  In Unit B, the ResN and PI decided together, and 
then the other intensivists were informed of the studies that were going to be done.  A 
common finding for this part of the work was that both the PI and ResN were „accountable‟ 
for particular tasks.  Tasks such as feasibility data including number of patients likely to be 
recruited and the budget were collated by either the ResNs or PI, or done together which 
accounts for this finding. 
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Figure 7 Responsibility assignment matrix – selecting studies for ICU 
Person who does 
task →  
Principal 
Investigator 
Research Nurse Intensivist Nurse Manager Registrar ACNM Bedside Nurse Other Unknown 
As reported by → RN PI NM RN PI NM RN PI NM RN PI NM RN PI NM RN PI NM RN PI NM RN PI NM RN PI NM 
Task ↓ Unit ↓ 
Study 
feasibility - 
no. of 
patients 
A A R  A/R R A/R C                     
B C   A                  C1      
C   A/R A/R R A/R                      
D A/R A/R R R R R                      
E A A/R R R/C  R                      
F A/R  A R A/R R                      
Study 
feasibility - 
budget 
A A R A A/R R R                      
B A A  A R                 A2      
C  A/R  A/R R A/R                      
D A/R A/R R  C R                A/R3      
E A A/R R R/C  R                      
F A A R R A/R R                A2      
Final 
decision 
A A  R A/C  A/R C A/C R                   
B A/R A/R A/R R A/R A/R  I    C            C4    
C C A/R  A/R   C C   C A            A5    
D R A  R C   C                    
E A A A/R R/C C/R R  C                    
F A/R R A/RR A/R R A/R C C C   C                
1 Administrator 
2 Accountant 
3 Hospital research department 
4 ICU nurse educator 
5 Administrator and clinical director 
 
 
KEY 
R = responsibility (does task) 
A = accountability (overall responsibility) 
C = consulted 
I = informed  
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Few of the ResNs or PIs indicated that the NM was involved in this decision although two 
NMs stated they were consulted.  In Unit C, the NM reported that the research account 
trustees who were the NM, clinical director and administrator made the final decision about 
which studies would be done.  This was not however the view of the ResNs or PI in this 
ICU, who believed it was a research department decision, in consultation with the other 
intensivists and NM. 
Trial set up 
Once a trial had been accepted into ICU, documentation required for ethical review was 
typically the responsibility of the ResNs while the PI had ultimate accountability.  “Then the 
research coordinator starts work.  Everyone else forgets about it” (ResN10, L. 863).  In 
five ICUs, one ResN would take ownership for the set up phase of a particular trial to ensure 
that everything was done, while in the sixth this responsibility fell solely to the most 
experienced ResN.  Some of the ethics tasks were done by a ResN and PI together, or by the 
ResN alone.  The exception to this was Maori consultation.  The PIs (n=5) clearly thought 
that ResNs had sole responsibility for this task, although four ResNs thought the PI had 
ultimate accountability for Maori consultation.  The NMs reported that ResNs did these 
tasks for setting up trials, but were not always sure who had ultimate accountability. 
 
The ResNs usually wrote the full ethics application, either on their own, or in conjunction 
with the PI.  This included writing the information sheets and consent forms or adapting 
templates sent from the sponsor to make them more relevant to NZ.  Five ResNs recorded 
that they had overall accountability for this task, while the remaining six stated that the PI 
had ultimate accountability.  The PI would then read it, make any necessary adjustments and 
sign it.  The locality assessment was usually obtained by the ResNs or facilitated by them.  
One ResN reported that she got the PI to do it because they had better access to the hospital 
level management who needed to approve the study being conducted in ICU.   
 
The findings were similar for the documents required by the local hospital research 
department.  The budget was generally written by a ResN or sometimes by the hospital 
accountant.  Overall accountability for the budget lay either with the PI, the hospital 
research department and/or a hospital accountant.  The ResN was responsible for organising 
and facilitating this process.  In Unit E, the PI and NM thought the PI had overall 
accountability, while the ResNs, who facilitated the process, thought the hospital accountant 
had final sign-off.  It was unclear in Unit C who had overall accountability for the budget.  
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The ResNs thought that they and the accountant did the budget but didn‟t know who had 
overall accountability, the PI didn‟t know who did and the NM thought the ResNs did.  
Registering the research study with the hospital research department generally fell to the 
ResN, although in three ICUs, the PI had to sign the submission.  In some cases, there 
wasn‟t a clear process and in one hospital, there was no research department. 
 
There were differences in who was involved in contract negotiation between the sponsor 
and ICU.  Commonly the ResNs would facilitate the process by consulting with the hospital 
legal department, with various roles within the hospital having ultimate sign-off.  Five of the 
PIs stated they had overall accountability for the contract and in other cases only the legal 
department or hospital research department could do this.  As can be seen in Figure 8, the 
NMs (n = 6) and most PIs (n = 5) were unaware that ResNs consulted the hospital lawyer or 
legal department regarding the trial contract in five ICUs. 
 
Studies often required inter-departmental input and many ResNs talked about liaising with 
other departments to seek their support prior to the study commencing, in particular the 
emergency department (ED), pharmacy, laboratory and radiology (Figure 9).  The hospital 
pharmacy was sometimes unable to support research due to resourcing limitations in which 
case, the ResNs facilitated suitable alternative staff to be the „unblinded team‟ to store and 
dispense a study drug.  This included recovery room staff or non-clinical nurses from within 
ICU.  The ResNs liaised with ED about recruitment and management for particular studies.  
ResNs from four ICUs reported consulting the laboratory for quotes for local or study 
bloods and one ResN reported liaising with the radiology department for a particular study.  
Figure 9 shows relationships which exist in the setup and maintenance phases. 
 
The final step for trial set up was getting the study into practice in the ICU, which involved 
educating doctors and nurses, and creating resources for staff.  ResNs reported creating 
resource folders, posters, newsletters or updating information „boards‟ about new trials 
which put the study duties into a more understandable form than the study protocol.  
Educating staff was identified as an ongoing process which continued throughout the study, 
however initial education was considered part of the trial set up.  There was almost 
universal acceptance by all participant groups that the ResNs educated nurses about studies.  
The PIs were generally accountable for educating the doctors although the ResNs reported 
assisting with this.  A common quote was “doctors for doctors, nurses for nurses”.  In
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Figure 8 Responsibility assignment matrix – trial set up stage (selected tasks) 
Person who does task 
→  
Principal 
Investigator 
Research Nurse Intensivist Nurse Manager Registrar ACNM Bedside Nurse Other Unknown 
As reported by → RN PI NM RN PI NM RN PI NM RN PI NM RN PI NM RN PI NM RN PI NM RN PI NM RN PI NM 
Task ↓ Unit ↓ 
Budget 
A A A A A/R R R    I            C1      
B A A  R R A/R                  R2    
C    R  A/R                R1   A A  
D    R C A/R                A3      
E  A/R A/R R C   C   C           A1 C1     
F A A  R R R                      
Ethics 
application 
A A/R A A A/R R R    I                  
B  A R R R R                      
C  A/R  A/R R R                      
D A A/R R R R R                      
E A A  R R                       
F A A  R R R                      
Contract 
negotiation 
A A/R A  R4 R R                A5      
B  A  A R                 C5      
C A A/R C A  C      C          C5      
D  C A/R  C                 A3 A3     
E  A/R R         I          A/C5     A 
F A A/R A/R R R                       
Implementing 
the protocol 
(„makes it 
happen‟) 
A    A/R  A/R                      
B    A/R                        
C  R  A/R R A/R                      
D  R  A/R A/R A/R                      
E  R  A/R R R  R                    
F    A/R A/R A/R                      
1 Accountant  
2 Finance department 
3 Hospital research department 
4 Facilitates 
5 Hospital lawyer or legal department 
KEY 
R = responsibility (does task) 
A = accountability (overall responsibility) 
C = consulted 
I = informed  
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contrast, the ResN in Unit B was responsible for all research related education for doctors 
and nurses. 
 
Figure 9  Key functional relationships 
 
 
Trial maintenance 
The majority of the ResNs‟ time was spent managing the various aspects of clinical trials.  
This was their „daily work‟.  ResNs within research departments communicated by way of 
communication books, whiteboards and email, about which patients were already in studies, 
what issues were outstanding and if there were patients who could potentially be enrolled.  
Within each department everyone was responsible for all study maintenance tasks, including 
recruiting, consenting and data collection so ResNs had to know about all of the trials their 
ICU was participating in (Chapter 5, Table 9). 
They‟d be responsible for basically following the protocol which is 
encouraging, educating the unit staff, following the protocol, encouraging 
and enrolments, trying to avoid breaches of the protocol and making sure 
there‟s a paper trail of our activities for audit and follow up and trying to 
make sure those things are available for when we do get audited by the larger 
groups.  (PI02, L. 105 - 111) 
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Screening and recruitment 
Screening and recruiting patients into trials was a very large part of trial management.  
There was variability about who identified patients eligible for trials.  Among these were the 
ResN, PI, other intensivists, registrars, ACNMs and the bedside nurses.  While most 
participants indicated when the RAM questions were asked that all of these groups were 
expected to recruit, the interviews revealed that the majority of patients were identified and 
recruited by the ResNs and PIs.  This practice was more prevalent in some ICUs than others.  
In Unit F, almost all patients were identified by either the ResNs or PI although patients 
could only be enrolled into a study if the intensivist on call for the day agreed to it.  A 
common reason given for screening and recruitment being the research team‟s responsibility 
was that nurses were too busy caring for acutely unwell patients. 
The calibre of patients has changed so much in terms of the acuity.  They‟ve 
[clinical staff] just got too much else going on, and then to think about „does 
this patient actually qualify for any studies‟?  We try and get the word out 
there but at the end of the day it‟s quite difficult if you have got a really sick 
patient and you‟re trying to get your headspace around X, Y, Z and inotropes 
and whatever else.  It‟s not A [airway], B [breathing], C [circulation], 
Research.  (ResN05, L. 440 - 446) 
 
ResNs screened patients for eligibility for clinical trials early in the day and then throughout 
the day as new patients were admitted to the ICU.  One ICU worked closely with the ED on 
a study which was commenced in the ED but was run by ICU research staff.  This meant the 
ResNs screened in ED as well as ICU for patients.   
 
The ResNs maintained the screening log which documented patients who were considered 
for studies but found to be ineligible or eligible but not enrolled („missed‟).  When eligible 
patients were missed, there was variability about whether the PI or ResN was responsible 
for following up with staff.  In some ICUs this was not a major consideration, the ResNs 
were philosophical about „missing‟ patients and no feedback was given to staff.  In others, 
every patient admitted was considered as being eligible for a study, unless they met an 
exclusion criterion, and staff were followed up about every missed patient by the ResNs or 
PI.  Ensuring that consents had been obtained for patients in trials was part of the ResNs‟ 
daily routine and is discussed at length in the section about patient advocacy. 
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Protocol adherence 
Several of the ResNs talked about how they ensured a study protocol was adhered to.  This 
entailed the ResNs doing study activities themselves and checking to see that delegated 
study tasks had been performed by bedside nurses, doctors or other staff.  These delegated 
tasks included ensuring patients received the correct trial treatment at the correct time.  
Monitoring the patient involved ensuring that specific vital observations and blood tests 
were taken at the correct time.  In four ICUs, the ResNs centrifuged blood tests and stored 
them in the research freezer themselves; while in the remaining two ICUs, ResNs ensured 
the blood tests were taken and sent to the laboratory for processing.  If study interventions 
or monitoring occurred during the night or weekend, the ResNs organised it, delegating 
tasks to ACNMs or intensivists, and then checked by telephone to ensure that it happened 
correctly.  All who did this stated that they were still responsible for the study interventions 
occurring correctly and in the correct time-frame and some volunteered that they preferred 
to come in after hours and do it themselves, rather than delegate it.  There was a degree of 
anxiety about having to delegate some study tasks and various methods were employed to 
ensure these tasks were done correctly including education, pre-labelling blood tubes, filling 
in laboratory forms in advance, highlighting when tasks were due on the ICU flow chart, 
phoning staff to check, sending texts to intensivists, creating trial-specific instructions with 
tick boxes and checking blood results remotely from home.  ResN11 verbalised the stress 
when she had to delegate study tasks such as taking and processing study bloods to other 
personnel when she wasn‟t there.  She constantly checked that the delegated tasks had been 
done within the correct timeframes.  Part of trial maintenance also included on-going 
checking of study supplies including study fluid and laboratory supplies and checking the 
research fridges and freezers were working correctly. 
Recognising protocol violations and serious adverse events 
The vast majority of protocol violations were recognised by the ResNs, although ResN08 
stated that “occasionally” an ACNM might notice something had been done incorrectly and 
report it to the ResN.  Protocol violations were either noticed at the time they occurred, 
when ResNs checked on patients throughout the day, or later when data were being 
collected.  NM04 reported that bedside nurses would also realise and self-report, however 
this was not corroborated by the ResNs or PI in their ICU.  ResN09 shared that it was 
reasonable for ResNs to notice protocol violations as they were the ones who knew the 
protocol in depth.  Participants in some ICUs reported that protocol violations were rare, 
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and the number of protocol violations varied depending on the studies ICUs were 
participating in. 
 
Reporting and documenting of protocol violations was primarily the role of the ResNs, 
however this was often done in conjunction with the PI.  The PIs had ultimate accountability 
for the violations and ResNs stated that the PI was informed if a violation was noticed, and 
in most cases, signed it off.  In Unit B, all protocol violations were registered as „reportable 
events‟ because the patient had not received the correct treatment.  No similar organisational 
reporting was done in any other hospital. 
 
Serious adverse events (SAEs) were uncommon but time-consuming when they occurred.  
The SAE reporting documentation was usually written by the ResNs although there was 
consensus that the PI had ultimate accountability for signing these off.  SAEs involved 
investigation of what had happened and ResN02 reported that when they happened, they 
took “a big chunk of the day”, gathering and collating the information to report to the 
sponsor and the lead site. 
Data collection and data entry 
Ten of the ResNs talked about data collection and data entry.  In most cases this was done 
on a daily basis, although ResN04 preferred to do it all at once after the patient had left ICU.  
The PIs rated data collection as a key role that ResNs did, and for PI02, it was the most 
important thing they did.  ResNs regarded high quality data collection as important because 
it respected the patient‟s contribution to the study and ensured that the study findings were 
valid.  However, three ResNs expressed that the role was “more than data collection”.   
 
Outcome data were generally collected by phoning the patient, and enquiring after their 
well-being.  An assessment was also made during this phone call about whether any adverse 
events had occurred since the patient was in ICU or hospital.  ResNs primarily conducted 
the follow-up phone calls or if they were unable to contact the patient, gathered this 
information from the patient‟s family, computer system, general practitioner (GP) or 
outpatient clinics.  ResNs reported that when contacted, patients frequently sought advice 
about non-research related issues that were concerning them.  The ResNs generally referred 
patients to the appropriate health-care provider or GP to address these matters.  In some 
cases, they were able to offer explanations if it was related to their treatment in ICU.  
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ResN11 reported that in the past, phoning patients had been delegated to other staff, but now 
preferred to do it herself so that she knew of any issue or difficulty reaching the patient. 
Trial closure 
The final step in any study is disseminating results when they are published.  Disseminating 
results to the nursing staff was seen as the responsibility of the ResN and was done by way 
of „communication books‟, newsletters, education sessions and posting results on research 
notice boards.  This was described by NM01 as “clos[ing] the loops to find out, has it 
actually made a difference” (L. 336 - 337).  In addition to informing staff of the results, 
ResNs also sent results to study participants who had requested them during the consent 
process. 
Research nurses balancing patient needs with research requirements 
The ResNs contributed to balancing the rights and needs of the patient and their family, with 
the demands of the research at every stage of the trial process.  This theme is about their role 
as patient advocates throughout the study and in particular, during the consent process. 
It starts right from the beginning, making sure you‟re putting the right patient 
into the study so that the study gets the right participants and is a true 
reflection of that group.  So you‟re protecting the study requirements and 
then you‟re making sure that the intervention that‟s to be delivered is 
delivered correctly.  And you might see that at the bedside or you might see it 
when you‟re collecting the data and realise that there‟s been a mistake made 
or something‟s gone wrong and then you‟re educating the staff at the same 
time in terms of the study requirements, what to watch out for, for adverse 
events or whatever.  So you need some knowledge of the patient and the care 
that‟s being provided whether it‟s a standard care or the intervention.  And 
then educating the family when you‟re talking to them for consent and the 
same with the patient hopefully later on as well.  So making sure that the 
patient is getting the best possible care, that they‟re not at risk by being in the 
study.  And that the study data and study requirements are all met and true.  
(ResN08, L. 738 - 752) 
Patient advocacy 
There were different interpretations of patient advocacy amongst the ResNs.  ResN06 stated 
that the term „patient advocacy‟ was interchangeable with patient safety, and she and 
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ResN02 said this was the main role of the ResN.  Some ResNs advocated for patients by 
offering them the opportunity to participate in research, while others reported advocacy as 
refraining from offering some patients this opportunity.  Others thought patient advocacy 
was present right from when the protocol was written.  Protocol adherence was also seen as 
patient advocacy as it ensured the patient was kept safe and the study results were 
trustworthy.  ResN06 stated “we are basically, in a lot of cases we are the only people 
standing between another National Women‟s and they don't recognise that.  They don't 
recognise the risk to the organisation if things aren‟t done properly” (L. 1204 - 1208).  
„National Womens‟ refers to a landmark case in NZ which much of our current ethics 
legislation is based on (MOH, 2007).  This viewpoint was more extreme than beliefs 
expressed by most ResNs. 
 
ResNs talked of using their clinical judgement to refrain from enrolling patients into clinical 
trials, who they assessed as unsuitable, despite their meeting the inclusion criteria.  This was 
sometimes done without the knowledge of the PI.  ResN06 and ResN07 had both acted in a 
patient‟s interests by not offering them studies.  In one example, this involved supporting a 
family who wanted a patient to be enrolled into a study but thought the patient would not 
want to participate.  ResN06 encouraged them to make the decision based on what the 
patient would have wanted, not what the family wanted and the patient was not enrolled.  In 
another example, ResN07 had screened a patient for a study which required insertion of a 
central venous line (CVL).  The patient was frail and elderly and would not have needed the 
CVL for their usual care, so ResN07 did not suggest the study.  She expressed doubt that 
this was the way a ResN should behave “because I know that as a research nurse we should 
be going for it but I just think sometimes oh what are we doing, what are we doing?”  (L. 
479 - 480).  ResN02 stated that making a clinical judgement about the suitability of a patient 
being offered a trial, above and beyond the inclusion and exclusion criteria was definitely 
the role of the ResN.   
One example is choosing not to put patients in a study or even approach it 
with them because even though they fit the protocol, they may have been 
diagnosed with terminal Ca [cancer] or they‟ve got terminal Ca or you look 
at them, they‟ll say yes, but it‟s going to put an undue pressure on them to do 
things, and onerous things where they have to do this or that, and they‟re just 
not up to it, but they would do it.  (L. 800 - 806) 
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ResN01 shared a clinical situation when she was a patient advocate in her role as a ResN.  
Throughout the course of a study intervention for a patient on the ward, she assessed that the 
patient was sicker than initially thought, and she facilitated their admission to ICU.   
 
Three ResNs said that most of the time, advocacy was ensuring patients and their families 
were given the opportunity to be in a study.  ResN11 described this as a “patient‟s right” 
and ResN08 reported advocacy went both ways but more frequently involved arguing for 
patients to go into studies than being kept out.  The remaining ResNs answered in general 
terms about patient advocacy.  They didn‟t have examples but volunteered they definitely 
thought it was part of their role and would intervene if necessary to ensure patients‟ interests 
were upheld.  Although ResN04 and ResN09 thought it was done so automatically that they 
didn‟t think about it, they both talked about patients in special circumstances e.g. patients 
with an intellectual disability or with dementia potentially being enrolled under the delayed 
consent option, when they could never actually consent for themselves.  ResN09 stated that 
ResNs in the ICU setting tended to advocate more for the relatives than the patient 
themselves.   
 
Three of the ResNs volunteered that patient advocacy began at the trial design stage, thus 
validating the need for ResNs to be involved in writing the protocol and be on trial 
management committees.  ResN02 talked about ensuring that the protocol was written in a 
way that the research question would be answered and the patients would be kept safe, and 
then adhered to so that a patient‟s contribution was worthwhile.  Ensuring the protocol was 
adhered to and the data collected was of a high quality was seen as a way of respecting the 
patient‟s contribution. 
 
Two ResNs and one PI (ResN02, ResN04, PI05) made references to patients doing better 
overall when patients were involved in a research trial because care was delivered correctly 
and on time.  ResN11 also pointed out that patient care such as blood results were 
scrutinised much more carefully if a patient was in a trial.   
Consent process 
The part of the ResNs role with the greatest diversity amongst ICUs, was the issue of 
consent.  There were different levels of responsibility for obtaining consent, depending on 
the nature of the study and potential risk and side effects of study treatment.  The very 
minimum ResNs did in the process of consenting patients into clinical trials was to identify 
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potential patients and if they were eligible, give them or their family an information sheet 
about the trial.  If the family seemed interested, they would facilitate a doctor to obtain 
consent.  At the other end of the scale, one ResN was able to complete the full consent 
process for all clinical trials, including a commercial trial for an experimental drug.  The 
difference amongst practices tended to be at the ICU or hospital policy level, combined with 
the personal view of the individual ResN.  The PI and ResNs for two ICUs reported that the 
majority of consents were obtained by the research team.   
 
To make it easier to understand, the subject of consent is split into lower-risk studies which 
compare two standard existing treatments and where delayed consent is an option, and 
higher-risk studies in which prior assent or consent must be obtained (usually from a 
surrogate) prior to the commencement of any study procedures.  In reality, the degree of risk 
in research studies is on a continuum, rather than dichotomous, as there is always the 
possibility of side effects because the result of any treatment is unknown when it is being 
researched.  The scale of „Always, Usually, Sometimes, Rarely, Never‟ has been applied 
based on the findings from the interviews (Table 12).  For this table, the view of the ResN 
has been given more weight, as the assumption has been made that they know whether they 
obtain consents or not.  As will be seen in the RAM charts, the NMs were not always aware 
or certain of the level of involvement ResNs had in the consent process.  This could be 
because of a recent change in practice or the NM just not knowing.   
Lower risk 
Examples of lower risk were a study about glucose control in ICU patients (NICE Study 
Investigators, 2009) and comparison between two intravenous fluids for fluid resuscitation 
(CHEST Trial) (The CHEST Management Committee, 2011).  For these lower risk studies 
the ResNs in five of the ICUs were able to obtain prior or delayed written consent for 
specific trials from the patient (Figure 10).  The ResN from one of these ICUs did not obtain 
assents from family because of her interpretation of the wording in the Health and 
Disability Code of Rights: Right 7, which states that where a patient is not competent, health 
service delivery is „in the patient‟s best interests‟ (Health and Disability Commisioner, 
2009).  A ResN in this ICU shared that this was a decision only a doctor could make.  She 
also highlighted the issue of indemnity, and questioned who would be responsible if 
something went wrong with a trial if it was the ResN who had obtained assent.  In all five of 
the ICUs where the ResNs were able to obtain written consent, they were almost exclusively 
the staff who obtained follow-up consent from the patient once they were competent, when 
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the initial assent had been signed by a family member.  ResNs from two ICUs stated that 
they had only recently started obtaining consents and it was much easier than having to wait 
for doctors to do it.   
 
Table 12 Research nurses’ role in the consent process 
 
UNIT A B C D E F 
Lower Risk Study 
Discuss study  
(Patient or Family) 
Usually Sometimes Sometimes Usually Usually Usually 
Patient consent 
(prior) 
Usually Sometimes Sometimes Never Sometimes Usually 
Patient consent 
(delayed) 
Usually Sometimes Sometimes Never Sometimes Usually 
Relative assent  Usually Sometimes Sometimes Never Never Usually 
Follow up consent  
(patient) 
Usually Usually Usually Never Usually Usually 
Higher Risk Study 
Discuss study  
(Patient or Family) 
Rarely Sometimes Sometimes Usually Usually Usually 
Patient consent  Never Never Never Never Never Sometimes 
a  
Relative assent  Never Never Never Never Never N/A
b 
Follow up consent 
(patient) 
Never Never Never Never Never N/Ab 
a  dependent on seniority and of the research nurse and whether they are a sub-investigator 
b experimental study had pre-hospital consent only 
 
In Unit D, where ResNs never obtained written consents or assents, this was the policy of 
the hospital research department.  Although these Unit D ResNs were not able to obtain 
written consent, they were involved in the consent process.  It was their role to screen the 
patient for eligibility and they usually spoke to the family (or patient), gave them the 
information sheet to read and answered any questions they had.  After this the PI would 
answer any additional questions and get the consent form signed.   
 
In some instances, although obtaining consent was part of the ResN‟s role they used their 
judgement with particular patients to decide whether it would be more appropriate for a 
doctor to obtain written consent.  ResN03 and ResN08 said they gauged potential family 
reaction to research and also tried to minimise the impact or distress to families by 
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Figure 10 Responsibility Assignment Matrix - consent process (lower risk studies) 
Person who does 
task →  
Principal 
Investigator 
Research Nurse Intensivist Nurse Manager Registrar ACNM Bedside Nurse Other Unknown 
As reported by → 
RN PI NM RN PI NM RN PI NM RN PI NM RN PI NM RN PI NM RN PI NM RN PI NM RN PI NM 
Task ↓ 
Unit 
↓ 
Discusses 
study with 
patient or 
family 
A R   A/R A/R A/R R      I      I         
B R   A/R R A/R R      R  R             
C A R  R R R1 R R A                  A 
D A/R A/R R R R R A/R  R                   
E R R  A/R R  R                     
F A/R A/R  R A/R A/R  R                    
Obtains 
written 
consent - 
Patient 
A A/R  R A/R A/R A/R A/R  R    I  R    I         
B A/R A/R  R R A/R R      R R R             
C A R  R R R1 R R A                   
D A/R A/R R   R A/R  R                   
E A/R A/R  R   A/R                     
F A/R A/R  R A/R A/R  I                    
Obtains 
written 
assent – 
Family* 
A A/R  R A/R A/R A/R A/R  R    I      I         
B A/R A/R  R R A/R R R     R R R             
C A R  R R R1 R R A                   
D A/R A/R R   R A/R  R                   
E A/R A/R     A/R                     
F A/R A/R  R A/R A/R  I                    
Obtains 
written 
follow-up 
consent - 
Patient 
A    A/R A/R A/R I            I         
B  A/R  R R A/R  R       R             
C A  R R R R1 R R                   A 
D A/R A/R R   R A/R  R                   
E    A/R                        
F A/R A/R  R A/R A/R                      
1 Facilitates 
*Refers to Relative/Whanau member/Friend assent 
KEY 
R = responsibility (does task) 
A = accountability (overall responsibility) 
C = consulted 
I = informed  
110 
combining clinical trial discussions with family meetings about a patient‟s general 
condition.   
Higher risk studies 
Higher risk studies generally involved an experimental therapy, such as an unlicensed 
drug, new treatment or procedure, or a drug where one purpose of the study was to 
evaluate the risks of potentially harmful side effects compared to the beneficial use of the 
drug.  They were often, but not always commercial studies.  These studies tended to be 
for the sickest ICU patients who had a higher likelihood of poor outcomes including 
death. 
 
In most ICUs, the RAM results indicated that only an intensivist, who was also a sub-
investigator for a study could obtain consent/assent from a patient or family for these 
higher risk studies (Figure 11).  The role of the ResN in these situations was often to 
approach the family about the possibility of a trial and gauge the likelihood of them 
agreeing to a study.  The ResNs were sometimes present in the family meeting about the 
trial, along with the intensivist and assisted with answering questions about the research.  
ResN11 also talked about going over the information sheet with a sub-investigator before 
they spoke to the family, and sitting in the meeting to ensure the information was correct, 
as she was more familiar with the protocol.  Reasons given for ResNs not consenting for 
higher risk studies were that “doctors could explain complicated procedures better” 
(ResN02, L. 1244) and a belief that a “doctor should consent for novel and early phase 
studies” (ResN11, L. 303). 
Delayed consent 
Delayed consent had been used for studies in all of the participants‟ ICU.  The ResNs 
and PIs had a good understanding of delayed consent, while half of NMs either weren‟t 
familiar or had limited understanding of it.  Amongst those participants who were 
familiar with it, there was universal support for the process of delayed consent for ICU 
patients participating in clinical trials.  Most ResNs and PIs considered research would be 
impossible in the ICU setting without it.  However, all were conscious that such consents 
did not get misused or inappropriately used and several talked about using it 
“judiciously”, and stating that every practicable effort was made to contact family prior 
to enrolling a patient into a clinical trial. 
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Figure 11 Responsibility Assignment Matrix - consent process (higher risk studies) 
Person who does 
task →  
Principal 
Investigator 
Research Nurse Intensivist Nurse Manager Registrar ACNM Bedside Nurse Other Unknown 
As reported by → 
RN PI NM RN PI NM RN PI NM RN PI NM RN PI NM RN PI NM RN PI NM RN PI NM RN PI NM 
Task ↓ 
Unit 
↓ 
Discusses 
study with 
patient or 
family 
A A/R A/R  R  A/R A/R A/R     I      I        A 
B A/R   C R  A/R                     
C A/R A/R C   R1 A/R A/R A                   
D A/R A/R R R R R A/R  R                  A 
E A/R A/R  R   R                     
F A/R A/R  R A/R A/R R                    A 
Obtains* 
written 
consent - 
Patient 
A A/R A/R R    A/R A/R R   R I      I         
B A/R A/R     A/R A/R                   A 
C A/R A/R C   R1 A/R  A                  A 
D A/R A/R R   R A/R                     
E A/R A/R     A/R                     
F A/R A/R  A/R2 A/R A/R  I                   A 
Obtains 
written 
assent – 
Family** 
A A/R A/R R    R A/R R   R I      I         
B A/R A/R     A/R A/R                   A 
C A/R A/R C   R1 A/R A/R A                  A 
D A/R A/R R   R A/R  R                   
E A/R A/R     A/R                     
F A/R A/R  A/R2 A/R A/R                     A 
Obtains 
written 
follow-up 
consent - 
Patient 
A A/R A/R  R  A/R A/R A/R                    
B A/R A/R     A/R A/R                   A 
C A/R A/R C   R1 A/R A/R A                  A 
D A/R A/R R   R A/R/C  R                   
E A/R   R                        
F A/R A/R  A/R2 A/R A/R                      
1 Facilitates process 
2 dependent on the seniority of the ResN and whether they are a sub-investigator 
*For most higher risk studies, patient consent would be unlikely due to their severity of illness 
**Refers to Relative/Whanau member/Friend assent 
KEY 
R = responsibility (does task) 
A = accountability (overall responsibility) 
C = consulted 
I = informed  
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Reasons given for supporting delayed consent as an option for ICU studies included pragmatic 
reasons such as initiating study treatment in a timely fashion by being able to put a patient who 
was unconscious and without family present into a study and ethical reasons such as giving 
families more time to consider a study.  ResN08 questioned whether approaching families or 
patients for assent or consent in ICU could be seen as “informed”, even if it was obtained prior 
to initiation of study treatment.  This was because families were often upset and unable to 
comprehend the information being given to them, and that delayed consent as an option meant 
they could consider the study in their own time.   
 
Some participants (ResN, n = 5; PI, n = 1) volunteered that delayed consent was only 
appropriate to use in low risk studies.  Two examples of using delayed consent for patients who 
were conscious were given.  In both cases, the study had been discussed with the patient, and 
they had agreed to participate, but research staff assessed that the patient was unable to make 
an informed decision due to their illness (ResN01, ResN07). 
Difficulties with consent 
A difficulty highlighted with delayed consent was when and by whom the patient or family 
should be approached about the study and consent or assent sought.  Most participants agreed 
that it was best to inform the patient or family that the patient was in a clinical trial as soon as 
practically possible.  However, the ResNs and PI in one ICU strongly thought that it should be 
a member of the research team who approached the patient or family.  They stated that from 
past experience it was more important to wait for a member of the research team and if it was 
sought sooner by the bedside nurse, consent was more likely to be refused.   
So we would see the family as soon as we feasibly can at an appropriate time – 
when they‟re not too distressed, and just let them know who we are, and that 
they‟re in the study.  If it‟s appropriate you could leave them the information 
sheet at that point, well I‟d go back the next day and catch up with them and 
introduce myself again, and say this is what we‟re doing, “are you happy?”, 
give them the information sheet and go back at an appropriate time.  You just 
have to play it by ear, all the families are different, but try and get the family 
consent as soon as possible – certainly let them know about the study as soon as 
you can.  And then when the patient‟s better, you obviously follow up the patient 
on the ward and get the patient‟s consent.  (ResN03, L. 300 - 308) 
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In contrast, ResN06 stated that the patient or family should be told immediately by whichever 
staff member saw them first (usually the bedside nurse).  PI01 stated that withdrawal of 
consent after a patient being enrolled into a study using the delayed consent option was very 
low.  ResN09 spoke about missing consents after a patient was enrolled in a study using the 
delayed consent option.  If ResNs worked part-time, it was possible for the patient to have been 
discharged to the ward or home by the time the ResN became aware that they were even in the 
study.  This scenario made on-going consent “difficult to get” (ResN09, L. 1011).  
 
An additional difficulty in ICU was identifying the most appropriate person to talk to about 
research and ICU staff relied on family members identifying themselves as having a close 
relationship to the patient (ResN04).  It was also common to have to talk to several people and 
need them all to agree.  This was echoed by ResN11, who shared a situation where consent was 
obtained from one family member, then another, closer relative arrived, and the consent 
process was gone through again. 
 
Two ResNs had concerns about the consent process when doctors, who were not specifically 
involved in research, obtained consent from patients or their families.  ResN09 and ResN11 
were uncertain that these doctors always had sufficient knowledge to obtain consents.  ResN09 
questioned how “informed” the consents were and ResN11 reported feeling anxious about how 
correctly consents were done when some doctors did them.  The correct procedure, with correct 
dates, times and patients filling in all relevant sections were all cause for anxiety.   
Research nurses bridging gaps and making research happen 
This theme is about the necessity of having a ResN dedicated to research in ICU.  It also 
addresses key attributes including whether they need to be an ICU nurse.  The reasons cited as 
important for being an ICU nurse are grouped into specialist knowledge, communication, 
relationships and „other‟ attributes, which are discussed below.  The first three of these are 
interrelated and are about the importance of being an ICU nurse.  This section also discusses 
barriers to performing the job well. 
Essential to research 
Most of the contribution to patient care was described as long-term, and that the ResN was 
integral to the process of researching to find “best practice” (NM04).  ResNs were seen as 
essential for enabling ICUs to participate in a research programme.  Their dual role as 
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specialists in research and ICU was seen as advantageous for bridging knowledge gaps for 
patients and nurses, in particular.  Having the knowledge and ability to combine the two 
specialties in a way that kept the patient safe and produced high quality research was 
recognised as an important part of the ResN role.  There was universal agreement from PIs that 
without ResNs there would be little or no research in ICU.  The ResNs were described 
variously as the “link” (NM04), “lynchpin” (PI04), “driver of research” (NM04) and the 
“glue that makes research happen” (PI01).  Some reasons for these descriptions were 
pragmatic and included that the ResNs provided continuity by being dedicated to the research 
role and that they had time which PIs just didn‟t have.   
They make it happen.  It would not happen.  I mean we tried to do a little bit 
of stuff here back in the early 90s with nobody and it was just about 
impossible really.  I mean I, it‟s essential that we have them … so not only do 
they bring anything its kind of the whole lynchpin of the whole system really 
is a good research coordinator.  (PI04, L. 590 - 593) 
Specialist knowledge 
Amongst the ResN participants, there was a continuum of answers about the necessity of ICU 
ResNs being an ICU nurse.  These answers ranged from agreement being an ICU nurse would 
help with the job (n = 2) to strong opinion that ICU ResNs needed to be ICU nurses (n = 6), 
through to the need that they needed to be very senior ICU nurses (n = 3).  ResN01 and 
ResN03 stated that although being an ICU nurse would help, it wasn‟t essential and probably 
depended on the individual.  Two ResNs who had experience working with non-ICU and non-
nurse researchers in ICU strongly believed that you needed to be an ICU nurse to be an ICU 
ResN, in order to understand the complexities of the ICU patient and environment.   
 
Being proficient in ICU was generally considered more important than a background in 
research as it was considered that research could be taught more easily than ICU care.  All 
participants from one ICU universally supported this notion because of past experience, where 
a ResN who was experienced in research, but not ICU, had been employed.  This had been 
problematic and a conscious decision had been made for future employments to add more 
weight to ICU experience and ability to work with the research team.   
 
The NMs cited many reasons that ICU experience would be advantageous including the need 
for clinical skills unique to nursing and ICU, relationships with bedside nurses (credibility), 
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understanding the nursing perspective, severity of illness of ICU patients and ICU clinical data.  
NM04 and NM05 stated that it was important to be a senior or expert nurse and NM01 stated 
they should be at least a proficient-level, intensive care trained nurse.  NM06 volunteered that 
in a larger research department, it may be appropriate to have some non-nurses. 
 
All PIs agreed that that the “ideal” ICU ResN would be an ICU nurse and the role would be 
very difficult if the ResNs weren‟t ICU nurses first.  PI06 however speculated that it would be 
possible to incorporate non-nurses into a larger research department, and PI02 thought it would 
be possible for someone with a non-nursing health background to work in the role of an ICU 
ResN.  PI03 and PI06 volunteered that ResNs should have worked to quite a senior level or 
have „significant‟ ICU experience.  The reasons they gave were relationships with staff, 
knowledge of ICU for data collection and the ability to talk to patients about non-research 
clinical problems.  PI06 highlighted that being more senior meant the ResNs had a “degree of 
trust and respect out there amongst your peers” (L. 97 - 98). 
 
A reason given for needing to be an ICU nurse was the holistic view that nurses have and their 
ability to be able to bring the needs of the patient into research.  This intertwining of roles and 
patient advocacy were discussed in the previous section.  ICU trained nurses knew what was 
expected for the study and also assisting with the clinical components of the study.  Several 
ResNs said if you employed a data collector, then that is all you would get.  By knowing what 
was required for research and ICU care, the impact on the bedside nurse and therefore patient 
care could be minimised (ResN02, ResN06). 
 They need to be able to look at the patient in a very rounded view to see 
because it‟s not just about trial – it‟s about assessing the patient, having a 
disease prediction about where that disease could potentially go and if they‟re 
going to fill the trial or not, so we‟ve made it a proficient qualified critical care 
nurse.  NM01 (L. 178 - 182) 
 
Three areas of clinical knowledge regarded as specific to ICU included ventilation, an area 
most ICU nurses would be experts on, interpretation of arterial blood gases (ABGs) and 
„monitoring‟ patients.  Monitoring in the ICU context refers to both the close monitoring of 
patients through high nurse/patient ratios, and cardiac monitoring.  PI05 had recent experience 
with engineering PhD students who had little clinical understanding about ventilation which 
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reinforced their belief that ICU ResNs should be ICU nurses.  ResN01 also thought having 
ICU expertise was advantageous because you could do trial activities yourself, and not have to 
rely on the bedside nurses doing it.  ResN07, ResN10 and PI03 stated that you could do the 
research job without being a nurse in other clinical areas, but definitely not in ICU. 
Communication and education 
Communication was reported as a very important skill by most of the ResNs (n =10).  This was 
articulated either as “communication”, “good people skills” or “rapport”.  For ResN02 and 
10, there was a need for not only good verbal communication, but also written communication.  
ResNs were able to communicate with a wide sphere of people from stressed families, through 
to ICU nurses and medical specialists, and ethics committees.  They had expertise in research, 
but because of their additional expertise in ICU were able to understand and apply complicated 
research protocols and make them more understandable for patients and nurses.  ResNs also 
reported that being an ICU nurse helped to understand the clinical implications of a study from 
the bedside nurse‟s perspective. 
 
Communication with patients and families was important to ensure they had a good 
understanding of the research trial.  Having an ICU background was also important for 
communicating with patients and their families about all of their clinical issues (not just 
research).  ResN06 stated that ResNs could “take some of the stress off nurses by talking to 
families” (L. 1049) and PI06 volunteered that as ICU nurses, the ResNs were “comfortable 
talking about research” (L. 469) to families and patients. 
 
Communication with staff was essential to ensure the smooth-running of clinical trials.  This 
began before the trial even started, with educating nurses and doctors about what the trial 
involved.  When a patient was on a trial, the ResNs communicated with the bedside nurses, 
ACNMs, PI and other intensivists to ensure protocol adherence and the safety of the patient.  
ResNs delegating duties to bedside nurses has already been described in the first part of this 
section.  In the ICU setting, ResNs had to have clinical knowledge in order to ensure the safe 
conduct the trials.  Their extensive knowledge of individual study protocols meant they could 
„translate‟ information for other nursing staff.  Several ResNs volunteered that they talked to 
the bedside staff as part of their daily routine and educated them informally about research 
studies. 
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Relationships 
The NMs described the ResNs being the link between research and the bedside nursing staff.  
Many studies increased the workload of the bedside nurse, by requiring more laboratory 
testing, monitoring or delivery of a therapeutic substance.  ResNs reported working closely 
with the bedside nurse to ensure that the research protocol was conducted safely and within 
given timeframes.  To alleviate the increased workload of trials on the bedside nurse, ResNs 
often did clinical tasks which were required for the study, such as putting up intravenous or 
enteral feeds, taking routine blood tests when study bloods were taken and assisted with 
nursing cares.  The two reasons for this were to ease the burden to the bedside nurse‟s 
workload and to ensure that it was done correctly and in a timely manner.  It was widely 
reported by NMs that nurses were more likely to discuss aspects of the study with nurses, 
rather than an intensivist and ResN11, who had worked with medical and PhD students 
reported that nurses responded better to nurses than non-nurses.  She felt that rapport with the 
nurses and the respect earned from being a senior ICU nurse also helped with research.  
ResN03 also thought that nurses responded better to nurses.   
 
Maintaining relationships with bedside nurses was important for research, as without the input 
of bedside nurses, research was difficult.  Part of this relationship was being seen as being 
clinically “credible” by other staff, and „visible‟ in and around ICU.  Being part of the team 
has already been discussed in Chapter 5.  Two ResNs talked about wearing their nursing 
uniform or scrubs to feel like part of the team.  Visibility was seen as important for recruitment 
and for staff relations.  Ways of achieving visibility included having an office within ICU and 
being out on the unit. 
Other attributes 
The PIs stated that attributes such as “attention to detail”, “enthusiasm” and “being 
organised” were very important.  The ResNs identified additional attributes as “methodical”, 
“computer and numeric skills”, “good time management”, “good detective work” and 
“diplomacy” as essential to the role.  The ability to motivate the team and engender 
enthusiasm was identified frequently because engendering a research culture within an ICU 
was the biggest barrier to conducting research.  This belief was shared by all participant groups 
and was expressed as “marketing” (NM02), “motivate the team” (PI01), “raise the profile”, 
(NM02) and “enthusiasm” (ResN04).  PI05 and NM06 also stated that a tertiary level degree, 
such as a Masters (or working towards one) was important.   
118 
Nursing research 
A vocal minority which included one ResN, one PI and two NMs from different ICUs thought 
the ResN role should include more focus on nursing research.  Other ResNs (n = 8) reported 
that their role with regards to nursing and other primary research was more of an advisory and 
support role.  This was mainly for staff undertaking their Masters degrees and most advice was 
regarding ethics.  As stated earlier, two ResNs were conducting their own studies.  Four of the 
NMs reported that ResNs assisted with nursing research in an advisory and support role, and 
that they had particular knowledge about the ethics programme.  NM01 expressed frustration 
that the ResN role was solely clinical trials and not nursing research.  NM06 reported that part 
of the role was to “promote and lead nursing research in the ICU” (L. 198).  NM02 and 
NM04 stated there was no nursing research programme in their ICUs, and therefore the ResNs 
had no involvement in nursing research.   
Role challenges 
Although there was widespread satisfaction among ResNs, two main challenges were 
identified and echoed by the PIs and some NMs.  These challenges which are interrelated were 
“lack of a research culture” and “staff obstructiveness”, both of which are discussed below.  
These were identified as barriers to enrolling patients into trials, and were in no way related to 
patient safety. 
Research culture 
The issue of “lack of research culture” was reported by participants from four ICUs.  They 
expressed frustration that research only happened when the ResNs or PIs were present to 
recruit patients and had few solutions about how to “get people who are not really about 
research to screen for you” (PI01, L. 603).  One suggestion was employing ResNs with 
“enthusiasm” and “passion” for research.  Research staff wanted to change the culture of the 
unit so that research was an integral part of ICU care, however as ResN04 articulated 
“Everybody believes in evidence based practice and they like to think that they do it, but 
there‟s a real aversion if it requires any extra work” (L. 719 - 721).  For PI05 
It‟s changing the culture so that everybody knows that they‟re part of this 
research thing and it‟s not just for the money and it‟s not because you‟re short 
[of money] but you‟re in intensive care and you should be doing research.  (L. 
472 - 474) 
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This lack of research culture was certainly not unanimous and all participants in one ICU 
expressed a strong research culture which extended to senior doctors, registrars, charge nurses 
and bedside nurses.   
Staff 
The most common challenge identified by participants was a perception of “staff 
obstructiveness” or “disinterest”.  The obstructive staff most commonly referred to were (non-
PI) intensivists, as well as some senior nursing staff, such as ACNMs.  These difficulties with 
intensivists (other than the PI) were reported in four ICUs.  This was proffered not only by the 
ResNs (n = 8), but also the PIs (n = 3) and NMs (n = 2).  At the lower end of the spectrum, the 
ResNs knew that depending on which intensivist was in charge for the day, they would need to 
make a “good case” to be allowed to approach a patient for a study.  At the other end of the 
spectrum NM05 stated that “one or two [senior] doctors here who are quite obstructive and 
always don't want the patients in the trials” (L. 610 - 611).  In some cases, these intensivists 
had participated in the decision-making about whether units were going to participate in a 
study.   
It [research] comes way down the list.  And, and that‟s the feeling you get – 
that it‟s completely down the bottom of the list so it‟s the last thing anyone 
thinks of and us research nurses we have to just make it fit, they‟re not going 
to help us and it‟s all up to us to make it work.  (ResN10, L. 555 - 558) 
 
This was seen as a medical problem and ResN02 stated the solution needed to come from “the 
top”.  However, ResN08 reported there was a lack of support from all higher levels of nursing 
management, in particular the NM and ACNMs.  
Not feeling as though you have the support from the nursing leadership of all 
levels and again I think it starts at the charge nurse level.  I think there‟s a 
couple of charge nurses [ACNMs] who...I don‟t know if they intentionally set 
out to sabotage or just do it because they don‟t get it, but there could 
certainly be a lot more support after hours from that side.  And from the 
[NM].  (L. 896 - 901) 
 
Many ResNs volunteered that it depended which clinical staff were working and in particular, 
the ACNM, as to how well research worked.  When ResN02 was talking about protocol 
adherence, she shared 
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that‟s just part of the job, and part of the job is realising if you get a 100 
people, 50% actively try to help you do it, 30% passively try and help you do 
it, 5% will do things wrong if it occurs to them, and the other 10-15% will 
actively try and sabotage it without them putting it that way.  So it helps to 
work in a unit where you know your staff, so you know which ones to keep an 
eye out for and which ones to say „thank [goodness] that ones on‟.  (L. 918 - 
924) 
Future development of the role 
Much of the discussion about the future development of the ResN role was about recognition 
and the development of a career pathway.  This incorporated recognition of the work ResNs 
do, responsibility they have and their contribution to patient care and research (n = 6).  Two 
ways of showing recognition were identified as the advent of a career pathway (n = 6) and an 
appropriate level of pay (n = 6).  Additionally recognition needed to be through the Nursing 
Council of NZ (n = 1) and NZNO (n = 2) and nursing in general (n = 1).  ResN02 was 
“cynical” about the likelihood of these things happening, as they hadn‟t in the past.  ResN08 
highlighted the pay disparity between ResNs compared to nurse educators and ACNMs despite 
similar levels of responsibility and expertise.  While there was support for a career pathway, 
ResNs and NMs were uncertain how this would fit in with other clinical areas, because the 
ResN role in ICU was perceived as different to other areas by three ResNs and one NM.  
Another avenue expressed as a future direction (n = 3) was ResNs doing their own research, 
ResN06 expressing that “we‟ve got the expertise” (L. 1616).  There was acknowledgement that 
the development and acceptance of the position statement, recognition as a subgroup of the 
critical care section of NZNO and the meetings and networking within NZ had been a „good 
start‟ (n = 3), and that working together was important in the future. 
Summary 
The thematic findings presented in this chapter have collectively shown the importance of the 
role, and the components that ResNs do in the ICU setting.  Project management of every part 
of the trial process was a significant part of the ResNs work.  The finding that ResNs had a 
significant role to play in patient and trial advocacy added to the third finding that they bridged 
gaps in knowledge and relationships between research, patients, their families and other 
healthcare professionals.  Additionally, important attributes which enabled them to do these 
roles well, and barriers to performing their role were identified.  These themes, in addition to 
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the findings about demographic data, structures and background about the role of the ResN 
presented in Chapter 5, give a picture of the ResN role as a whole.   
 
The next and final chapter draws these findings together, and reflects on them in the context of 
the literature and all of the information provided in the preceding chapters. 
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Chapter 7  Discussion 
Introduction 
This study aimed to describe the role of ResNs in NZ Level III ICUs and the structures and 
funding arrangements they work within.  An in-depth description of the ResN role was 
achieved by interviewing ResNs, PIs and NMs.  The structures pertaining to ResNs, including 
line accountability and key relationships were described.  The objectives included describing 
the ICU ResNs in NZ, identifying important components of their role and assessing the 
similarities and differences about the role.  This chapter outlines key findings, and then 
discusses the three main findings in more depth.  These findings are:  The significance of the 
ResN role in trial management and „making research happen‟ in ICUs, patient advocacy, and 
employment issues.  Strengths and limitations of the study and the research design and process 
are then reflected on, particularly the use of the responsibility assignment matrix (RAM) as an 
analysis tool.  Finally, practice, educational and research recommendations drawn from this 
study are made. 
Overview of findings 
This study interviewed ResNs (n = 11), PIs (n = 6) and NMs (n = 6) from six NZ ICUs about 
the role of the ResN.  The ResNs were all female, well-educated and were an experienced 
workforce both in ICU and research.  They had a commitment to ongoing education and two 
were conducting their own studies.  All of the ResNs had learned how to do their job „on the 
job‟ – five from senior ResNs in their department and six were self-taught.  There were four 
different management structures within the research departments (Figure 6, p. 74), although the 
ResNs predominantly reported to a nursing or service manager (n = 10).  Only three ResNs had 
a job description which was reflective of their role, and only five had a current performance 
appraisal.  There was variability in the way ICU research departments were funded, which 
came from the ICU operational budget, studies and commercial sponsorship.  All ICUs 
received some commercial funding either through unconditional grants or by participating in 
commercial trials.  ICUs participated predominantly in investigator-initiated, grant funded 
studies, of which half were CTG endorsed. 
 
There was almost universal agreement amongst ResNs, PIs and NMs that the primary role of 
ResNs in NZ ICUs was managing clinical trials.  They had input into every stage of the 
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research process including protocol design, deciding which studies ICUs would participate in, 
and setting up and safely managing trials through protocol adherence.  ResNs worked in 
partnership with PIs on the daily management of clinical trials.  All ResNs had some role in the 
consent process, either as the first person to approach a family about a trial or obtaining full 
consent.  Individual hospital policy, PIs and ResNs determined how involved the ResNs were 
with the consent process. 
 
ResNs were seen as the link between patients, bedside nurses and research.  They balanced the 
needs of the trial with the needs of the patient using their dual specialty knowledge of ICU and 
research.  Patient advocacy was synonymous with patient safety, which underpinned all of the 
ResNs‟ work.  ResNs advocated for patients at every stage of research from the protocol design 
to ensuring the protocol was adhered to, and this advocacy ensured the patients‟ health needs 
had the highest priority.   
 
ResNs were generally satisfied with their role, however, along with PIs and NMs cited 
overcoming a negative research culture within their ICUs as a problem.  Additionally there was 
inconsistency in the expectations of ResNs regarding after hours availability and dissatisfaction 
about recognition and remuneration.  There was variability about whether ResNs were 
considered senior nurses within ICU or not, although if they were, this was usually related to 
their ICU role or experience, rather than their research role.  Research departments were 
regarded as being „to the side‟ of ICU. 
Trial management - the research nurse’s primary role 
The role of the ResN has been shown to predominately be managing clinical trials, which is in 
line with international literature (Bevans et al., 2011; Catania et al., 2012; Hill & MacArthur, 
2006; Jeong et al., 2007; Mori et al., 2007; Mueller, 2001; Nagel et al., 2010; Rickard et al., 
2006; Rico-Villademoros et al., 2004; Roberts et al., 2011b).  ResNs were like the conductor of 
an orchestra, who direct the parts to create the „whole‟.  Conductors ensure that everyone 
knows the part they have to play, and ensures they play it correctly so that the music is brought 
together harmoniously.  Like the conductor, ResNs knew what had to be done, when it had to 
be done and by whom.  They also understood why it had to be done, and in some cases, they 
did the task, and in all other cases they facilitated it.  ResNs became experts on individual trials 
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and probably knew more about the practical aspects of conducting the study than any other 
person involved. 
 
The components of the ResN‟s role were in alignment with the international literature, with a 
focus on administering the protocol, protocol adherence, data collection, patient follow-up, as 
well as consenting, which is discussed later in this chapter.  The ResNs were responsible for 
the ethical components of trial set-up including writing ethics submissions, information sheets 
and consent forms.  They also facilitated contract negotiations, liaised with other departments 
and educated nurses (and sometimes doctors) about new trials.  One important component of 
their daily work which kept emerging was the importance of screening and recruitment for 
studies.  Where ICUs were funded by studies, recruitment was essential to generate funding.  
This made the ResNs reliant on other staff because recruitment into studies in ICU was a 24 
hour a day job.  Recruitment was previously only articulated in the literature by Hill and 
MacArthur (2006) and Roberts et al. (2011b).  Hill and MacArthur also reported that ResNs 
were dependent on recruiting patients to pay their salary.  
 
Research tasks were divided between ResNs and PIs according to practicalities such as 
availability and expertise.  This division of labour can be seen as the delegation of duties 
referred to by Mueller (2001) and Mueller and Mamo (2002) but also as a practical application 
of teamwork in the healthcare setting (Opie, 1999).  Teamwork in research is not only 
practically advantageous, but offers patients the best that professional groups have to offer.  
The finding that nurses had different knowledge to doctors, who tended to have a more 
scientific approach was similar to the findings in a paper by Snelgrove and Hughes (2000).  
These authors identified nursing knowledge as patient advocacy and holistic care which were 
similar to the findings in this study.  When PIs spoke of the ResN, they appreciated the 
practical elements and expertise they brought to the role; however they never spoke about more 
nursing-focussed activities such as patient advocacy.  Similar to the findings in Anderson 
(2008), ResNs worked in partnership with PIs and there was significant trust between them.  
The PI trusted the ResNs to do some difficult trial-related tasks, which they would then “sign 
off”.  ResNs respected that trust and would seek their guidance and help when required as seen 
in Mueller and Mamo (2002).  The ResNs had a close and autonomous working relationship 
with the PI, who held the ResNs in the very highest regard and were their biggest advocates.  
They worked with ResNs and delegated responsibilities such as obtaining consent to them, as 
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the ResNs became more experienced.  While this was reminiscent of Mueller and Mamo‟s 
(2000) finding that study duties were delegated along socially-stratified lines from higher 
(doctor) to lower (nurse), the close working relationship described above was suggestive of a 
collegial and collaborative division of labour according to skill set and work expectations.  
ResNs were solely responsible for the day-to-day management of the trials, which was not 
delegated, but was considered their work.  The RAM analysis often had both the PI and ResN 
being „accountable‟ for a task.  In a management setting this might be concerning (Smith & 
Erwin, 2007), however in the context of the ResN and PI working in a partnership this was an 
understandable finding.  This close nurse-doctor relationship is reportedly more common in 
specialised areas such as ICU, where nurses are seen as having specialised knowledge 
(Chaboyer & Patterson, 2001; Coombs & Ersser, 2004). 
 
The role of the ResN was identified as essential for ICUs participating in research.  While 
some of the reasons may have been pragmatic, it was also recognised that ResNs had extensive 
skills and experience, both in ICU and research.  The ResN was the „face of research‟ for 
nurses and patients, and „made research happen‟ on a daily basis.  To achieve this, they needed 
to be skilled and knowledgeable.  There was resistance from ResNs to being seen as “just data 
collectors”.  While all acknowledged this was an important part of their role, and in some cases 
was seen as essential for respecting the patients‟ contribution, ResNs did not want to be 
defined by this.  Perhaps this side of the role is all that many clinical staff see, but their role 
was so much more.  ResNs were clearly not „handmaidens‟, and were not „doing doctors 
work‟, although it was highlighted that few were leading their own research, which is an area 
that may be developed in the future.   
 
The ResNs‟ contribution to patient care is perhaps best viewed as a long-term investment.  In 
the time that I have worked as a ResN, the ICU I work in has contributed to two significant 
studies which, when published changed or reaffirmed practice in ICU.  The first of these 
compared tightly controlled blood glucose levels with a more liberal approach (NICE Study 
Investigators, 2009).  The study showed that ICU patients who had their blood glucose levels 
tightly controlled by insulin had a higher mortality rate, at the 90 day follow up.  Another study 
showed that early decompressive craniectomy in patients with a severe traumatic brain injury 
worsened the functional outcome of these patients (Cooper et al., 2011).  These studies 
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highlight the significant contribution ICU research can make to improving patient care and 
outcomes. 
 
Many ResNs and PIs spoke about their frustrations with medical and nursing staff within their 
ICUs, and a „lack of a research culture‟ was reported in four ICUs.  This was reflective of the 
study by Spilsbury et al. (2008) where management had agreed to participate in a trial, then the 
ward staff were uncooperative with study treatment.  In the case of ICUs what is interesting is 
that the CICM Minimum Standards of Intensive Care Medicine (CICM, 2010b) state that level 
III ICUs should have an “active research programme” and “employ a research coordinator”.  
Additionally, this guideline states that “the majority of nursing staff will have a post 
registration qualification in intensive care or the specialty of the unit” (p. 2) and must have a 
“formal nursing education program” (p. 2).  On the basis of the Minimum Standard guideline, 
it could be assumed that all nurses and intensivists would want research to occur in their ICUs, 
yet their lack of cooperation was cited as a barrier to recruiting patients into research studies.  
Johnson (2008) completed a thesis on the perspectives of nurses towards clinical trials in one 
NZ ICU.  Johnson‟s study reported that bedside nurses needed more support regarding 
education and trial implementation, because clinical trials impacted on their workload.  The 
nurses also raised ethical concerns about consent procedures.  Without speaking to (non-
research) intensivists, it is impossible to determine why they don‟t fully participate in studies, 
even though their ICU has agreed to participate.   
Patient advocacy 
While all staff involved in research act as ethical gatekeepers, ResNs played a particularly 
significant role in advocating for patients.  The ResNs in this study acted as patient advocates 
throughout the entire research process.  While Davis (2002) importantly found that study 
coordinators had a key role in balancing the needs of the trial, the patient and the patient as a 
study subject, this research has shown that advocacy extends beyond what is done clinically in 
research.  In participating at the development stage of trial protocols, ResNs were able to 
advocate for the patient, but also for the study, by identifying study components that would and 
wouldn‟t work, or would be too difficult in the ICU setting.  They were experts in the 
practicalities of conducting clinical research in this challenging environment, and their 
involvement enabled trials to start with a clear and practical protocol.  
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To be a patient advocate, ResNs needed to use their clinical judgement and experience to 
decide which patients were suitable for clinical trials from a holistic point of view, taking into 
account human elements beyond a trial‟s inclusion and exclusion criteria.  This tendency to 
advocate for the patient is an inherent part of nursing (Fouka & Mantzorou, 2011; MacDonald, 
2007; Nursing Council of New Zealand, 2012); however, perhaps it is also good for clinical 
trials.  Although Chatfield (2008) states that the quality of research is improved if nurses are 
involved, we don‟t really know what effect the ResN role has on clinical trials.  ResNs had a 
significant role in protocol adherence, which adds to the overall quality of studies and the data 
collected.  It is possible that their involvement may reduce the number of patients who decline 
consent, are „lost to follow-up‟ or were assessed as unsuitable for enrolment in the first place 
because of the constant checking and monitoring they do. 
 
Another layer of advocacy identified was that ResNs „bridged knowledge gaps‟.  This was 
most significant for the bedside nurse, and patients and/or families.  Providing information in a 
way that patients and families understood provided them with the opportunity to make an 
informed decision about participating in trials.  „Translating‟ medical information for families 
is an important role for ICU nurses (Coombs & Ersser, 2004) and communicating information 
about studies to bedside nurses and associate charge nurse managers (ACNMs) contributed to 
good conduct of clinical trials and adherence to the protocol.  ResNs have been variously 
described in the literature as „the hub‟ (Davis et al., 2002) and the „glue‟ (Duane et al., 2007), 
and the findings in this study are congruent with these studies.  ResNs had a key relationship 
with the bedside nurse, assisting with trial duties, and educating them about aspects of trials.  
This finding is in contrast to those reported in Johnson (2008). 
 
ResNs had extensive knowledge about ethics – both at the bedside advocating for patients, and 
the procedural requirements of ethics committees.  ICU patients are extremely vulnerable and 
ResNs took this responsibility seriously.  This study provides important findings about the role 
of ResNs in the consent process.  The consent process was the area which showed the most 
difference across the ICUs.  The level of involvement with regard to consent varied according 
to the institution ResNs worked in and their interpretation of guiding documents.  What this 
study has done is articulate that there are different levels of risk associated with different 
clinical trials, and in some cases ResNs were able to obtain consent from patients and/or their 
families.  When ResNs did obtain consent for trials, it was generally for „low risk‟ studies 
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where two existing standard treatments were being compared.  In particular, ICUs that were 
participating in the CHEST trial (The CHEST Management Committee, 2011), which was 
considered lower risk, had recent experience of ResNs obtaining written consents.  Considering 
the trials that ResNs in the Australian literature were participating in were likely to be similar 
or the same CTG-endorsed studies, it is not surprising that this finding was similar to those 
studies (Rickard et al., 2006; Roberts et al., 2011b), in which 78 - 80% of ResNs obtained 
consent.  It was unclear how involved ResNs were in the consent process in other studies 
(Bevans et al., 2011; Catania et al., 2008; Nagel et al., 2010).  Informed consent has 
traditionally been the domain of the medical profession.  The more studies that ICUs 
participated in, the more „routine‟ obtaining of consent became and so ResNs‟ obtaining 
consent could be seen as a task delegated „down‟ from doctors to nurses (Mueller, 2001).  
Other reasons identified for ResNs obtaining these consents were that they had more time, and 
had extensive knowledge about trials.  In addition, as ResNs became more experienced, they 
may have developed the expertise and confidence necessary.  Some ResNs went as far as to say 
they were more familiar with the protocol than many non-research doctors, and were sceptical 
about non-research doctors completing consents.  By enrolling patients into studies and 
obtaining consents correctly, ResNs could be seen as straddling medical and nursing work as 
Mueller suggests. 
 
ResNs and PIs used their judgement to decide the most appropriate time to obtain ongoing 
consent, following entry into a study with delayed consent or assent.  ResNs also used their 
experience and judgement to decide if it would be more appropriate for a doctor to talk to a 
patient or family, in some situations.  As long as ResNs are fully aware of any risks associated 
with consenting patients into clinical trials and are acting within accordance of their 
professional responsibilities, these institutional and personal beliefs must be respected.   
 
The „Guideline on the Regulation of Therapeutic Products in NZ‟ states that “supplying 
clinical trial medicines to trial participants is not considered to be prescribing or dispensing” 
(MOH, 2011, p. 20), however the relevance of this to the ICU setting is unknown.  There is no 
doubt that consent in the ICU setting is a complex ethical situation, to which both doctors and 
nurses contribute.  ResNs, even those who do not obtain consent for some or all ICU studies, 
participate in the process, by ensuring that it is done correctly and ethically.  What would 
happen to this process if ResNs were replaced with data collectors?  The area of consent in 
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unconscious patients is largely untested (MOH, 2006), and ResNs must continue to be ethical 
gatekeepers.  It is unknown what the role of ResNs in other clinical areas is in obtaining 
consent for clinical trials.   
Employment issues 
ResNs were a highly skilled and experienced workforce, yet despite this, many thought this 
work was poorly recognised.  All ResNs did most of their learning „on the job‟, not unlike 
apprentices, although eight had attended formal GCP training through external agencies or 
their hospitals.  The finding that newer ResNs were trained by more experienced ResNs in their 
departments is pleasing as it reveals the depth of experience that is now available to new 
ResNs.  Apprenticeship type training is, however, dependent on the opportunities that arise, a 
degree of trial and error, and the skills of the trainers.  
 
The finding that eight (73%) of the ResNs did not have an accurate job description, and three 
had never had a formal performance appraisal for their research position highlights a major 
issue.  A similar problem was identified by both Hill and MacArthur (2006) and Rickard et al. 
(2006) where 28% and 31% respectively did not have job descriptions.  In these studies, there 
was also concern that ResNs did not have permanent contracts, which was identified as a 
reason for not having a job description.  The difference in the NZ setting is that virtually all of 
the ResNs studied were employed on permanent contracts (or were soon after the interviews), 
yet 73% did not have an accurate job description.  The reasons for no job description were not 
identified; however their absence highlights risk and safety issues both to the individual and 
the hospital.  If anything ever went wrong with a patient in a research trial, this could be 
problematic for an individual ResN and the hospital.  Not having an accurate job description 
also adds to role confusion, even more so when ResNs were employed for one reason, and then 
their job changed.  Equally difficult was where there was no chance of a ResN completing 
tasks such as quality and audit within their funded FTE.  This study was conducted during a 
time of change, and I am aware that some ICUs were updating job descriptions.  This lack of 
clarity about the role in some ICUs would make it difficult to conduct a performance appraisal.  
On top of this, ResNs expressed that their NMs didn‟t know in detail what they did and had no 
involvement in the day-to-day management of the research departments.  In most cases, the 
NM was their line manager, who they were professionally accountable to and who was 
responsible for their appraisal.   
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ResNs enjoyed their autonomy and did not suggest that NMs became more involved with the 
day-to-day management of research.  While some NMs had limited knowledge about specific 
aspects of research, others had considerable knowledge about many parts of the ResN role and 
their work.  Most NMs took the stance that as senior nurses ResNs were capable of working 
independently and were responsible for the day-to-day work which had been delegated to them.  
This could be considered an appropriate stance as perhaps the NMs were only involved with 
the management of ICU patients if a problem arose.  The question is, to what extent do NMs 
need to know about the role of the ResN and how much should be known for line 
management? 
 
It was not an objective of this study to advocate one structure over another; however, the study 
did highlight the importance of a shared understanding amongst those in key positions about 
lines of accountability and responsibilities.  There was not always agreement between 
participant groups about the management structure that ResNs worked in.  The reason for this 
is unknown and because the ResNs did not have current job descriptions, it is difficult to assess 
the most accurate viewpoint.  One possibility is that in some ICUs, an informal structure co-
exists along with a formal structure.  While the official accountability for all but one ResN was 
a nursing manager, over half of ResNs also reported an informal accountability to the PI.  This 
differed from the literature in which only 16 - 17% had a nursing line management (Hill & 
MacArthur, 2006; Rickard et al., 2006), although Rickard et al. reported dual line management 
with the PI in a further 18%.  The appropriateness of the NM being the ResNs line manager 
was questioned by one PI – a view that was also inferred by the informal accountability with 
PIs, reported by ResNs.  While it was unclear whether the NM was the most appropriate line 
manager, the question about who would be an appropriate line manager is then raised.  What is 
of utmost concern is that a two-tiered (formal and informal), dual accountability (NM and PI) 
structure was the most common structure in use.  Dual accountability and unclear lines of 
accountability are very confusing.  The problem with dual accountability is that it has the 
potential to mean no accountability, direction or leadership.  There would be professional 
accountability implications for a nurse having a doctor as a manager although this was the 
management structure for one ICU.   
 
131 
Despite ResNs being employed on the collective agreement as senior nurses (DHB/NZNO, 
2012) another area of concern was the ambiguity reported by NMs about whether ResNs were 
senior nurses in ICU and the suggestion that they were considered senior nurses „in name 
only‟.  This was not a view shared by most PIs, who had the greatest respect for the 
contribution ResNs made.  ResNs were (generally) expected to perform their duty of care if an 
ICU patient experienced a clinical emergency, yet weren‟t necessarily considered a senior 
nurse operationally.  Despite this, NMs expected ResNs to manage their own workload, be 
autonomous and professional.  While ResNs did not identify themselves as feeling isolated, in 
many ICUs, research was seen as „separate‟ from ICU.  It was unclear whether the 
„separateness‟ of the research departments was beneficial or not although it contributed to the 
role of ResN not being seen as part of the senior team within some ICUs.  While much of the 
work ResNs did in ICU was seen as clinical, there was still a need, either self-imposed or 
contractual, to be seen as „credible‟ with nursing staff by doing clinical shifts as a bedside 
nurse.  This suggests that, in the absence of doing clinical or bedside nursing, the ResN role 
was not seen as contributing to patient care, which is not congruent with the findings of this 
study.  It would be of value to see if the bedside nurses agreed with this finding and whether 
they think that nurses who have „stepped away from the bedside‟ are no longer nurses, or if it‟s 
an “old notion” as suggested by one NM.   
 
Many ResNs were protective about their set research hours, citing reasons such as funding as a 
reason not to help clinically when the ICU was short-staffed.  This stance has to be viewed in 
the larger context and that in most ICUs ResNs received no help with their research workload.  
The ResNs took their role and responsibilities seriously and were prepared to do nearly all 
research activities for a patient who was enrolled in a trial including phoning from home to 
check on them or come in out of hours when a problem occurred.  When they did work clinical 
shifts, they continued to do research duties where possible, while also looking after an ICU 
patient.   
 
The reported „separateness‟ is significant not only because ResNs are working in ICU and 
doing research, but also for their career pathway.  Only one ICU had a formal career pathway, 
although there was an informal hierarchy in others where a more senior ResN delegated tasks 
to a junior.  Having no career pathway meant that no matter how experienced ResNs were, 
their grade and pay remained the same.  As seen in the ICU which had developed a career 
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pathway, this could be developed at a local level, and did not rely on a national collective 
agreement.  However, in order to achieve this, the role needed to recognised as important, 
which was not always the case.  ResNs clearly have expert skills in a wide variety of study-
related activities including clinical, ethical and financial.  In order to retain this depth of 
knowledge, a career pathway must be considered to ensure experienced ResNs are retained in 
these positions, an issue recognised by Leonie Walker, a researcher at NZNO (Walker, 2009a, 
2009b, 2010).  Although the ResN role has arisen out of a need to have „someone‟ taking 
responsibility for managing clinical trials in ICU, it is an important role and its origins as work 
delegated by doctors does not preclude the role from becoming a specialised position.  Bevans 
et al. (2011) described a pathway of sorts, which defined clinical research nurses in a large 
research centre as those that delivered care to patients, while research nurse coordinators 
focussed on the whole process including study coordination.  As this role has been identified as 
a nursing role in the NZ setting, it is imperative that Directors of Nursing and other nurse 
leaders understand the significant work that ResNs do, and acknowledge the importance of it 
by establishing a defined career pathway with an appropriate salary scale.  While PIs recognise 
that without ResNs there would be no research, nurse leaders have yet to acknowledge the 
importance of this role. 
 
Remuneration was a source of dissatisfaction for some ResNs.  This was because they were 
reportedly on a lower „grade‟ than other senior nurses, including ACNMs and educators in 
ICU, despite having similar levels of ICU experience.  Some ResNs had also been 
„downgraded‟ in the past, when the role was re-scoped by NZNO.  The pay one receives can be 
seen as a form of recognition.  Lack of recognition was reported by Roberts et al. (2011a) as 
the „worst‟ aspect of the role and dissatisfaction about pay was similar to the findings in their 
earlier studies (Roberts et al., 2006).  When I contacted the NZNO about the pay structure, 
their only suggestion was to apply for the role to be re-scoped at a local level through the “Job 
Evaluation Review Committee” (DHB Shared Services, 2012).  More work needs to be done 
collectively amongst ResNs if the job is to be re-scoped to a higher grade, as in the past re-
scoping had not worked in the ResNs‟ favour.   
 
The need for an on call system varied depending on the particular trials that units were 
participating in.  ResNs generally did not express dissatisfaction about their on-call 
arrangements, because they had developed informal systems which worked for their ICU and 
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possibly because they didn‟t know what was happening in other NZ ICUs.  However, some of 
these arrangements were problematic because they relied on the goodwill of ResNs, and as 
such are unsustainable in the long term.  ResNs in three ICUs were not paid to be on-call, yet 
there was a tacit understanding that they would be available to come in after hours to enrol 
patients into studies.  Goodwill and tacit understandings are problematic and mean the ResN 
who can‟t respond to such requests could be vulnerable.  It also means the ability of the ICU to 
enrol patients is at risk.  The Australian ICU studies (Rickard et al., 2007; Roberts et al., 
2011a; Roberts et al., 2006) reported on call arrangements as a source of dissatisfaction.  
ResNs must be involved in any changes to on call arrangements because one ResN who was 
paid to be on call was dissatisfied, and an appealing aspect of the role for others was the 
„flexible hours‟.  For most ResNs, this was not a job which could be left behind at the end of 
the day.  In many cases, ResNs worked above and beyond the terms of their contract to ensure 
protocol adherence both for the patient and the trial, by phoning and checking on trial patients 
after hours and during their days off.  In this context, the bitterness about downgrading of 
ResNs pay rates and dissatisfaction with pay can be understood.   
 
Funding was an issue for half of research departments which meant that the job security of 
some ResNs was tenuous.  There was a mix of how ICU research departments were funded, 
and while commercial sponsors and ICU operational funding added to the overall security of 
the research department, the ResNs‟ sense of security was equally related to the research 
culture of the ICU they worked in.  The two PIs who were unconcerned about finances had an 
unconditional ongoing grant from an external commercial sponsor.  In these difficult financial 
times, more public/private partnerships may need to be considered for future funding for 
research.  However, careful consideration must be made about how research remain rigorous 
and independent if there is a dependence on commercial funding, before embarking on this 
route.  There was widespread belief amongst ResNs and PIs that research should at least be 
partly funded by the government or DHB.  The NMs were more pragmatic about this, and 
thought any additional health spending would be better spent operationally rather than on 
research.  This disagreement between nursing and medicine is of concern, particularly given 
the dual accountability that ResNs had to them.   
 
The network established by NZ ICU ResNs themselves is an important forum for future 
development of the role.  While many employment issues were decided locally, a collective 
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national voice would raise the profile of ResNs, and a shared understanding about the role 
would help all ICU staff to understand it better.  There was widespread acknowledgement that 
initiatives already underway such as the draft National Competency Framework for Clinical 
Research Nurses (Walker et al., 2010), were an important first step for all ResNs. 
Strengths and limitations of this study 
This study is the first of its kind in NZ describing ResNs in the ICU setting.  It draws on the 
views of multiple stakeholders and 100% of invited participants agreed to be interviewed.  This 
has enabled triangulation of data within ICUs and across professional groups to provide a 
balanced role description.  Early consultation with ResNs about this study and being known to 
participants enhanced recruitment and was also important for informing what to ask.  Being an 
„insider‟ in this study also proved to be advantageous and was a strength.  When participants 
talked about specific trials or parts of the role, I understood what they were talking about and 
was able to concentrate on what they were saying.  Additionally, people were interested in the 
study, were open with their answers, and the range of views provided indicates they probably 
answered honestly.  This thesis has presented a detailed methodology chapter which highlights 
rigour strategies employed such as member checking, triangulation and audit trail.  For 
example, relevant quotations with line numbers are evidence of the audit trail. 
 
In the main, limitations are an inherent part of the research question, which had a limited scope 
of ResNs in the NZ ICU setting.  Generalisability to settings other than ICU was never an aim 
for this study, or methodology, although describing the role within this setting adds to the body 
of knowledge about ResNs generally.  While ICU patients are extremely ill, and it could be 
assumed that they are the „sickest of the sick‟, patients are also extremely sick in areas such 
cardiology and oncology, and with different requirements, so it is possible that some of the 
findings could be transferable to other clinical areas.   
Reflection on methods of inquiry  
Two main methods were used for this study – semi-structured interviews and RAM.  While 
both of these tools had advantages and limitations, the overall data were comprehensive and 
rich.  I would recommend the use of both of these methods in any future research about the 
topic, however some considerations are needed when using the RAM in this type of study 
again. 
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Interviews 
Using semi-structured interviews was a sound method as the data elicited were rich and 
provided good information about the role of the ResN.  However, there are always ways to 
improve the way we do things and this section reflects on what I learnt from my first 
interviewing experience. 
 
The technique of using closed questions first to establish rapport with participants worked well 
with ResNs and NMs, but less so PIs, who were generally very busy.  One of the background 
questions intended to establish rapport with the PIs was „Can you tell me which major studies 
you have been involved in, and your role, in the past?‟  One PI, who had been involved in 
many research studies before, offered me their curriculum vitae with a list in lieu of answering 
this question.  This question had the opposite effect on the interview, and it took some time for 
me to settle again.  Because of other commitments, two PIs imposed time limits for the 
interview, and another had to eat their lunch during the interview.  Because of these time 
limitations, I made judgements about which questions were essential.  While all main points 
were covered, thorough discussion about some topics was limited.  Next time, I would consider 
a shorter interview schedule. 
 
Semi-structured interviewing allowed for participants to talk about topics they thought were 
important.  It also meant that interviews often proceeded in a different order to the interview 
schedule and the odd question was omitted or asked differently.  Changes to the way I asked 
some questions also evolved throughout the interviews, although ultimately this did not affect 
the data collected.  The way answers were elicited from the three groups also differed.  The 
ResNs were generally happy to talk around topics, whereas the PIs and NMs tended to just 
answer the questions asked of them.  There was an inclination in all of the interviews for the 
participants to talk about their own role in research, rather than that of the ResN.  This was to 
be expected and most attempts made to bring the interview back to the ResN were successful.   
 
I took the stance not to question participants‟ answers which I believe I achieved.  However, 
questions about which studies ICUs were participating in became more of a statement than a 
question in some of the PI and NM interviews.  In some interviews, the participant didn‟t 
answer a question, even with prompting.  It was difficult to determine the meaning of this.  For 
example did they not know the answer, did they not understand the question or did they 
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disagree with what was stated or did they just not get around to saying it, as I had prompted 
them too soon?  I did however ask for examples and not just opinions. 
 
ResNs who were more experienced and senior spoke with more clarity about the role, and were 
able to identify a range of examples, compared to those who had been in the role for a 
relatively short period of time.  While this clarity was useful, care was taken to give newer 
ResNs‟ views the same weighting as their more experienced colleagues. 
 
There was little time in-between interviews, which was confusing at times, and meant I relied 
heavily on the interview schedules to „keep on track‟.  The use of recordings meant I could 
distinguish responses without reliance on my field notes or memory of the interviews.  This 
was unavoidable due to time constraints of the participants and my own budgetary limitations, 
and while I don‟t think it affected the overall quality of the study, I would not recommend that 
such a tight timeframe is used for future studies of this type. 
 
One ResN said she was disappointed that I hadn‟t asked them to complete the time-in-motion 
diaries, as she found it difficult to recall her previous day, citing how busy the role was, and 
how different the days can be.  This is a valid point, however most ResNs were at least able to 
describe a „typical‟ day in detail.  Another method which had been considered was a document 
analysis of the ResNs‟ job descriptions.  While this would not have made a difference to this 
study, as ResNs reported they did not have accurate job descriptions, it would be a useful 
adjunct, when writing about the management structures and I would recommend this for future 
research. 
 
One aspect of the ResN‟s role which I did not directly address on the interview schedule and 
did not arise in the interviews was whether ResNs were named in publications.  This was an 
oversight as it was noted as an issue in the literature review.  I already knew before starting this 
study that PIs and ResNs who are involved in CTG-endorsed studies are usually listed at the 
back of publications – a stance which must be commended by authors who do this.  ResNs are 
only listed as a named author if they are on the management committee for a study, of whom 
five ResNs were.  I am unaware of ResNs being named on publications resulting from other 
studies, such as commercial trials.  I perhaps incorrectly interpreted that if ResNs did not bring 
this issue up, then they did not view it as important.   
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Responsibility assignment matrix 
Using the RAM was a novel addition to analysing the work that ResNs do.  Overall, its use 
contributed to the study.  In some cases, not all questions related to the RAM had been asked 
and in some cases the participants misunderstood the terms used or did not know or understand 
the specific tasks the ResNs did.  This was evident in the NM interviews.  Adding „Unknown‟ 
as an option was a useful modification for this research.   
 
Analysing data using the RAM from a qualitative method, such as one-to-one interviews was 
difficult.  One of the limitations of this particular model was that it didn‟t reflect the extent to 
which an activity occurred.  An example of this was study recruitment.  When participants 
answered that particular professional groups recruited patients for studies “very occasionally” 
and “seldom” there was no way of articulating this degree of engagement on the matrix.  In the 
case of consent, all participants stated that non-research intensivists obtained patient consents, 
in addition to the research team.  On the RAM, this looks like they actively do, whereas the 
qualitative data from the interviews revealed consents were obtained almost exclusively by the 
ResN or PI in some ICUs.   
 
A short-coming in my own use of the RAM was that it was designed as an analysis tool, and I 
did not validate it before the completed matrices were sent to participants for verification.  
Only later did I realise that „protocol development and design‟ was not listed and so the data 
collected in the interviews were used in the final results. 
 
A modification of the way the tool was used would have been to send the RAM out for the 
participants to fill in themselves.  Given that 93% (n = 13) of those who returned their RAM 
made changes, this may have been an easier option, however; there was potential for low return 
rates and misinterpretation of the tool and tasks.  A disadvantage of asking participants to 
review their RAMs was that collaboration appears to have occurred amongst participants at 
some ICUs.  Although this may have resulted in data changing, enabling a shared 
understanding amongst participant groups must be seen as positive.  The use of the RAM, 
along with qualitative data collection added to the overall depth of understanding, and I would 
recommend its use in a similar study. 
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Recommendations 
Practice recommendations 
Issues regarding employment conditions such as remuneration, on-call payments and line 
management must be addressed.  Ensuring ResNs have an accurate job description and current 
job description is the responsibility of both the individual ResN and of the organisation.  Some 
ResNs need to find out if they have a job description, read it, and determine its accuracy.  If it 
is not accurate, this must be addressed urgently with management.  ResNs must also ensure 
their own professional safety in the domain of consent. 
 
Nursing management in consultation with medical staff, and DHBs‟ legal services must 
address the issue of professional accountability, including indemnity, and who is responsible if 
something goes wrong in a clinical trial.  ResNs should not be put at risk by assuming tasks 
which were once the domain of doctors. 
 
While less urgent, the ambiguity about whether the ResN role was a senior position must be 
addressed by the sector, in order to retain this experienced workforce.  ResNs had specialist 
knowledge (about research) in an already specialised clinical area (ICU) and should not be 
side-lined because management are uncertain where the role fits into the overall structure.   
 
The recommendation that all CTG-endorsed studies have a „research coordinator‟ on the 
management committee is very sound and must continue.  It allows studies to succeed in a 
practical, rather than just theoretical way.  ResNs were also involved in reviewing study 
documents, to ensure the smooth-running of studies.  The CTG must be commended for these 
initiatives which logically increase the success and quality of CTG-endorsed studies.   
Educational recommendations 
As the number of ResNs increase, the appropriateness of the „apprentice‟ style of learning 
about their role must be addressed.  In addition to the research opportunities at universities that 
offer postgraduate studies in nursing, there is now a Postgraduate Diploma in Clinical Research 
(Victoria University of Wellington, n.s.) and a clinical research postgraduate pathway through 
to Masters level at University of Otago (University of Otago, n.s.).  These options may offer an 
avenue for ResNs to pursue academically in the future.  All those who don‟t yet have a Masters 
degree should be supported to do one, and where possible PhDs should be encouraged.   
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Few professional development opportunities for ResNs were identified.  When these 
opportunities do arise, NMs must support ResNs to attend to ensure the ongoing success of 
research in ICU.  The experience amongst ICU ResNs throughout NZ is now considerable, and 
they themselves have established a network, to support newer members.  This work needs to 
continue, and I am aware that there is development of a website affiliated with the NZNO 
Critical Nurses Section.  These opportunities need to be embraced to ensure that ResNs are 
seen as a cohesive group.   
Research recommendations 
Several avenues for further research were identified throughout this thesis.  These concern the 
issue of consent, research culture, knowledge translation and other ICU professionals‟ views 
about research issues in ICU. 
 
The area of consent was contentious, and very reliant upon research staff acting ethically and in 
the best interests of the patients.  I believe research staff in NZ ICUs do act ethically; however 
it would be useful to see how patients feel when they are de-sedated after a prolonged stay in 
ICU only to find they have participated in a research study.  Delayed consent is considered 
essential for conducting research in ICU.  A future study should investigate how often it is used 
in this setting, studying the time it takes to obtain full consent and the number of patients who 
withdraw from trials.  It would be important to see if other staff treated the option of „delayed‟ 
consent with as much care as research staff, who seemed to understand the value of this ability 
to enrol patients into ICU studies without their prior consent was.  Another study should also 
ask patients how they feel when a study shows „no result‟ or worse still a negative result, or a 
positive result when they were in the control group.   
 
Incorporating bedside nurses and non-PI doctors would be a useful adjunct to this study as their 
viewpoint has not been heard.  Although this study has extended the boundaries of what is 
known by seeking the views of the NM and PI, it highlights that ResNs work with many other 
professional disciplines within ICU.  Lack of research culture in ICUs was a significant 
problem and must be investigated in the future.  It would be useful to know what other 
intensivists and nurses in the ICU setting think about research and find out why they didn‟t 
participate more actively.  What are the barriers to conducting research?  Do staff nurses and 
non-research doctors even consider it part of their role?   
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As already stated, this thesis is limited to the ICU setting.  It would be useful to compare their 
role with research nurses working in other settings such as primary and secondary care, 
academic settings and private research companies.  Additionally, the majority of ResNs 
assisted and supported nursing research – a future project could explore the barriers and 
enablers fpr ResNs supporting nursing research.  
 
Future research must also, and to some extent already is, focus on the financial and social 
savings benefits of ICUs participating in research.  Additionally, work must focus on 
translating these research findings into ICU patient care, thus improving outcomes for intensive 
care patients.  The role of the ResN in such practice development work should be explored.  
Finally, the increased value ResNs add to this research through increased recruitment and 
having a dedicated role should be included in these studies. 
Conclusion 
When I began this research, my starting point was my own experience, seeking answers to 
whether my experiences were similar to those of other ResNs.  As an insider in a role which 
participates in research, seeking answers through research was a good solution for my 
questions.  I have learned so much along the way.  By conducting this research, I have learned 
how to do my role better, and I understand the larger environment we work within.  Some of 
my experiences were similar to others, while other ResNs had taken a different path to arrive at 
their individual destination.  What was clear was that they all wanted the same thing, and that 
was to participate in research with the potential to improve the outcomes of ICU patients in a 
way they saw as valuable. 
 
This study will enable ResNs, their PIs and NMs in ICUs around NZ to have a more global 
picture of the role.  There was already literature about the ResN role, but where this study goes 
further, is it has described and given specific examples of exactly how ResNs contribute to 
research in ICU.  This research, in turn, improves outcomes for future ICU patients.  This is an 
important study which celebrates the significant work that ResNs do in NZ ICUs.  It 
demonstrates that they are not only the glue that holds ICU research together but they „make 
research happen‟ on a daily basis.  ResNs enable ICUs to participate in research which is 
imperative not only for improving patient outcomes for ICU patients, but to ensure Level III 
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ICUs fulfil their obligation to be involved in research.  ResNs ensure that patients and their 
families are offered the opportunity to improve the care of future patients.  Major issues that 
ResNs encounter have been identified, and this will pave the way to enhancing and developing 
this role.   
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Hill & MacArthur  2006 
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Spilsbury  et al. 2008 n/a N Y Y Y Y Y Y Y Y Y Y Y Y N Y Y N Y N Y Y Y 18 
 
1 Although the stated return rate was 83%, 1000 people were invited, but only a quarter opened the email and accessed the link.  Of this number, 83% 
participated.(Duane et al., 2007) 
2 Did not use a validated questionnaire 
3 Selection bias present - not overcome, but discussed 
4 Part of questionnaire was validated; part was not 
n/a The type of methodology did not elicit a response rate eg a snowballing recruitment for focus groups 
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Appendix B Interview schedule – research nurses 
A descriptive study about the role of the Research Nurse in 
New Zealand tertiary level ICUs 
 
Questions Interviewer Prompts 
1. Background information and employment 
I would like to start by asking a few background questions. 
1.1 Do you work full or part time? If part-time  
 What hours do you work? 
 Is part-time your choice? 
 What other work do you do? 
1.2 Are you required to work as 
an ICU nurse as part of your 
employment agreement? 
 How necessary do you think it is? 
 Would you if you didn‟t have to? 
 How does it help your research position? 
1.3 Are you on the MECA 
(collective contract)? 
 
 How are you paid if you are an on-call or have to 
come in after hours to enrol a patient? 
 How secure do you feel your job is? 
1.4 Tell me when and why you 
became a research nurse 
Consider: 
 Enjoy research work 
 Convenient hours 
1.5 How long have you worked in 
your current position? 
 
1.6 What positions did you work 
in prior to this Research Nurse 
position? 
 Other Research 
 ICU Nurse 
 Other nursing 
 If not ICU Nurse, what additional challenges do 
you experience? 
1.7 When you first started as a 
research nurse, how did you 
learn what to do in the role? 
How about your ICU role? 
 Formal training or study or qualifications 
 Inservice Education 
 Past experience 
 Orientation – who orientated you? Was it 
sufficient? 
1.8 Is the work what you 
expected when you applied for 
the job? 
 In what ways does it differ? 
1.9 Do you have a job 
description? 
 Do you think is is a true reflection of your role? 
1.10 When did you last have a 
performance appraisal? 
 
 
2. Accountability and Funding 
The next set of questions is more about the way your ICU Research department is 
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structured. 
2.1 How many Research Nurses 
work in your ICU? 
 What FTE is that? 
2.2 How many medical staff are 
Principal Investigators in your 
ICU? 
 
2.3 Tell me about the way the 
Research Department is 
structured in your ICU. 
 Research Nurses 
 PIs 
 Managers 
 Accountant/Finance Person 
 Support Staff 
2.4 Where do you fit into the 
overall ICU structure? 
For example: 
 Are you recognised as a senior nurse? 
 Do you attend unit-wide senior nurse meetings? 
2.5 In your role as a Research 
Nurse, who are you accountable 
to for governance and 
management issues? 
 Who is „in charge‟? 
 Who is your line manager? 
 How involved are they on a day to day basis? 
2.6 How is the research 
department in your ICU funded?  
Is your position funded that way 
too? 
For example: 
 Self funded through studies (trust account) 
 Company sponsored 
 Funded through ICU budget 
2.7 Is there a certain mix of 
studies your ICU likes to do 
because of financial 
considerations? 
For example: 
 1 pharmaceutical sponsored study/CTG studies 
One of the recommendations that the College of Intensive Care Medicine (IC-3) has 
made for tertiary training accredited ICUs is that your ICU should have access to “an 
appropriate level of funding for research coordinators to support the active research 
programme”.   
2.8 What do you think about this 
guideline? 
How do you think it should be 
funded? 
 
2.9 Who manages the finances 
and makes financial decisions for 
the research department within 
your ICU? 
 
2.10 How are meetings such as 
the annual CTG in Noosa 
funded? 
How important do you consider it 
is to attend these meetings to 
help you do your job well? 
 Is it dependent on funds? 
 Funded through study grants? 
2.11 What do you see the role of 
your hospital research 
department as being? 
 How much do you pay for overheads or other 
fees? 
 Does the service they deliver meet your 
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expectations? 
 Any other issues? 
 
3. Research Nursing Role 
Now I will be asking you more about your role and responsibilities as a Research Nurse 
3.1 What studies is your ICU 
currently participating in? 
For example: 
 CHEST 
 EPO-TBI 
 PROWESS-Shock 
 POLAR 
 HEAT 
3.2 Tell me how it works with the 
studies – do you all work on the 
same studies or are you 
responsible for individual ones? 
 Do you all have the same role in every study? 
 Are there parts of a study that one nurse is 
responsible for? 
 How is the allocation worked out? 
 Any issues? 
3.3 What involvement do you 
have in nursing research? 
 Your own projects 
 Other nursing projects 
I‟d like you to think about the last day you worked as a Research Nurse 
3.4 Tell me about what you did 
that day and how.  Think about 
interruptions too. 
 
3.5 Was the day you described a 
typical day? 
Why? 
 
3.6 Can you tell me what sort of 
things could happen on an 
atypical day? 
 
Consider: 
 Protocol Violations 
 Serious Adverse Events 
 Assisting staff with research projects 
 Monitoring 
3.7 What do you think Research 
Nurses bring to research in ICU? 
 What do you consider the most important part of 
your role as a research nurse is? 
3.8 How do you think research 
nurses contribute to patient care 
and outcomes? 
 
You‟re probably aware that in some Australian ICUs and many other clinical areas not all 
Research Coordinators are nurses. 
3.9 How important do you think 
being a nurse is in your role as a 
Research Coordinator in ICU? 
 In what ways? 
A lot of the literature talks about one of the main roles of the Research Nurse as being a 
patient advocate, which is one of our roles as a nurse. 
3.10 Can you tell me about a 
situation in research when you 
had to act as a patient advocate?  
 Was there a time when you would have liked to 
advocate or a patient (in research) but didn‟t feel 
able to? 
3.11 What skills do you think are Consider: 
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necessary for being an ICU 
Research Nurse? 
 ICU clinical skills 
 Research 
 Multi-tasking 
 Communication 
3.12 Have you ever been 
involved in protocol, CRF or 
eCRF development? 
Or on a management committee 
for a study? 
 What do think Research Nurses could contribute 
in these situations? 
3.13 What challenges do you 
face in your role? 
Consider: 
 Staff frustrations 
 Non-adherence to protocol 
 Short of time 
 Paperwork 
The international literature talks about one of the challenges for Research Nurses being 
a sense of isolation they experience.  I‟m interested to see if this is a problem in New 
Zealand ICUs because there are so few of us. 
3.14 Have you ever experienced 
a sense of isolation? 
 Professionally from other staff 
 Geographically isolated from support network 
3.15 If you did feel isolated, what 
things would help or have helped 
in the past? 
 
3.16 In what situations would you 
assist the bedside nurse with 
direct patient care? 
It may or may not be research 
related. 
 
 
Consider: 
 Doing extra bloods when you‟re taking trial 
bloods 
 Helping with turning heavy patients 
 Getting equipment or staff stuck at bedspace or 
in a sideroom 
 Do you help with short-staffing or do lunch 
reliefs? 
 If there was an emergency like a patient you 
were nearby having a cardiac arrest or a patient 
trying to extubated themselves, what would you 
expect to contribute to the arrest situation?   
 
4. Processes around studies 
The next set of questions is about who does each aspect for studies.  I‟ll start with the 
process when you are considering new studies, through to the day-to-day work involved 
in running studies 
4a. Considering new studies 
4.1 Tell me about the process in 
your ICU when a new trial is 
being considered.  
 
 What do you take into consideration (fee being 
offered, whether it‟s cost neutral, clinical relevance, 
areas of interest)? 
 Who is involved in the final decision?   
 Who works out feasibility (budget and number of 
potential patients) of doing a new study? 
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 Is the Research Nurse workload discussed with 
you? 
 
4b. Processes when you are starting a new study 
4.2 Once your unit decides to do 
a study, tell me what happens 
then. 
Who is responsible for the following? 
 Budget 
 Maori approval 
 Locality assessment 
 Ethics application 
 Information Sheet 
 Contract 
 Educates staff 
 Anything else? 
  
4c. Day-to-day Management of 
studies 
 
4.3 Who is responsible for 
maintaining the ongoing ethics 
reporting in your ICU? 
 If you are the lead site, who in your unit does the 
reports to ethics committees? 
 Do you have a system for knowing when these 
are due? 
 If you‟re not the lead site, do you know when 
reports are due? 
4.4 Tell me about recruiting 
patients for studies in your ICU 
 
 Whose role is it? 
 Who identifies patients? 
 Who does the screening log? 
 How do you communicate about missed 
patients? 
 Any issues? 
4.5 What is your role in obtaining 
consent for clinical trials? 
If nurse doesn‟t obtain consent:  
 Who does the consent in your unit? 
 Why don‟t you? 
 Who answers questions that patients have about 
the studies? 
 Any issues with this? 
4.6 Tell me about your 
experience using the delayed 
consent option for any current or 
past studies.   
 What do you think about delayed consent in the 
ICU setting? 
4.7 Tell me about data collection 
and follow-up for studies 
 Who does it? 
 Do ever get help from other staff? e.g. with data 
entry or phone calls 
 Do you think it is/would be appropriate for 
someone other than a research nurse to help with 
this? 
4.8 What is your role when a  Getting ready for monitoring 
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study is being monitored?  Any issues? 
4.9 In what circumstances, if any 
do you delegate research duties 
to staff at the bedside?   
How do you manage this? 
Think about: 
 Blood collection, study drug administration 
 Timing of patient observations 
 
5. Development of the Role  
We‟ve talked at some of our New Zealand meetings about developing the Research 
Nurse role and getting more recognition. 
5.1 What do you think needs to 
happen for the role to be 
developed? 
 Professionally across New Zealand 
 Within your unit 
 Career Pathway 
I‟m not sure if you‟re aware but there is a consultation paper about developing a 
Competency Framework for Research Nurses in New Zealand. 
5.2 Have you read it? 
What do you think about it? 
If not: What do you think about this sort of work 
going on? 
One of the recommendations that the ANZICS Clinical Trials Group have agreed to is 
that there should always be a Research Coordinator on the management committee for 
CTG-endorsed studies. 
5.3 What do you think about this 
recommendation? 
What impact, if any, do you think 
it will have on New Zealand 
Research Nurses? 
 
  
6. End of interview 
Any other comments?  
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Appendix C Interview schedule – principal investigators 
A descriptive study about the role of the Research Nurse in  
New Zealand tertiary level ICUs 
Questions Interviewer Prompts 
1. Background information  
I would like to start by getting some background about your ICU and your work with 
Research Nurses. 
1.1 Can I confirm that your ICU is 
currently participating in the 
following studies? 
(Details completed before each interview) 
1.2 Which of these studies are 
you the PI for? 
 
1.3 Can you tell me which major 
studies you have been involved 
in, and your role, in the past? 
 Role – Chief Investigator, PI, Co-investigator 
1.4 How long have you been 
working as a Principal 
Investigator for ICU studies?   
And have you worked with a 
Research Nurse all of that time? 
 
 
 
 Now that you have worked with a Research 
Nurse, how is it different? 
 
2. Accountability and Funding 
The next set of questions is more about the structure and funding of your ICU Research 
department. 
2.1 I understand that research in 
your ICU is ………………. funded 
 How worried are you about the finances and 
funding of research in your ICU? 
2.2 Who manages the finances 
and makes financial decisions for 
the research department within 
your ICU? 
 
2.3 Is there a certain mix of 
studies your ICU likes to do 
because of financial 
considerations? 
 E.g. 1 pharmaceutical sponsored study/CTG 
studies 
2.4 What is your view about 
funded vs non-funded research? 
 For example, would you consider taking on an 
unfunded study if it was something that as a unit you 
had a particular interest in? 
2.5 Tell me about the way your 
ICU Research Department is 
structured 
 PIs 
 Research Nurses 
 Managers 
 Accountant/Finance Person 
 Support Staff 
 Who is „in charge‟? 
2.6 Where would you say For example: 
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Research Nurses fit into the 
overall ICU structure? 
 Are they recognised as senior nurses? 
 Do they attend unit-wide senior nurse meetings? 
2.7 How important do you think it 
is for Research Nurses to attend 
meetings such as the annual 
CTG in Noosa? 
How are these meetings funded?  
 
 
 
 
 E.g. Trust account or study grants 
2.8 What do you see the role of 
your hospital research 
department as being? 
 How much do you pay for overheads or other 
fees? 
 Does the service they deliver meet your 
expectations? 
 Any other issues? 
 
3. Research Nursing Role 
Now I‟d like to ask you about you more about the role and responsibilities of the 
Research Nurse. 
3.1 Tell me about the role of the 
Research Nurse in relation to 
your role as Principal 
Investigator.   
 
 In what things do you consider they are 
accountable to you?   
 Who is their line manager? 
 Do you work as a team on particular studies? 
3.2 What do you consider their 
role and responsibilities in 
research to be? 
Consider: 
 Compared to the role of the PI 
 Day to day management of studies 
 Does the PI have overall responsibility for 
studies? 
3.3 Do you know how the 
Research Nurses are orientated 
to the role within ICU?  Do you 
assist in this? 
 
3.4 What sort of occupational 
background helps them to fulfil 
the role expectations of an ICU 
Research Nurse? 
 
3.5 Do you think Research 
Nurses should also do bedside 
nursing in ICU on a regular 
basis? 
 What do you think this brings to their role as 
Research Nurses? 
3.6 If the unit was short staffed, 
would you expect the Research 
Nurse to change from research 
duties to clinical duties? 
 Or help out with lunch reliefs or side rooms? 
3.7 If there was an emergency 
like a patient having a cardiac 
arrest or a patient was trying to 
extubated themselves and the 
Research Nurse was nearby, 
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what would you expect the 
Research Nurse to do in this 
situation?   
 
4. Processes around studies 
The next set of questions is to help me get an understanding of who does the various 
aspects required for clinical trials.  I‟ll start with the process when you are considering 
new studies, through to the day-to-day work involved in running studies 
4a. Considering new studies 
4.1 Tell me about the process in 
your ICU when a new trial is 
being considered.  
 
 What do you take into consideration (per patient 
fee, cost neutral, clinical relevance, areas of 
interest)? 
 Who is involved in the final decision?   
 Who works out feasibility (budget and number of 
potential patients) of doing a new study? 
 Is the potential workload discussed with the 
Research Nurse? 
4b. Processes when you are starting a new study 
4.2 Once your unit decides to do 
a study, tell me what happens 
then. 
Who is responsible for the following? 
 Budget 
 Maori approval 
 Locality assessment 
 Ethics application 
 Information Sheet 
 Contract 
 Educates staff (doctors and nurses) 
 Anything else? 
4c. Day-to-day Management of 
studies 
 
4.3 Who is responsible for 
maintaining ongoing ethics 
reporting in your ICU? 
 If you are the lead site, who in your unit does the 
reports to ethics committees? 
 
4.4 Tell me about recruiting 
patients for studies in your ICU 
 
 Whose role is it? 
 Who identifies patients? 
 Who does the screening log? 
 How do you communicate about missed 
patients? 
 Any issues? 
4.5 What is the Research Nurse‟s 
role in obtaining consent for 
clinical trials? 
 Are there any circumstances where you do/don‟t 
think it‟s appropriate for them to obtain consent? 
 Any issues with this? 
4.6 Tell me about your 
experience using the delayed 
consent option for any current or 
past studies.  
 What do you think about delayed consent in the 
ICU setting? 
4.7 Tell me about data collection  Who does it? 
154 
and follow-up for studies  Do you think it would be appropriate for 
someone other than a research nurse to help with 
this? 
4.8 What happens when you 
have protocol violations or 
serious adverse events occur? 
 Who tends to notice them? 
 Who reports them? 
 Who follows up with staff involved? (Doctor or 
nurses) 
4.9 Who‟s responsibility is it to 
prepare for monitoring visits? 
 Any issues? 
 
5. Development of the Research Nurse Role 
One of the recommendations that the College of Intensive Care Medicine (IC-3) has 
made for tertiary training accredited ICUs is that your ICU should have access to “an 
appropriate level of funding for research coordinators to support the active research 
programme”.   
5.1 What do you think of this 
guideline?  
How would you like to see it 
funded? 
 
One of the recommendations that the ANZICS Clinical Trials Group have agreed to is 
that there should always be a research coordinator on the management committee for 
CTG-endorsed studies. 
5.2 What do you think about this 
recommendation? 
What impact, if any, do you think 
it will have in New Zealand? 
 
5.3 What do you think Research 
Nurses bring to research in ICU? 
 
5.4 How do you think research 
nurses contribute to patient care 
and outcomes? 
 
  
6. End of interview 
Any other comments?  
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Appendix D Interview schedule – nurse managers 
A descriptive study about the role of the Research Nurse in  
New Zealand tertiary level ICUs 
 
Questions Interviewer Prompts 
1. Background information  
I would like to start by getting some background about the research work your ICU is 
participating in, and the overall structure of research in your ICU. 
1.1 Can I confirm that your ICU is 
currently participating in the 
following studies? 
(Details completed before each interview) 
 
1.2 Is there any other research 
work going on within the ICU at 
the moment? 
For example: Nursing research 
Investigator-led research studies 
 Are research nurses involved in this sort of 
work? 
 In a support or advisory role? 
1.3 Tell me about the way your 
ICU Research Department is 
structured. 
 Research Nurses 
 PIs 
 Managers 
 Accountant/Finance Person 
 Support Staff 
  
1.4 Where would you say the 
Research Nurses fit into the 
overall ICU structure? 
For example: 
 Are they recognised as senior nurses? 
 Do they attend unit-wide senior nurse meetings? 
 Is the research department considered part of  
ICU or is it a separate department? 
1.5 What is your role in relation to 
the Research Nurses? 
 
 In what things do you consider they are 
accountable to you?   
 Are you their line manager? 
 Who does their performance appraisals? 
1.6 Who manages the research 
that is done in your unit on a day-
to-day basis? 
 All the aspects involved with running clinical 
trials 
 
2. Research Nursing Role 
Now I‟d like to ask you about you more about the role and responsibilities of the 
Research Nurse. 
You have multiple studies going on at any one time.   
2.1 How is it decided which 
research nurse is responsible for 
each study? 
For example: 
 Are they each responsible for a study or do they 
all have the same role in every study? 
  
156 
2.2 What do you know about how 
the research nurse is orientated 
into the role? 
 
2.3  Tell me about what you 
consider to be the role and 
responsibilities of the Research 
Nurse. 
Consider: 
 Day to day management of trials 
 Compared to PI 
 
2.4 What sort of occupational 
background helps them to fulfil 
the role expectations of an ICU 
Research Nurse? 
 
2.5 In what situations would you 
expect the Research Nurse to 
assist the bedside nurse with 
direct patient care? 
It may or may not be research 
related. 
Consider: 
 Helping with turning heavy patients 
 Getting equipment or staff stuck at bedspace or 
in a sideroom 
 Doing routine bloods when they‟re taking trial 
bloods? 
2.6 Do you think Research 
Nurses should also do bedside 
nursing in ICU on a regular 
basis? 
 What do you think this brings to their role? 
2.7 If the unit was short staffed, 
would you expect the Research 
Nurse to change from research 
duties to clinical duties? 
 Or help out with lunch reliefs or side rooms? 
2.8 If there was an emergency 
like a patient having a cardiac 
arrest or a patient was trying to 
extubated themselves and the 
Research Nurse was nearby, 
what would you expect the 
Research Nurse to do in this 
situation?   
 
2.9 What do you think Research 
Nurses bring to research in ICU? 
 
 
3. Accountability and Funding 
The next set of questions is more about the funding of your ICU Research department. 
3.1 I understand that research in 
your ICU is ………………. funded 
 How worried are you about the finances and 
funding of research in your ICU? 
3.2 Who manages the finances 
and makes financial decisions for 
the research department within 
your ICU? 
 
3.3 Is there a certain mix of 
studies your ICU likes to do 
because of financial 
 For example: 1 pharmaceutical sponsored 
study/CTG studies 
 Is the „per patient‟ fee a major factor when you 
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considerations? are considering a new study? 
3.4 What is your view about 
funded vs non-funded research? 
 For example, would you consider taking on an 
unfunded study if it was something that as a unit you 
had a particular interest in? 
One of the recommendations that the College of Intensive Care Medicine (IC-3) has 
made for tertiary training accredited ICUs is that your ICU should have access to “an 
appropriate level of funding for research coordinators to support the active research 
programme”.   
3.5 What do you think of this 
guideline? 
How do you think it should be 
funded? 
 
3.6 How important do you think it 
is for Research Nurses to attend 
meetings such as the annual 
CTG meeting in Noosa, to help 
them do their job well?  
How are meetings like this 
funded? 
 
 
 
 
 
 Is it dependent on funds? 
 Funded through study grants 
 
 
3.7 What do you see the role of 
your hospital research 
department as being? 
 How much do you pay for overheads or other 
fees? 
 Does the service they deliver meet your 
expectations? 
 Any other issues? 
 
4. Processes around studies 
The next set of questions is to help me get an understanding of who does the various 
aspects required for clinical trials. You may or may not know the answer to some of the 
questions as they may be managed at the clinical level.  I‟ll start with the process when 
you are considering new studies, through to the day-to-day work involved in running 
studies.   
4a. Considering new studies 
4.1 Tell me about the process in 
your ICU when a new trial is 
being considered.  
 
 What do you take into consideration (per patient 
fee, cost neutral, clinical relevance, areas of 
interest) 
 Who is involved in the final decision?   
 Who works out feasibility (budget and number of 
potential patients) of doing a new study? 
 Is the potential workload discussed with the 
Research Nurse? 
4b. Processes when you are starting a new study 
4.2 Once your unit decides to do 
a study, tell me what happens 
then. 
Who is responsible for the following? 
 Budget 
 Maori approval 
 Locality assessment 
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 Ethics application 
 Information Sheet 
 Contract 
 Educates staff (doctors and nurses) 
 Anything else? 
4c. Day-to-day Management of 
studies 
 
4.3 Who is responsible for 
maintaining ongoing ethics 
reporting in your ICU? 
 If you are the lead site, who in your unit does the 
reports to ethics committees? 
 If you‟re not the lead site, who would know when 
reports are due? 
4.4 Tell me about recruiting 
patients for studies in your ICU 
 
 Whose role is it? 
 Who identifies patients? 
 Who does the screening log? 
 How do you communicate about missed 
patients? 
 Any issues? 
4.5 What is the Research Nurse‟s 
role in obtaining consent for 
clinical trials? 
 Are there any circumstances where you do/don‟t 
think it‟s appropriate for them to obtain consent? 
 Any issues with this? 
4.6 Tell me about your 
experience using the delayed 
consent option for any current or 
past studies.  
 What do you think about delayed consent in the 
ICU setting? 
4.7 Tell me about data collection 
and follow-up for studies 
 Who does it? 
 Do you think it would be appropriate for 
someone other than a research nurse to help with 
this? 
4.9 What happens when you 
have protocol violations or 
serious adverse events occur? 
 Who tends to notice them? 
 Who reports them? 
 Who follows up with staff involved? (Doctor or 
nurses) 
 
5. Development of the Role 
5.1 What do you think needs to 
happen for the Research Nurse 
role to be developed? 
 Professionally across New Zealand 
 Within your unit 
 Career Pathway 
I‟m not sure if you‟re aware but there is a consultation paper about developing a 
Competency Framework for Research Nurses in New Zealand. 
5.2 Have you read it? 
What do you think about it? 
If not: What do you think about this sort of work 
going on? 
One of the recommendations that the ANZICS Clinical Trials Group have agreed to is 
that there should always be a research coordinator on the management committee for 
CTG-endorsed studies. 
5.3 What do you think about this  
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recommendation? 
What impact, if any, do you think 
it will have in New Zealand? 
5.4 What do you think Research 
Nurses bring to research in ICU? 
 
5.5 How do you think research 
nurses contribute to patient care 
and outcomes? 
 
  
6. End of interview 
Any other comments?  
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Appendix E Information sheet for research nurses 
 
 
Research Nurse  
Information Sheet 
 
A descriptive study about the role of the Research Nurse in New 
Zealand tertiary level Intensive Care Units 
 
 
My name is Diane Mackle.  I have worked at Wellington Hospital Intensive Care 
Unit (ICU) since 1996, and have been a Research Nurse there since 2007. I am 
currently undertaking my Master of Nursing at Victoria University of Wellington 
Graduate School of Nursing, Midwifery and Health.  As part of this, I am completing 
a thesis about the role and responsibilities of the Research Nurse in New Zealand 
(NZ) tertiary level ICUs.   
 
You have been invited to participate in this study because you are currently working 
as a Research Nurse in a tertiary-level ICU. 
 
Ethics approval for the study has been granted by the Victoria University of 
Wellington Human Ethics Committee. 
 
Background 
Research Nurses, also known as Research Coordinators have been employed in 
NZ ICUs since approximately 1995.  Research studies in NZ ICUs are increasing, 
and it is likely that more research nurses will be employed in the future.  This study 
will add to the body of knowledge about research nursing, and will potentially add to 
the overall quality of future research.  It will inform Unit Management, who may be 
considering employing research nurses. 
 
Over time, the Research Nurse role has evolved in an ad hoc manner within 
individual ICUs.  There is little literature about the role and responsibilities of the 
research nurse, and their place in the ICU structure.  International literature has 
focussed on the research nurse role only from the perspective of the research 
nurse.  This study will analyse their role and responsibilities from the perspective of 
Research Nurses, Principal Investigators and Unit Managers.  This study is a 
descriptive study, using semi-structured interviews.   
 
 
What would participating involve? 
Participating in this research would involve being interviewed in person by the 
Principal Investigator about the role and responsibilities of the Research Nurse, and 
the structure of research undertaken within your ICU.  This interview will be semi-
structured, take approximately 1 – 1½ hours and will be digitally recorded with your 
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consent.  The interviews will be conducted at a mutually agreeable time and place 
in March-April, 2011. 
 
A professional transcriber will be employed and be subject to a transcriber 
agreement.  You will be able to view your own transcript if requested, and make 
amendments.  The data will be analysed using content and thematic analysis. 
 
Tertiary level ICUs are commonly known within the ICU community, as are the 
research staff.  Findings will be aggregated by theme, and quotations will be 
reported by research role and number.  Attention will be given in the presentation of 
results to remove all identifiable language patterns or content data.  While every 
effort will be made to maintain confidentiality, there is the potential for identifiability 
of who has participated in the study. 
 
 
Who will have access to the recordings, transcripts and field notes? 
The only people who will hear the recordings or see the transcripts and field notes 
will be the Principal Investigator, my research supervisor, and the transcriber.  The 
transcripts and recordings will be kept in a locked cupboard until 2 years after the 
completion of the thesis.  After this time they will be destroyed. 
 
 
Publication 
In addition to my thesis, it is my intention to publish the findings of this study in a 
New Zealand nursing journal and present at ICU and Research conferences and 
forums. 
 
 
If you have any questions about the study, please contact: 
 
Diane Mackle (Principal Investigator) 
Specialty Nurse – Research 
Intensive Care Unit 
Wellington Regional Hospital 
Private Bag 
Wellington South    
Email: xxxxxxxxxxxxxxxxxxxxxxxx 
Phone xxx xxx xxxx 
 
 
Dr Katherine Nelson (Supervisor) 
Senior Lecturer 
Graduate School of Nursing, Midwifery & Health 
Victoria University of Wellington  
P.O. Box 7625 
Wellington 6242 
Email: xxxxxxxxxxxxxxxxxxxxxxxx 
Phone xx xxx xxxx 
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Appendix F  Consent form for all participants 
 
 
CONSENT FORM 
 
A descriptive study about the role of the Research Nurse 
in New Zealand tertiary level ICUs 
 
I have been provided with adequate information relating to the nature and objectives of this 
research project.  I have understood that information, and have been given the opportunity 
to seek further clarification or explanations. 
 
I understand that the information I provide and the digital recording of the interview will be 
kept confidential to the interviewer and her supervisor. 
 
I understand that what I say in the interview will be confidential.  Every effort will be made 
to protect my confidentiality and that of the ICU I work in.  However, given the small size of 
the ICU research community, it is possible that I may be identifiable as a participant. 
  
I understand that I do not have to answer any questions which I am not happy with or think 
could potentially identify the ICU I work in or me. 
 
I agree to be interviewed for the above study and for the interview to be digitally recorded. 
 
I am aware that I can withdraw from the study up to 2 weeks after the interview or after 
receiving the transcript.  If I withdraw, the digital recording and transcript will be destroyed.  
 
On completion of the project I understand that Diane Mackle will contact me and inform me 
of where I can access a copy of the completed thesis, should I wish to read it. 
 
 
I would like the opportunity to review the transcript of my interview.    YES/NO 
 
I would like a summary of the results of this study.     YES/NO 
 
 
 
Name of Participant  …………………………………………………….. 
 
Address for transcript/results …………………………………………………… 
 
    …………………………………………………….. 
 
    …………………………………………………….. 
 
Signature of Participant …………………………………………………….. 
 
Date    …………………………………………………….. 
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Appendix G Information sheet for principal investigators and nurse 
managers 
 
 
Principal Investigator and Unit Manager  
Information sheet 
 
A descriptive study about the role of the Research Nurse in New 
Zealand tertiary level Intensive Care Units 
 
 
My name is Diane Mackle.  I have worked at Wellington Hospital Intensive Care 
Unit (ICU) since 1996, and have been a Research Nurse there since 2007. I am 
currently undertaking my Master of Nursing at Victoria University of Wellington 
Graduate School of Nursing, Midwifery and Health.  As part of this, I am completing 
a thesis about the role and responsibilities of the Research Nurse in New Zealand 
(NZ) tertiary level ICUs.   
 
You have been invited to participate in this study because you are currently working 
as Principal Investigator (or have recently) for a research study or are a Unit 
Manager responsible for a Research Nurse in a tertiary-level ICU. 
 
Ethics approval for the study has been granted by the Victoria University of 
Wellington Human Ethics Committee. 
 
Background 
Research Nurses, also known as Research Coordinators have been employed in 
NZ ICUs since approximately 1995.  Research studies in NZ ICUs are increasing, 
and it is likely that more research nurses will be employed in the future.  This study 
will add to the body of knowledge about research nursing, and will potentially add to 
the overall quality of future research.  It will inform Unit Management, who may be 
considering employing research nurses. 
 
Over time, the Research Nurse role has evolved in an ad hoc manner within 
individual ICUs.  There is little literature about the role and responsibilities of the 
research nurse, and their place in the ICU structure.  International literature has 
focussed on the research nurse role only from the perspective of the Research 
Nurse.  This study will analyse their role and responsibilities from the perspective of 
Research Nurses, Principal Investigators and Unit Managers.  This study is a 
descriptive study, using semi-structured interviews.   
 
What would participating involve? 
Participating in this research would involve being interviewed in person by the 
Principal Investigator about the role and responsibilities of the Research Nurse, and 
the structure of research undertaken within your ICU.  This interview will be semi-
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structured, take approximately 1 hour and will be digitally recorded with your 
consent.  The interviews will be conducted at a mutually agreeable time and place 
in March-April, 2011. 
 
A professional transcriber will be employed and be subject to a transcriber 
agreement.  You will be able to view your own transcript if requested, and make 
amendments.  The data will be analysed using content and thematic analysis. 
 
Tertiary level ICUs are commonly known within the ICU community, as are the 
research staff.  Findings will be aggregated by theme, and quotations will be 
reported by research role and number.  Attention will be given in the presentation of 
results to remove all identifiable language patterns or content data.  While every 
effort will be made to maintain confidentiality, there is the potential for identifiability 
of who has participated in the study. 
 
Who will have access to the recordings, transcripts and field notes? 
The only people who will hear the recordings or see the transcripts and field notes 
will be the Principal Investigator, my research supervisor, and the transcriber.  The 
transcripts and recordings will be kept in a locked cupboard until 2 years after the 
completion of the thesis.  After this time they will be destroyed. 
 
Publication 
In addition to my thesis, it is my intention to publish the findings of this study in a 
New Zealand nursing journal and present at ICU and Research conferences and 
forums. 
 
If you have any questions about the study, please contact: 
 
Diane Mackle (Principal Investigator) 
Specialty Nurse – Research 
Intensive Care Unit 
Wellington Regional Hospital 
Private Bag 
Wellington South    
Email: xxxxxxxxxxxxxxxxxxxxxxxx 
Phone xxx xxx xxxx 
 
 
Dr Katherine Nelson (Supervisor) 
Senior Lecturer 
Graduate School of Nursing, Midwifery & Health 
Victoria University of Wellington  
P.O. Box 7625 
Wellington 6242 
Email: xxxxxxxxxxxxxxxxxxxxxxxx 
Phone xx xxx xxxx 
Wellington 6242 
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Appendix H Transcriber agreement 
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Phone  0-4-463 5676 
Fax  0-4-463 5209 
Email Allison.kirkman@vuw.ac.nz 
Appendix I  Ethics approval 
 
 
TO Diane Mackle 
COPY TO Kathy Nelson 
FROM Dr Allison Kirkman, Convener, Human Ethics Committee 
 
DATE 25 March 2011 
PAGES 1 
 
SUBJECT Ethics Approval: 18345 The Role of the Research Nurse in 
Level 3 Intensive Care Units in New Zealand - a descriptive 
study 
 
Thank you for your application for ethical approval, which has now been considered by the Standing 
Committee of the Human Ethics Committee.  
 
Your application has been approved from the above date and this approval continues until 31 July 
2012. If your data collection is not completed by this date you should apply to the Human Ethics 
Committee for an extension to this approval. 
 
 
 Best wishes with the research. 
 
 
 Allison Kirkman 
 Human Ethics Committee  
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